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ABSTRACT
N-linked glycosylation is a ubiquitous protein modification involved in a wide range of cellular
functions and diseases (Varki, 1993). The oligosaccharyl transferase (OTase), the principle
enzyme responsible for catalysis of N-linked glycosylation, facilitates the transfer of a pre-
assembled oligosaccharide from a polyprenyl-lipid donor to the side-chain nitrogen of asparagine
acceptors. In a majority of eukaryotes the OTase is a multimeric, membrane-bound complex,
which has precluded detailed structural and mechanistic studies. The discovery of a homologous
bacterial N-linked glycosylation system in 1999 provided new opportunities to study the
fundamental biosynthetic and mechanistic components of the process. Specifically, the bacterial
OTase, PglB, is monomeric and homologous to the catalytic subunit of the eukaryotic OTase.
The following chapters describe studies designed to learn about the OTase transfer reaction using
PglB as a model. Optimization of expression and purification of PglB is first described, as initial
expression of PglB in E. coli showed poor yields and instability upon purification. Bioinformatic
analysis was performed to define sequence regions of functional importance and to ascertain the
extent of homology between PgIB and other OTases, which verified the value of Pg1B studies for
understanding OTases generally. The bioinformatics analysis was based on topology predictions
for PglB and various homologs. The general conservation in OTase membrane configuration was
used to structurally guide and simplify sequence analyses for a large number of diverse OTases.
The method revealed highly conserved motifs within the soluble loops appearing between
transmembrane domains and biochemical analysis was carried out to establish the functional
importance of these domains. These results were published concurrently with an independently
determined X-ray crystal structure of PgIB, which validated and complemented the bioinformatic
and biochemical results. Subsequently, a sensitive luminescent assay was designed and
developed as a way to investigate the dynamics of substrate binding and conformational changes
in the OTase reaction. Initial results demonstrate the informative value of the system.
Measurements using this system will be continued by Imperiali lab members.
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CHAPTER 1:
INTRODUCTION
20
Asparagine-linked glycosylation: significance, applications, and progress
Asparagine-linked glycosylation (Ngl) is a ubiquitous, complex protein modification
found in all domains of life [1,2]. While details vary with regard to function, structure, and
identity of N-glycans between organisms, a general biosynthetic infrastructure is conserved
(Figures 1, 2) [3]. A series of glycosyl transferases sequentially add specific monosaccharides to
a polyprenyl-phosphate or polyprenyl-diphosphate lipid carrier. The result is a specific core
oligosaccharide anchored to the membrane by a phosphate- or diphosphate-polyprenyl carrier,
which serves as the donor substrate in the N-glycosylation of proteins.
The N-glycosylation reaction is catalyzed by the oligosaccharyl transferase (OTase),
which transfers the core oligosaccharide to select asparagines appearing within the consensus
sequence Asn-Xaa-Ser/Thr, in which Xaa represents any amino acid other than proline [4]. In the
vast majority of eukaryotes, the OTase is a multi-subunit, integral-membrane complex that
interacts with the translocon and transfers the core oligosaccharide to asparagines within the
nascent polypeptide chain (Figure 3) [5-7]. In the species of Gram-negative bacteria known to
possess a pathway for protein N-glycosylation, such as Campylobacterjejuni, the transfer
reaction occurs on the periplasmic face of the inner membrane by a single-subunit, integral-
membrane OTase. There is some evidence that the process occurs post-translationally and post-
translocationally in bacteria, although there are still very limited studies addressing this issue
with diverse proteins [8]. Nearly all eukaryotes transfer the conserved tetradecasaccharide
Glc 3Man9GlcNAc 2 (Figure 4). After transfer, the tetradecasaccharide is modified, abridged or
extended in the ER and Golgi, resulting in proteins with a diversity of glycan structures. In
contrast, the structure of the core oligosaccharide varies for different bacterial species, though no
further modification occurs after transfer to a protein [9,10].
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Figure 1: The N-linked glycosylation biosynthetic pathway in S. cerevisiae.
Monosaccharides are sequentially added by a series of glycosyl transferases to form dolichyl-
diphosphate-Glc 3MangGaNAc2. Synthesis begins in the cytoplasm and is completed in the
lumen after action of a flippase. The completed glycan is transferred by the OTase to
asparagines within the consensus Asn-Xaa-Ser/Thr (Xaa Pro).
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Figure 2: The N-linked glycosylation biosynthetic pathway in C. jejuni.
The core oligosaccharide is GlcGalNAc5Bac, where Bac is Bacillosamine, or 2,4-diacetamido-
2,4,6-trideoxyglucose. The polyprenyl carrier is undecaprenol.
The structural diversity of eukaryotic N-glycans accounts for the involvement of Ngl in
diverse cellular functions [11]. The addition of the core oligosaccharide is a cotranslational
process; thus, the addition of the chemical group affects the energy landscape of sampled
polypeptide configurations and accordingly plays a major role in protein folding [9,12-14]. The
presence of the glycan goes on to affect critical structural aspects of the protein, including
stability, solubility, and myriad forms of interactions [12,15-19]. Not only does the glycan affect
protein-protein interactions, but it is frequently a determining factor in protein trafficking and
localization, signaling, and the functionality of the protein [20-26]. Ngl, which is exclusive to
proteins synthesized on the ER membrane, largely affects cell-surface and secretory proteins.
Consequently, Ngl is extensively associated with broad, multicellular processes, specifically the
immune response, signal transduction, cell migration and cell-cell interactions [23,27-31].
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Figure 3: The cotranslational process of eukaryotic N-linked glycosylation.
The OTase is a multi-subunit membrane-bound protein complex that interacts with the
translocon machinery, scans the nascent peptide chain, and transfers the glycan to select
asparagines in the consensus Asn-Xaa-Ser/Thr sequence (Xaa # Pro).
Ngl is of major interest to researchers due to the varied and critical role that it plays in
human health and disease. The host Ngl pathway is frequently involved in the maturation and
secretion of proteins made by intracellular pathogens; for example, glycosylation of viral
envelope proteins allows many viruses to evade immune detection and invade new cells, with
key examples including Influenza A and Human Immunodeficiency Virus (HIV) [32-36]. The
ability of influenza to rapidly evolve new strains that continually challenge the immune system is
often due to the alteration of the position or presence of Ngl at specific sites within viral coat
proteins [35,37-41]. Similarly, Ngl of envelope proteins accounts for antibody neutralization by
HIV [13,34,42,43]. The bacterial pathogen Campylobacterjejuni, a major cause of
gastroenteritis, requires its innate Ngl pathway for effective colonization and invasion of host
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cells [44-46]. Proper functioning of the immune response in mammals also depends greatly on
Ngl of key proteins such as IgG antibodies and the major histocompatibility complex (MHC);
hence, autoimmune in addition to numerous congenital disorders have been linked to dysfunction
of the Ngl pathway [47-51]. Regrettably, variability in disease phenotypes complicates diagnoses
and hinders informative genetic screens, leaving many of the disorders ill-defined [52-55].
Conversely, the variable nature of Ngl makes it a useful indicator of cell state: cellular
profiles and serum markers of N-glycosylation represent prospective methods for diagnosing
disease states or stages of cancer progression [56-59]. Many promising methods are being
evaluated for utility in better understanding correlations of Ngl with different diseases [22,60-
63]. Additionally, researchers have positively used Ngl in developing and improving drug
efficacy and in modifying protein properties for research purposes [15,27,64,65].
Correspondingly, considerable research is directed toward development of a system to synthesize
glycosylated proteins robustly and with a high degree of control and specificity [66-69].
SGlycan
- (tetradecasaccharide)
-a / I.3 PIA '*
S 'r113 VIA A P-0-I0
Diphosphate
linker
ml0..
Lipid
(in ER membrane)
(Dolichol)
Figure 4: Structure of the polyprenyl-diphosphate-glycan substrate common in eukaryotes.
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Despite the importance of Ngl in so many cellular processes, little is known about the
details of the process relative to other common protein modifications such as phosphorylation,
0-linked glycosylation, and ubiquitination. The factors that determine which appearances of the
consensus sequon will be successfully glycosylated are not well understood, preventing the
prediction of site occupancy from protein sequence. It is unknown which factors influence the
nature of modifications for specific glycosylated sites on proteins. The effect of specific glycan
structures on the ultimate function of the modified proteins is also unpredictable.
OH
OH OH OHOH
0 Q
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HO OH HO OH
OH HOA H HO OH
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HO OH
Glucuronic Acid (GNcA) N-acetyl-glucosamine (OlcNAc) N-acetyl-neuraminic Acid (N(yAc)
OH OH
OH
HO OH H HO .A.U"~..~~~OH
AN H HO OH
OH
N-acetyl-galactosamine (GaINAc) Fucose (Fuc) Xylose (Xyl)
Figure 5: Structures of biologically relevant monosaccharides in eukaryotes.
The minimal understanding of N-linked glycosylation can be explained by a number of
factors. Carbohydrates are structurally challenging and diverse, and characterization of a specific
oligosaccharide requires knowledge of the length, sugar composition, order, and the position and
stereochemistry of each glycosidic linkage. In eukaryotes, there is a known group of
monosaccharides that most commonly is associated with biological function (Figure 5).
However, bacteria and particularly archaea are increasingly expanding this paradigm, which
increases the number of possible structures that must be considered when characterizing a novel
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glycan [70,71]. Characterization of glycan presents many challenges due to the role of
stereochemistry in identifying each sugar. Multiple monosaccharides may have the same mass
and molecular formula and differ only in the stereochemistry of a single C-OH bond (such as in
the case of glucose and galactose, Figure 6). Yet this single difference has enormous effects on
determining the function and interactions of the sugar molecule. The multiple sites on a
monosaccharide available for linkage to additional sugars result in an extremely high number of
possible structures. The stereochemistry of each sugar-sugar linkage, along with branching
locations and sugar identities, are similarly critical in determining oligosaccharide structure and
function (Figure 6). Characterization of an unknown glycan can quickly become overwhelming
upon consideration of the diversity of possible structures and the stereochemical details required
to fully describe an oligosaccharide [72]. Further complexity results from the fact that a
particular protein can be heterogeneously glycosylated at one or more sites.
Monosaccharides Glucose vs. Galactose
OH O&H
(Stereochemical determinants) HO"OH H OH
HOO
OH 'OH
Linkages
Location of addition
Branching
Stereochemistry H
00 0 H0H OR H HO H O HO
I OO HO OH oil OH00
'OHH OH HO RO 0._-4"
o 1l OH
Figure 6: Structural complexity of monosaccharides and oligosaccharides.
Stereochemical and isomeric properties cannot be evaluated using mass spectrometry.
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The stereochemistry of a molecule cannot be ascertained using mass spectrometry, which
reduces the number of methods available for identifying carbohydrates. Methods used to identify
a particular oligosaccharide include NMR and enzymatic and chemical separation steps in
addition to mass spectrometry. Determining the identity of an individual oligosaccharide requires
direct analysis because carbohydrates are not template-driven products (as opposed to proteins
and nucleic acids); therefore, direct purification and examination of material from biological
sources is often required. When chemical and enzymatic steps are used, the material available for
late-stage examination is reduced, which can be particularly problematic provided the quantity of
material necessary for conclusive NMR analysis. Thus, low sample quantities and a shortage of
sufficiently sensitive instruments have significantly stymied characterization of N-linked
glycosylation.
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The oligosaccharyl transferase
Despite challenges, the methods used to analyze oligosaccharides have advanced
remarkably in sensitivity and reliability over the last decades. In addition, progress has been
made in classifying the common Ngl structures and linking structural classes to particular
functions [71,72]. Continued progress would be facilitated and accelerated greatly by successful
development of Ngl inhibitors and other small molecules allowing control of enzyme activation
for in vivo studies. A realm of prospective strategies using protein engineering has been
suggested, such as modifying enzyme specificity for investigation of glycotherapeutics and
enhancement of in vitro activity for rapid, homogenous glycosylation of proteins, which could be
applied toward improving therapeutic effects of current protein therapies and optimizing those of
novel drugs [73-75]. The biophysical impacts of glycosylation on proteins, such as enhancement
of solubility and effects on stability and folding, also present opportunities for pursuing general
strategies to control, study, and optimize proteins for a range of applications [74].
However, these multifold uses require the ability to produce homogenous and efficient
protein glycosylation, which necessitates an understanding of the enzymes that accomplish the
tasks in nature. In addition to the intrinsic complexity of oligosaccharides described above,
additional impediments to Ngl research result from the nature of the involved enzymes. Both
biosynthetic and modifying Ngl enzymes are diverse, numerous, and frequently membrane-
associated, making isolation and characterization challenging. Consequently, structural and
mechanistic characterization of key enzymes remains elusive.
In 1999, the first bacterial system of N-linked glycosylation was discovered in the
enteropathogen Campylobacterjejuni. Prior to this discovery, the process was thought to exist
exclusively in eukaryotes and archaea [76]. The presence of an N-linked glycosylation pathway
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represented a breakthrough in the field of Ngl research; the evolutionary conservation further
validates the importance of the modification throughout all domains of life, and the existence of
a bacterial system has potential to function as a simplified model to study. Since then, the N-
linked glycosylation pathway in C. jejuni has successfully been functionally transferred to E.
coli, characterized and established as a relatively accessible model system of Ngl [77-84]. A
comparison of the pathways depicted in Figures 1 and Figure 2 reveals fundamental similarities,
though also apparent is the increased complexity of the Ngl system in S. cerevisiae relative to
that in C. jejuni.
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Figure 7: Comparison of the OTases in C. jejuni (bacteria) and S. cerevisiae (eukaryotes).
Images highlight the similarity between the S. cerevisiae catalytic subunit 'STT3' and Pg1B.
Figure 7 compares the eukaryotic and the prokaryotic OTases. In C. jejuni, the OTase,
PglB, is a single-subunit enzyme, while the eukaryotic OTase is composed of at least eight
subunits, all of which are membrane-bound and five of which are required for function.
Importantly, the catalytic subunit of the eukaryotic OTase, Stt3, is homologous to PglB. As
described in the following chapters, homology between all Stt3 subunits and monomeric OTases
is far more extensive than originally imagined [85,86]. Additionally, the fundamental chemical
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nature of the transfer reaction is conserved (Figure 8). However, the substrates differ; the
heptasaccharide in C. jejuni is simpler than the eukaryotic tetradecasaccharide (Figures 4, 8).
Thus, PglB presents an exceptional opportunity for learning about the fundamental biochemistry
involved in asparagine glycosylation, as well as studying the effects of Ngl in bacteria and as a
tool for protein engineering and high-level N-glycoprotein synthesis [67,87].
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Figure 8: N-linked glycosylation transfer reaction in C. jejuni.
Top: In C. jejuni, PglB transfers the heptasaccharide GlcGalNAc5Bac (Bac is di-N-acetyl-
bacillosamine or 2,4-diacetamido-2,4,6-trideoxyglucose) to the polyprenyl lipid. The eukaryotic
transfer reaction is similar except the Bac sugar is GlcNAc and the R-group is -
GlcNAcMan 9Glc 3 (Figure 4). Bottom: Structure of the full heptasaccharide from C. jejuni,
shown linked to the nitrogen on the asparagine side chain.
The recent structural and biochemical data published on PglB show the motifs
responsible for catalysis are conserved throughout all domains of life, solidifying its role as an
important and general mechanistic model for N-linked glycosylation (Figure 9) [85,86]. The
publication of the crystal structure of a close homolog of PglB from Campylobacter lari
represents a reliable model for PglB in C. jejuni, as the protein sequences are highly similar
(Figure 10) [86]. The crystal structure is resolved to 3.5 A and shows the placement of the major
conserved loop motifs in the vicinity of one another, forming a presumed active site (Figure 9)
[86].
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Figure 9: Topology model of PglB agrees with X-ray structure data.
Top. Topology model of PglB showing locations of conserved motifs. Model is based on a
combination of topology prediction and conservation of loop regions and agrees with the C. lari
crystal structure (shown right, PDB:3RCE). The N-terminus is located in the cytoplasm Bottom.
Alignments of conserved residues and motifs that informed the topology model above.
Alignments include a selection of representative sequences. The corresponding residue number
in PglB (C. jejuni) is designated in superscript. Alignments and conservation histograms shown
were made using Jalview multiple alignment editor. (doi: 10.1093/bioinformatics/btpO33).
Histogram shading: light to dark designates most to least conserved.
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However, the structure provides very little conclusive information on the mechanism of
the OTase. Unfortunately, in vitro activity is not shown for the purified enzyme and it is unclear
whether the structure represents an active conformation. Additionally, the 3.5- A resolution
leaves uncertainty in the positioning of the side chains and potential hydrogen bonding networks.
At this resolution, it is impossible to differentiate between the nitrogen and the oxygen on the
side chain of the nucleophilic asparagine. The structural data also lacks one of the major loops
expected to be involved in catalysis (designated EL5, containing the I/V-xx-S/T-I/V-E motif).
The loop is unresolved due to flexibility and mobility of the region; though the conservation of
its length and amino-acid content implies this very mobility may implicate the loop in a
conformational change of the enzyme upon binding or release of the substrate.
The conditions of the crystallization provide further reasons to interpret the structural
data with skepticism; the pH of crystallization is 9.4, which is not representative of the state of
the active enzyme in vivo and increases uncertainty with respect to the charge of key amino acids
and thus the ability of the enzyme to adopt an active conformation or participate in necessary
acid-base-type chemistry. Like many membrane-protein crystal structures, the structure of PglB
was determined in the absence of its native lipid environment. The detergent micelles
surrounding the PglB monomers bear little resemblance to a membrane bilayer, casting further
doubt on whether the structure represents the active enzyme.
The peptide shown bound in the PglB crystal structure has been assumed to represent a
picture of the native binding behavior of PglB to its substrate, and mechanistic arguments were
made based on this assumption [86]. However, there are multiple reasons to call this assumption
into question. First, the structure is solved for only a single conformation in the presence of
substrate peptide, yet it remains unknown in which order the peptide and oligosaccharide
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substrates bind, and thus it is uncertain whether the conformation and interactions are
representative of the active state. As noted above, the activity of the crystallized enzyme fraction
has not been shown, calling into question the biological relevance of the enzyme-substrate
interaction [86].
It is also important to note that N-glycosylation in C. jejuni has not been determined as
occurring co- or post-translocationally. The system in S. cerevisiae is co-translational and co-
translocational; the OTase closely interacts with the translocation machinery, which feeds to the
OTase the nascent peptide chain. N-glycosylation by PglB has shown capability in vitro of
glycosylating exposed, flexible loops on fully folded proteins, which has led to a hypothesis that
PglB glycosylates proteins post-translocationally and after periplasmic folding [8]. Nonetheless,
evidence beyond in vitro capability is lacking; thus, it is unclear whether PglB is associated with
translocational or other cellular machinery when glycosylating proteins and whether that
interaction affects binding of the substrate. Therefore, the nature of the peptide-substrate bound
in the crystal structure of PglB is further drawn into question.
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Figure 10: Alignment of PglB sequences from C jejuni and C lari.
Alignment constructed using ClustalW. Gene identifiers of sequences: C. lari gi:7410986;
C. jejuni gi:218562740
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The peptidyl substrate of the oligosaccharyl transferase
As discussed above, the X-ray crystal structure of the OTase in the presence of bound
substrate peptide (Ac-Gly-Asp-Gln-Asn-Ala-Thr-Gly-pN-Phe, where pN-Phe is para-nitro
phenylalanine, [83]) represents a remarkable achievement, though also leaves significant
uncertainty with regard to speculative mechanistic conclusions [86]. Particularly, an ongoing
question has revolved around the function of the consensus sequence of the peptide substrate,
Asn-Xaa-Ser/Thr, in which Xaa can be any amino acid other than proline.
Substantial biochemical evidence exists to support the formation of a specific
conformation of the consensus sequence. Figure 11 shows the possible local conformations that
a peptide containing the minimal consensus sequence may adopt [88]. The Asx-turn involves
hydrogen bonding between the carbonyl oxygen of the side-chain of asparagine and the proton
donors on the hydroxyl side chain and backbone amide of the amino acid at the +2 site. The p-
turn, conversely, does not include interactions between the asparagine side chain and other
chemical groups within the consensus sequon, and intramolecular interactions consist largely of
backbone hydrogen bonds.
Asx-type P-type
H2N 0
...H H R H R
H2N HO Q<OH
2 NH 2
Figure 11: Comparison of the Asx-type and p-type turn peptide Ac-Asn-Xaa-Thr-NH 2.
Figure adapted from [89].
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Several mechanisms have been proposed that implicate the Asn-Xaa-Ser/Thr consensus
sequon in the activation of the asparagine side-chain nitrogen, which is usually a very poor
nucleophile. A proposal by Marshall suggests that the hydroxyl group of the Ser/Thr residue
engages in a hydrogen bond with the carbonyl oxygen of the asparagine side chain, which
promotes deprotonation of the amide nitrogen and subsequent nucleophilic attack (Figure 12-A)
[90]. Bause proposes that the amide nitrogen of asparagine engages in a hydrogen bond with the
hydroxyl group of the Ser/Thr residue, facilitating deprotonation of the amide nitrogen upon
attack of the hydroxyl proton by a general base (Figure 12-B) [91]. A third mechanism has been
formally proposed by Imperiali, which implicates the formation of the Asx-type conformation in
the activation of the amide nitrogen (Figure 12-C) [92,93]. In this scheme, the carbonyl on the
Asn side chain is engaged in hydrogen bonding with protons on the hydroxyl side chain in the +2
position and a backbone nitrogen amide proton, which shifts the electron density away from the
nitrogen toward the carbonyl group. The pKa of the nitrogen protons is therefore lowered,
facilitating removal of a proton by a basic group and freeing a nitrogen electron pair for
subsequent attack of the electron-poor phosphate-linked carbon on the first sugar of the
oligosaccharide [92,93].
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Figure 12: Proposed OTase mechanisms. A) Marshall. B) Bause. C) Imperiali.
Reasons to favor the mechanism proposed by Imperiali include the substantial evidence
that the peptidyl substrate adopts the Asx-type conformation when binding the OTase.
Importantly, in vitro characterization of tetrapeptides has shown that the P-type turn is favored
and the Asx-type turn conformation is structurally prohibited when a proline is present at the i+2
position [94]. This structural requirement accounts for the fact that the OTase can turn over the
consensus sequence peptide with any amino acid at this position except proline [4]. The
interactions between the side chains of the two consensus residues in the sequon also provide an
explanation of the strict consensus requirement. Notably, the involvement in catalysis explains
absolute requirement for asparagine over glutamine. Given the chemical similarity of the amino
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acids, it is striking that glutamine is not accepted by the OTase even as a weak substrate [83].
The central role of the Asx-turn in catalysis would require the precise alignment of chemical
groups to achieve the activation of the poorly nucleophilic nitrogen, thus explaining this rigid
specificity. The catalytic role is also highly plausible given the fact that the consensus sequence
is conserved in all systems of N-linked glycosylation, as it is far more likely that an enzyme
evolves the specificity of binding interactions over time than the chemical mechanism.
In addition to these observations, rigorous biochemical studies have been performed that
support the suggested mechanism (Figure 12-C) [93]. Particularly, the use of synthetic peptide
chemistry in the creation of constrained peptides provides a convincing method for testing the
Asx-turn mechanistic proposal [88,89,92,94]. Figure 13 shows four peptides synthesized in a
fashion that structurally bias the consensus sequon into formation of a P-type or an Asx-type turn
conformation. Two P-type peptides were synthesized using the prolyl-D-amino acid dipeptide to
circularize and constrain the structure (Figure 13, structures 1 and 2). NMR and CD studies were
performed to support the presence of the predicted conformations [88,89,92,94]. Two additional
peptides were synthesized and constrained via oxidation of thiol groups (Figure 13, structures 3
and 4) [92]. Structural studies confirmed the predicted Asx-type conformation for 4. Peptide 3 is
not highly constrained to form the Asx-turn; however, it is incapable of forming the P-type turn
and due to its flexible nature the peptide is expected to be capable of adopting the Asx-turn [92].
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Figure 13: Structures of peptides constrained to bias formation of Asx-type or P-type turn.
Peptides 1 and 2 are shown in the P-type conformation. Peptides 3 and 4 are shown in the Asx-
conformation, which is stabilized by the constrained structure of the peptide. The predicted
conformations of peptides 1, 2, and 4 were validated using NMR and CD. Peptide 3 is not fixed
as an Asx-type turn; however, the peptide is restricted from formation of the alternate P-type
conformation and the flexibility of the peptide suggests that it is capable of adopting the Asx-
type conformation. Kinetic results show that 1 and 2 are not substrates for the OTase, while 3
and 4 are substrates and show similar kinetic parameters to control substrate peptides containing
the consensus motif [92].
The constrained peptides shown in Figure 13 were subjected to kinetic analysis. Activity
studies showed that 1 and 2 are not accepted as substrates by the OTase, while 3 and 4 have
kinetic parameters similar to standard substrate peptides [92]. The results described above are
supplemented by kinetic studies showing potent inhibition by non-substrate peptides adopting
the Asx-turn type conformation [95]. Additional substrate-specificity studies suggest the
absence of a formal negative charge occurring during the catalytic reaction, which is supported
by the mechanism proposed in Figure 12-C [93].
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The experiments discussed above provide convincing evidence of the role of the Asx-turn
in the OTase catalytic mechanism. Nonetheless, publication of the C. lari crystal structure shows
the bound peptide in a conformation dissimilar to the Asx-turn, and the authors conclude that the
mechanism does not involve adoption of the Asx-turn. Instead, the consensus Asn-Xaa-Ser/Thr
consensus sequence is explained by the binding interactions of the peptide with the conserved
Trp-Trp-Asp-Xaa-Gly (WWDxG) motif [86].
An argument posed against the Asx-turn requirement for OTase catalysis include the
existence of exceptions to the consensus rule, in which non-canonical consensus sites are
successfully glycosylated [2]. There have been several anecdotal examples of non-canonical
sequons in specific proteins that, when purified from cells, are shown to have been glycosylated
[96-98]. Other than anecdotal evidence, very few large-scale studies have been performed to
show the frequency of non-canonical glycosylation sites. One notable exception involved a
large-scale precision mapping of N-glycosylated sites present in the in vivo glycoproteome in
mouse tissues, which included thorough analysis of the false discovery rate and confidence levels
for identified sites [99]. This study showed that the vast majority (> 96%) of glycosylated
asparagines are followed by a serine or threonine in the +2 position. Strikingly, not one of these
sites contains a proline in the +1 position. The 3.5% of non-canonical sites were dominated by
Asn-Xaa-Cys (Xaa # Pro) , which account for 1.3% of the total glycosylated sites and agrees
with anecdotal studies showing asparagines within Asn-Xaa-Cys can be glycosylated [100]. In
this site, it is easy to see that the cysteine resembles a serine or threonine in the length of the non-
carbon atom from the backbone and harboring an accessible proton. Of the remaining 2.2%
glycosylated asparagines, two motifs could be identified with statistical significance, with Asn-
Gly accounting for 0.5% and Asn-Xaa-Val/Leu accounting for 0.4% of the total glycosylated
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asparagine residues. The Asn-Xaa-Val motif also agrees with an anecdotal study showing the
ability of a valine or leucine to substitute for the serine of threonine in the canonical Asn-Xaa-
Ser/Thr sequon [98].
Yet, the presence of non-canonical glycosylation sites is consistently an exception to the
rule, and organisms from bacteria through archaeal and up through mammals maintain the nearly
exclusive preference for the canonical Asn-Xaa-Ser/Thr. The studies showing glycosylation of
non-canonical sequons lack the crucial evidential component of performing the reaction in vitro
using purified enzymes and substrates. Showing the reaction occurring in vitro will be necessary
to determine which specific sites can be glycosylated by the unaccompanied enzyme. However,
the evidence for some non-canonical sites, such as Asn-Gly and Asn-Xaa-Val/Leu, appears
compelling [99]. It is not clear that the infrequent nature of these occurrences contradicts the role
of the Asx-type turn in OTase catalysis. It can be imagined that atypical sequons can acquire
Asx-type turns with hydrogen bonding supplied by the peptide backbone or neighboring
residues. Most importantly, no examples have been seen of glycosylated canonical sequons when
a proline is present at the +1 site. Evidence of OTase glycosylation of a peptide constrained in a
way that disallows formation of the Asx-type turn would provide the strongest challenge to the
proposed role of the Asx-type conformation in the OTase mechanism.
The recent discovery of an unusual N-linked glycosylation system may provide the most
convincing evidence yet for the fundamental role of the Asn-Xaa-Ser/Thr consensus in catalysis
of N-linked glycosylation [101]. HMW1 C is a soluble N-glycosyl transferase from Haemophilus
influenzae. The enzyme glycosylates two adhesin proteins, which mediate adherence to epithelial
cells and thereby facilitate pathogenesis of H. influenzae [102]. HMW1C functions in the
cytoplasm, adding glucose monosaccharides from nucleotide-activated precursors to asparagine
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residues [101]. The localization in the cytoplasm, the nucleotide-activated monosaccharide
substrate, and the soluble structure defy a whole set of qualities that were thought to be common
to all oligosaccharyl transferases. The sequence motifs and structural features that are conserved
in other OTases are all lacking in HMW1C. Structurally, HMW1C is considered a part of the
GT41 family of glycosyl transferases according to CAZy (Carbohydrate Active Enzymes
database at www.cazy.org). The GT41 family is otherwise composed entirely of O-GlcNAc
transferases (OGTs). Like other OGTs, HMW1C contains an N-terminal all a-domain fold and a
C-terminal GT-B fold with two Rossmann-like domains. However, HMWI C lacks the
tetratricopeptide repeat fold at the N-terminus that is characteristic of the rest of the GT41 family
[103].
The single conserved feature in the HMW1 C N-glycosylation system is the presence of
the Asn-Xaa-Ser/Thr consensus sequence determining the sites of glycosylation [101]. The
evolutionary background shared with GT41 OGTs clearly indicates N-glycosylation function of
HMW1 C is a result of convergent evolution. The fact that the independent evolution of
asparagine glycosylation was accompanied by the specificity for the Asn-Xaa-Ser/Thr sequon is
a striking indication of the fundamental mechanistic role that the sequon is playing in catalysis-
specifically, the precise combination of residues with correct order and spacing and thus
conformation that allows vastly different proteins to activate the poorly nucleophilic asparagine
nitrogen for attack.
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Conclusion
The significance of N-linked glycosylation to human health has been well-established,
with N-glycosylation demonstrating deterministic role in signal transduction, protein-protein and
cell-cell interactions, protein folding and targeting, and microbial immune evasion. The chemical
complexity of the modification and the structural complexity of pathway enzymes have stymied
efforts to understand the process in greater detail. The discovery of a bacterial pathway of N-
glycosylation has provided a convenient model system that is relatively simple to characterize.
Importantly, the conservation of certain sequence motifs suggests the monomeric bacterial
OTase, PglB, functions in a catalytically similar manner to the eukaryotic OTase.
The following chapters describe steps taken toward characterization of the bacterial
OTase PglB. Chapter 2 describes extensive efforts devoted to optimizing heterologous
overexpression of PglB in E. coli and the purification procedure. These efforts resulted in
significant increases in PglB expression and attainment of improved levels of pure PglB that
remains stable and active for several months. The availability of stable PglB at mid-micromolar
concentration in solution allows for precise kinetic, biochemical, and biophysical investigations
into the enzyme function. Chapters 4 and 5 demonstrate two examples of successful studies that
make use of the well-expressed, pure, and stable PglB.
Chapter 3 describes bioinformatic analysis of the sequences of PglB and homologs. A
method was developed to parse the sequences based on topological predictions in order to
discover pockets of conservation within otherwise divergent regions of the protein sequences.
Chapter 4 uses the predictions derived from the bioinformatics analysis to guide site-directed
mutagenesis studies of PglB. Results validated the functional relevance of previously
unrecognized, highly conserved motifs.
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The publication of a crystal structure of a homolog of PglB from a closely related
bacterial species provided striking validation of the predictions and biochemical data from
Chapters 3 and 4. The structural data represents an impressive step toward visualizing and
understanding the OTase mechanism. However, the crystal structure provides visualization of
only a single conformation of PglB resolved to 3.5 A with a bound substrate peptide. There is
inevitable uncertainty about the relevance of data obtained for any protein in the non-native
environment of a crystal. However, additional factors indicate the PglB structure should be
interpreted with caution: activity data is not provided for the PglB fraction used to obtain
crystals, the membrane protein is in a detergent micelle and thus is in a highly non-native
environment even prior to crystallization, and the crystallization conditions include an alkaline
pH at which PglB shows dramatically reduced activity in solution. Nonetheless, the peptide is
bound in a conformation that does not resemble the Asx-type turn that was previously proposed
function in OTase catalysis, and bold conclusions were drawn that dismissed the significant
biochemical data previously presented in support of the Asx-turn proposal.
Described in Chapter 5 is the design and development of a method to measure distances
between PglB and the peptide substrate and between locations within the enzyme using resonant
energy transfer. Requisite components were assembled and distances measurements were
conducted between PglB and the peptide substrate, demonstrating the success of the approach.
This system provides the groundwork for precise measurements of conformational changes
within the enzyme and substrate-binding location and order. The measurements will be made on
the pure solutions of active Pg1B, providing a degree of confidence that crystallographic data
cannot provide. Future use of this system for studies of PglB as well as an archaeal monomeric
OTase, AglB, are currently being continued and advanced by Imperiali lab members..
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CHAPTER 2:
AN OPTIMIZED PROTOCOL FOR
EXPRESSION AND PURIFICATION OF PGLB
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Summary
Characterization of the oligosaccharyl transferase (OTase) is critical for developing ways
to inhibit, engineer, and otherwise manipulate the enzyme for research and therapeutic purposes.
The minimal understanding of this enzyme can be attributed to its complex, transmembrane
structure, and the resulting instability and resistance to overexpression and purification. The
following chapter describes an optimized procedure for recombinant expression and purification
of PglB in a stably active form. The conditions screened at each step, the order of screening, and
the method of comparing conditions are described. Ultimately, the following approach increased
expression levels from tens of micrograms to several milligrams of active protein per liter of E.
coli culture, and increased stability from several hours to greater than six months post-
purification. This represents the first detailed procedure for attaining a pure, active, and stable
OTase in milligram quantities. These quantities of pure protein makes detailed kinetic and
biophysical analysis of an active OTase a realistic possibility. In addition to presenting an
optimized protocol for expression and purification of PglB, these results present a general guide
for the systematic optimization of the expression, purification, and stability of a large,
transmembrane protein.
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Introduction
Biological researchers are invariably familiar with the importance of membrane proteins
in therapeutic development and throughout cell biology. Several well-known statistics
demonstrate this import; most notably, membrane proteins account for approximately one-third
of the human proteome and comprise a majority of current drug targets [1-3]. However, standard
overexpression and purification techniques are often unsuitable for this class of proteins, which
presents a major obstacle to research progress. There exist promising developments for acquiring
large quantities of membrane proteins, including cell-free translation systems, directed evolution
of well-expressing bacteria, and the ever-increasing advances in the efficiency of current
approaches [4,5]. However, expressing and purifying membrane proteins currently remains a
largely empirical, time-consuming, and high-risk endeavor, leaving many important membrane-
bound enzymes uncharacterized and presenting significant gaps in the understanding of cellular
pathways.
The proteins in the eukaryotic N-linked glycosylation (NLG) biosynthetic pathway
provide an example of this phenomenon, as virtually all of the enzymes are membrane-bound.
NLG plays a major role in many cell processes, including immune-system response, protein
signaling and trafficking, and pathogenic invasion strategies [6-9]. In addition, NLG introduces
several prospective tools in therapeutics; N-linked sugars are capable of functioning as indicators
of cell state and type [10-12] and represent a novel chemical platform for developing new
therapeutics and enhancing efficacy of current drugs [10,13]. Most current studies involving
NLG, however, focus on determining the specific effects of the glycan modification on a target
of interest, often aimed primarily at establishing the glycosylated sites within a protein and the
effects of the modification on function [14-17]. Far less is known about the enzymes comprising
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the biosynthetic pathway of NLG due to the difficulty of expressing and purifying the involved
membrane proteins in a stable and active state. Closing this knowledge gap would allow for
enhanced ability to efficiently manipulate, study, and thus control and utilize NLG.
In yeast, the OTase is a complex composed of eight subunits, all of which have one or
more transmembrane domains. In comparison, PglB is comprised of a single subunit, which is
homologous to the catalytic subunit of the eukaryotic OTase (Figure 1). Although PglB is
ostensibly a tractable target relative to the eukaryotic OTase, the enzyme represents a challenge
in its own right. PglB has thirteen transmembrane domains and is fairly large (82 kDa), which
accounts for poor recombinant expression and instability in E. coli. Thus, characterization of
PglB has lagged relative to other C jejuni NLG enzymes, despite the potential of this OTase to
reveal fundamental principles about the mechanism of OTases across the evolutionary spectrum.
This chapter describes the systematic approach used to optimize the expression, purification, and
stability of active PglB. The conditions screened at each step, the order of screening, and the
method of comparison for each condition are described.
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Figure 1: Comparison of the OTases in C. jejuni (bacteria) and S. cerevisiae (eukaryotes).
Images highlight the similarity between the S. cerevisiae catalytic subunit 'STT3' and PglB. The
relative simplicity of the bacterial OTase when compared to the eukaryotic enzyme complex is
also demonstrated.
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Specific activity values are used to determine the optimal conditions for balancing protein
recovery with activity recovery. The activity-guided approach can be contrasted with expression
screening approaches undertaken with the primary interest in X-ray crystallographic studies,
which generally focus on protein quantity and monodispersity and do not account for the
proportion of active to inactive protein purified. Thus, the following method is intended to aid
researchers interested in C. jejuni N-linked glycosylation, and also to illustrate an activity-guided
approach to optimizing expression, purification, and stability of a specific membrane protein of
interest. This following data represents the first available protocol for expressing and purifying
milligram quantities of a stable and active OTase.
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Results
Expression optimization of PgB in E. coli: general strategy
Optimization of PglB expression in E. coli involved screening many expression
constructs and conditions. To facilitate testing the multitude of expression conditions, 5-mL
cultures are grown for each condition specified (direct comparisons are always grown
simultaneously). Unless specified otherwise, the cultures are grown at 37'C until they reach an
O.D. of 0.6-0.8, at which point the temperature is shifted to 16'C for overnight growth. These
mini-cultures are then centrifuged to concentrate the cells. The cell pellets are weighed and
resuspended in a volume of lysis buffer for 0.1 g/mL and are then lysed using sonication.
Activity rates are compared for series of lysates derived from cultures with varied expression
conditions. The lysates with highest activity are used to determine which expression conditions
yield the most functional enzyme. Expression and activity comparisons are carried out on at least
two separate occasions to ensure conclusions drawn are accurate.
Protein Tags and Gene Truncations
Membrane proteins are often expressed as truncations of the native protein to impart
higher expression or stability to the protein [18]. It has been shown that the C-terminal, soluble
domain of PglB is not functional when expressed on its own (roughly from residue 420 to C-
terminus) [19]. However, an apparent proteolytic degradation product of PglB is consistently
observed via western blot when full-length PglB is over-expressed in E. coli (Figure 2). The
roughly 50 kDa band is expected to contain the C-terminal domain of PglB because it is visible
on western blots when an anti-His (C-terminal) antibody is used but not when an anti-T7 (N-
terminal) antibody is used. However, at 50 kDa, the degradation product is significantly larger
than the soluble domain alone and thus likely contains several transmembrane domains, as well.
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It was considered that this degradation product might, in contrast to the soluble domain alone,
represent an active version of PglB that is more stable or easily expressed than the full-length
protein. To test this hypothesis, several truncated PglB constructs were made (Figure 2).
Constructs were expressed and normalized for expression via western blot. However, it was
found that all of the constructs lacked catalytic activity, including those that lacked only
approximately 50 residues from the C- or N-terminus (Figure 2).
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Figure 2: Investigating a natural degradation product of PglB.
Top left: topology diagram for PglB based on available structural data (PDB 3RCE). The
horizontal bar represents PglB with the protein sequence numbered along the bottom starting
with the N-terminus. The location of each transmembrane helix is represented by a vertical bar
and the thin black horizontal lines represent the location of the soluble regions (lumen on top,
cytoplasm on bottom). Bottom left: Bars representing the various truncated constructs of PglB,
with length aligned to X-axis of topology diagram. The name assigned to each construct is listed
on the left along with the residues encompassed by that construct. Right: Western blots showing
the degradation product of interest (indicated by the arrow) when stained with the anti-His
antibody (C-terminal tag) but not when stained with the anti-T7 antibody (N-terminal tag).
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The observations that even short N-terminal truncations cause complete activity loss can
now be explained by the recent structural and biochemical data, which reveal that a required
catalytic motif appears in transmembrane-loop regions close to the N-terminus [20,21].
However, the available data - structural, biochemical, and bioinformatic- has not located major
conservation or apparent involvement of the C-terminal portion of the soluble domain in
catalysis, so it remains to be seen why the presence of last 50 or so residues of this enzyme is
required for activity.
Table 1: Fusion constructs used in PglB expression screening.
Vector N-terminal fusion tag Fusion tag MW (kDa, References
approx.)
pET24a(+) T7 1 [22]
pGBH Protein G, B1 domain (GBI) 6 [23]
pET SUMO Small Ubiquitin-Like Protein 11 [24](SUMO)
pET Trx Thloredoxin (Trx) 12 [25]
pGEX Glutathione-S-Transferase (GST) 26 [26]
pMAL-c2x Maltose-Binding Protein (MBP) 42.5 [25,27]
Screening of expression tags represents another common approach used to alter
expression, solubility, localization, and other functional aspects of proteins [28]. The pgB gene
was cloned into several vectors encoding N-terminal fusion tags that have been shown to
positively affect expression (Table 1). These tags include: T7, Glutathione-S-transferase (GST),
Maltose Binding Protein (MBP), SUMO, Thioredoxin, and GB1 [23-27]. Within those tested, it
was estimated that the MBP (pMAL-c2X), the T7 (pET-24a(+)) and the GB1 (pGBH, [23]) tags
are associated with the highest expression under standard expression conditions, which can
easily be discerned from a visual inspection of SDS-PAGE analyses (Figure 3). These three
constructs were thereafter used for systematic optimization.
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Figure 3: Coomassie-stained SDS-PAGE of fractions of multiple PgIB constructs.
Each lane contains a version of Pg1B with the expression tag indicated: 1. GB 1, 2.T7,
3.Thioredoxin, 4. MBP, 5. SUMO, 6. GST. (Figure courtesy of Dr. Mark Chen).
Expression and induction conditions
A variety of E. coli competent cells were screened to determine the highest-yielding
strain for PglB expression. Seven types of E. coli expression strains were transformed with the
MBP-PglB and T7-PglB vector constructs; these included C41(DE3), Rosetta 2, Rosetta 2 gami,
and the following BL21(DE3) strains: RIL, Gold, RP, pLys. It was observed that BL21(DE3)
RIL cells show the highest level of expression of both MBP-PglB and T7-PglB as measured by
activity levels and western blotting. This result suggests that this strain is optimal for PglB
generally and that the outcome is not tag-specific.
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A range of induction parameters were investigated, including IPTG concentration used to
induce expression, optical density of cultures at the time of induction, incubation temperature
post-induction, and length of time cultures were grown following induction. The effects of each
of these variables are interdependent; thus, each combination should ideally be tested. Table II
displays the organization scheme for this screening process. Ultimately it was found that cultures
induced at a very high O.D. (>1.2) rather than the typical O.D. of 0.6-0.8 results in significantly
improved expression levels (Figure 4A).
Table 2: Induction conditions varied to screen for improved expression of PglB.
O.D. of Temperature shift upon [IPTG] (mM) to
induction" induction induce
0.6 37*C 4 16*C 0.2
0.6 370C + 160C 0.7
0.6 370C + 16 0 C I
I 370C + 160C 0.2
1 37*C + 16*C 0.7
1 37 0C 4 16 0C 1
0.6 370C 0.2
0.6 37*C -- 0.7
0.6 37*C 1
1 37*C -- 0.2
I 37*C -- 0.7
1 37*C I
a. For each condition, time points were taken at 3, 6,
b. - indicates no shift.
and 20 hours post induction.
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The improvements in PglB expression due to induction at high O.D. suggested that auto-
induction, or 'high-density cell growth', may be an advantageous way to express PglB. Auto-
induction involves growing the expression culture (expressing a protein under the control of the
inducible T7 system) in complex media containing a small amount of lactose. Amino acids and
other carbon energy sources in the media prevent induction by lactose during log phase of cell
growth. Depletion of these components and approach to a saturating density automatically
prompts the cells to uptake lactose, causing induction of the target protein [29]. The procedure is
similar to IPTG-induced expression, except auto-induction requires a media specifically
developed and optimized to couple induction of protein expression by lactose with the approach
of the culture to saturating density (see Materials and Methods). This method not only eliminates
the need to frequently monitor O.D. of the culture, it also ensures that the expression cultures
have the highest beneficial O.D. when induction occurs, and prevents any significant expression
of the target protein prior to induction.
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Figure 4: Expression improvement with IPTG induction at high O.D and auto-induction.
A. Cell cultures were grown at 37*C to an O.D. of 0.7 and 1.2, at which point the cultures were
induced with 1 mM IPTG and the temperature was shifted from 37 to 161C. Fractions from
equal cell-pellet weights were purified over Ni-NTA resin and elutions were compared via SDS-
PAGE. B. Cell cultures of each construct were grown in LB using IPTG (induced at O.D. = 1) as
well as using auto-induction media. Equal weights of cell pellet were lysed and spun at 10000 x
g to remove debris. The cleared lysates were used to measure initial rates of activity for each
fraction. C. Graph indicates activity levels for PglB-pET24a (+) expression cultures that were
grown under the specified conditions. For the auto-induced cultures, it was of interest to
determine the optimal time to grow the cultures at 37 *C before the temperature shift to 16 C;
hence, the hours post-inoculation at 37 TC were varied and compared. Error bars indicate the
standard error of activity measurements. Activity assays were performed as described above
using cleared lysate fractions from equal weights of cell pellet from each condition.
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Due to the fact that auto-induction involves growing cell cultures to saturation, the cell
weight obtained per liter of culture is dramatically increased relative to other expression and
induction conditions. While one liter of IPTG-induced culture (induced at an O.D. of 0.6-0.8
with 1 mM IPTG) gives roughly 2 grams of cells, one liter of auto-induction culture generally
yields at least 25 grams of cell weight (with expression parameters otherwise held constant).
Therefore, when comparing auto-induction expression to IPTG-induced expression, it
was of interest to determine whether improvements in protein yield are due to the greater number
of cells produced per liter of culture or to improved expression of PglB per cell. Activity per
gram of cell weight was measured for PglB in pMAL, pET24a(+), and pGBH vectors grown
with both auto-induction and IPTG induction (Figure 4B). In order to determine the optimal
time of induction (or temperature shift) to use in the comparison, PglB-pET24a(+) was expressed
using both IPTG-induction at various O.D.s and auto-induction with varying time spent growing
at 37'C before shifting the temperature to 16'C (Figure 4C).
Results show that PglB expressed using auto-induction is optimal with a temperature shift
occurring at 4.5 hours post-inoculation and that PgIB expressed using IPTG induction is optimal
when induced at an O.D. ~ 1.6. Furthermore, auto-induction yields significant increase per gram
of cell weight over expression using IPTG induction in addition to yielding more cell weight per
liter of culture (Figure 4B). It was additionally shown that with auto-induction, PgIB expressed
in the pET24a(+) vector yields higher levels of active protein than PglB expressed in the pMAL
or the pGBH vector (Figure 4B).
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For this reason, the Pg1B-pET24a(+) construct was used for subsequent optimization and
experiments. Use of this construct was also advantageous because the T7- tag is significantly
smaller than both MBP and GB1 (see Table I), and thus most closely resembles the native
(untagged) PglB.
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Optimization of PglB purification
Once expression levels of PglB had been improved using auto-induction, the purification
procedure was optimized so that the higher expression would translate into higher levels of pure,
active protein. A flow chart of the general procedure for PglB purification is shown in Figure
5A. Optimization begins at the top of the flow chart, and the following steps were not optimized
until optimized conditions were established for all previous steps. Optimizing a purification step
involved dividing the 'crude' fraction into equal parts. Each part was subjected to one of several
conditions. The total activity and protein concentration in the fractions before and after the
purification step were measured for each condition.
[Zate
Centrifuge (slow)
cleared lysate
Centrifuge (fast)
crude CEF
Homogenize in high salt buffer
Centrifuge (fast)
salt-washedCEF
Homogenize in detergent
Centrifuge (fast)
detergent-solubilized proteins
I Ni-NTA affinity chromatography
pure PgIB
B
90
60
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30
Figure 5: Procedure for optimizing purification protocol for PgLB.
A. Flow chart of the general procedure for purifying PglB. The boxes contain the fraction
acquired at each step, and adjacent to the arrows is the physical procedure performed to get from
one fraction to the next. B. The values of total protein and total activity in percent of initial
(where 'initial values' refer to those in lysate) obtained using optimized procedure. Values are
shown for each purification step diagrammed in the flow chart in part A and correspond to the
values in Table 3. Note the steep decrease in total protein concentration associated with each step
and the comparatively mild loss of total activity.
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A
The activity and protein-concentration measurements allowed calculation of specific
activity, fold purification, and percent yield (see Materials and Methods). These values provide a
definitive measure by which to judge the optimal condition for each purification step, where
optimal is defined as maintaining maximal activity and minimal levels of total protein (Figure
5B). Table 3 provides the values obtained using the final optimized purification protocol, while
Figure 6 shows the activity data which was used (along with the quantities of total protein
present in each fraction) to calculate the values in Table 3. A stepwise procedure for the
purification steps can be found at the conclusion of this chapter's results.
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Table 3: Values from final optimized purification protocol of PglB.
A 3.6-gram pellet was used, representing approximately 1/7 the weight from 1 L culture.
Concentration Total protein Rate Total activity Specific activity Percent Fold
(mg/mL) (mg) C (nmol/min) '" (nmol/min) (nmol/min*mg) Yield Purification
lysate 12.85 515 1.OE-05 8.4E-02 1.6E-04 100 1.0
cleared 6.74 270 9.5E-06 7.6E-02 2.83E-04 91 1.7lysate
CEF 2.25 83 1.1E-05 7.9E-02 9.48E-04 93 5.8(unwashed)
(washed) 1.6 68 8.6E-06 7.3E-02 1.08E-03 87 6.6
solubilized 0.59 25 7.OE-06 5.9E-02 2.36E-03 70 15
prifed 0.2 0.6 8.5E-05 5.4E-02 9.06E-02 64 550
a. Concentration of total protein in fraction.
b. Measured value (see Methods).
c. Volume-corrected.
d. Rate of transfer of radioactive sugar substrate to peptide substrate by active PgIB in fraction.
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Figure 6: Activity-rate data for fractions used to calculate Table 3 purification values.
Best fit lines were used to estimate the activity rates of PglB contained in 5 LL of each
purification fraction. The rates from 5 pL were volume corrected to find the total activity present
in the entire fraction.
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Isolation and processing of cell-membrane fraction
Cell lysis was performed with sonication in three sets of two minutes each. Cells were
incubated on ice before, during, and post-sonication to prevent the temperature of the cell
suspension from rising and potentially inducing cellular stress response and increased protein
degradation and denaturation. Sonication is considered a relatively harsh method of lysis, so as a
comparison two PglB cell pellets of equal weight were lysed either by French Press or by
sonication. Purification and activity results were unaffected by the method of lysis, indicating
sonication is not causing significant impairment to protein yields.
After lysis of cells, a 10000 x g centrifugal spin is performed to remove unbroken cells
and other extraneous cell debris, yielding the 'cleared lysate' supernatant. While there are
general recommendations for the speed at which to achieve this desired separation, at times it is
beneficial to vary the exact speed of the spin to improve retention of the protein of interest. In
this case, the first spin was initially performed at the standard speed of 10000 x g. Calculation of
the fold purification and the percent yield showed that the step was increasing the specific
activity by only a small amount, but 40% of the activity was being lost (Table 4). The speed was
lowered to 8000 x g, which improved the yield and fold purification (Table 4). Particularly, as
this is one of the first purification steps, the effects of changes in percent yield on the final yield
of protein are compounded. Thus, a relatively small difference in initial the centrifugal
separation speed had considerable effects on the ultimate yield of pure protein.
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Table 4: Minor change in centrifugal spin significantly affects yield of purification step
Fraction Concentration Rate Total activity Specific activity Percent Fold(mg/mL) protein (nmol/min) (nmol/min) (nmol/min*mg) Yield Purification(mg)
Prep lysate 9.5 380 1.2E-04 2.3E-01 6.12E-04 100 1.0
1 cleared lysate 80 304 7.5E-05 I4E-01 4.70E-04 61 0.8
(10000 x g)
lysate 12.9 514 351 4.7E+06 9.1E+03 100 1Prep
2 cleared lysate 6.7 270 318 4.2E+06 1.6E+04 91 2(8000 X g)
a. Numbers are given for two PgIB preparations representative of numbers seen in additional preps.
The supernatant ('cleared lysate') is then subjected to a second centrifugal spin at 150000
x g, which pellets the membrane fraction, and soluble proteins remain in the supernatant. The
membrane fraction, or the 'cell-envelope fraction' (CEF), is then resuspended as a semi-pure
fraction containing only the cell-membrane content (cell-membrane lipids and all membrane-
associated proteins). A good percent yield (90-95%) and high fold purification (3-6 fold) were
observed with standard parameters; thus, it was not necessary to optimize this step further.
A subsequent salt wash of the membrane fraction involves homogenizing the pellet from
the first 150000 x g spin (which pellets the 'unwashed CEF') in a buffer containing a high
concentration of salt. The high salt presumably disrupts electrostatic interactions between
proteins associated with membrane lipids or integral-membrane proteins, such that any non-
integral membrane proteins are released into the aqueous surrounding. The CEF is then
repelleted in a second 150000 x g spin, which is expected to contain only integral-membrane
proteins ('washed CEF'). It was of interest to determine whether the identity of the salt would
play a role in the effectiveness of the wash.
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Table 5: Comparison of several salt solutions in CEF salt wash efficiency.
Fraction Total Protein Rate Total Specific Percent Fold(mg) (nmol/min) activity activity Yield Purification
NaCi CEF (pre-wash) 143 5.6E-06 7.2E-02 5.OE-04 100 1.0
NaC1 CEF (post-wash)a 75 2.5E-06 3.6E-02 4.7E-04 49 0.9
KCl CEF (pre-wash) 152 5.2E-06 6.8E-02 4.5E-04 100 1.0
KCl CEF (post-wash) 75 1.6E-06 2.5E-02 3.3E-04 36 0.7
NaCl + KCl CEF (pre-wash) 189 6.2E-06 8.OE-02 4.2E-04 100 1.0
NaCl + KCl CEF (post-wash) 75 3.6E-06 5.4E-02 7.2E-04 68 1.7
a. The percent yield and fold-purification values for 'post-wash' fractions were determined relative to
the pre-washed state only.
To test this possibility, a comparison was made between three solutions with the
following salt contents: 500 mM NaCl, 500 mM KCl, 250 mM NaCl + 250 mM KCl (Table 5).
The results show the fold purification and percent yield are highest for the CEF wash performed
using the combination of KCl and NaCl. While the salt wash using the combined salt solution
was advantageous, the use of solutions of only 500 mM KCl or 500 mM NaCl surprisingly
resulted in both unfavorable yields and fold purification. The comparison was repeated to show
reproducibility of this result, and the combination salt wash was used routinely thereafter'. At
this point, the CEF is resuspended in a small volume (less than 10 mL lysis buffer) so that
membrane structure remains intact and will provide stability. An additional 10-20% glycerol can
be added as a cryoprotectant. This concentrated solution can be dispensed into aliquots and
stored at -801C, where it remains stable for a year or more.
1 It is worth noting that the specific activity measurements were indispensable for determining that this customary
purification step is actually obstructive for PglB purification unless it is carried out in specific salt conditions.
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Solubilization of membrane proteins
Solubilization of the CEF involves addition of a high concentration of detergent to the
membrane fraction, such that the native lipid structure surrounding the membrane proteins is
disrupted and the membrane proteins may be released into solution. The lost lipid periphery on
these proteins is presumably replaced with stabilizing detergent micelles, or a mixture of lipids
and detergent. The identity and concentration of the detergent used imparts highly variable yields
of active protein. However, many detergents are very costly and large detergent screens are often
time-consuming. Rather than investigating a large range of detergents, four detergent conditions
were initially screened to resolve the amount of optimization that needed to be performed. The
detergents initially screened were DDM (n-dodecyl-p-D-maltoside), OG (n-octyl-p-D-
glucoside), Triton X- 100, and an equal combination of the former three. A final concentration of
0.5% (w/v) was used for the four detergent conditions (see Materials and Methods). These
detergents were chosen for the following reasons: DDM has traditionally been successful in the
solubilization of membrane proteins [30,31], OG has a high CMC (critical micelle concentration)
which facilitates easy removal of detergent at later points, and Triton X-100 is economical and
oft-used in protein biochemistry. The concentration of detergent (0.5% w/v) was used as an
initial trial concentration based on previous reports of OT solubilization efforts [32]. While it
was not necessary in the presently described case, the critical micelle concentration (CMC) - the
concentration of detergent at which detergent micelles form from the individual detergent
molecules-is an important factor that can guide detergent choice and concentration. Often a
range of detergents are screened concomitantly at 40X CMC of each detergent, which leads to
very different percentages of detergent in each solution tested. However, it also important to note
that reported CMC values are estimates and the true CMC is highly dependent on specific
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environment, including buffer (identity and concentration of buffer used), salt concentration,
temperature, and any other buffer additives.
Table 6: Comparison of several detergent solutions in CEF-solubilization efficiency.
Fraction Total protein Rate Total activity Specific activity Percent Fold(mg) (nmol/min) (nmol/min) (nmol/min*mg) yield purification
pre-solubilizeda 27.9 1.4E-05 8.3E-03 3.0E-04 100 1.0
post-DDMb 9 1.2E-05 7.1E-03 7.9E-04 86 2.7
post-OG 2.7 1.1E-06 6.6E-04 2.4E-04 8 0.8
post-Triton 6.3 9.8E-07 5.9E-04 9.3E-05 7 0.3
post-combination 7.2 7.OE-06 4.2E-03 5.8E-04 51 2.0
a. Percent yield and fold-purification values for 'post-solubilized' fractions were determined relative to pre-
solubilized fraction.
b. Fraction after solubilization with DDM. All conditions had a final detergent concentration of 0.5%.
A 5% solution of detergent is diluted 10-fold into the resuspended CEF, which has been
diluted to 10 mg/mL total protein. This mixture is homogenized and vortexed vigorously,
followed by dilution to lower the detergent concentration (see Materials and Methods). Results
(Table 6) indicate clearly that DDM is most efficient at solubilizing active PglB relative to the
other detergent solutions tested. The use of 0.5% DDM gives a very favorable percent yield,
eliminating the need to further optimize this step. In the common case that initial detergent
conditions fail to provide satisfactory results, one can expand the comparison to include
additional detergents with a range of properties and vary the concentration of the detergents.
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Affinity chromatography
The specificity of PglB affinity purification using Ni-NTA affinity was inefficient under
batch binding conditions initially used. Initial concentrations for batch-binding were 50 mM
HEPES, pH 7.5, 0.17% DDM, 10 mM imidazole. A high relative concentration of contaminating
proteins co-eluted with PglB and recovery of PglB from the column was incomplete. There are
several additives which are known to decrease non-specific binding to Ni-NTA resin and
between proteins [33]. Figure 7A shows a gel of PglB elutions after batch binding with several
different conditions. Addition of glycerol to all buffers and increasing imidazole from 10 to 20
mM successfully decreased the amount of the low-molecular weight impurities relative to the
full-length PglB. Diluting the solution two-fold during batch binding significantly decreased
impurities as well; however, only when batch binding proceeded for a longer duration did the
dilution result in increased purity without loss of significant protein in flow through. This is not
surprising, because in general, longer batch binding time is required for maximal binding of a
more dilute solution of His-tagged proteins. For PglB, batch binding diluted, solubilized CEF to
fresh Ni-NTA resin overnight, in the presence of glycerol and increased imidazole, resulted in
the highest purity with the least loss of protein in the flow through and washes.
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Figure 7: Optimization of Ni-NTA purification.
A. Batch binding conditions screened for effect on PglB purity after Ni-NTA column. Lane 1
contains the Benchmark pre-stained standard (Invitrogen), Lanes 2-6 contain standard buffer of
50 mM HEPES, pH 7.5, 10 mM imidazole, 0.17% DDM, plus the additive noted to the right of
the gel. Buffer 7 contained only standard buffer. B. Improved purification of PglB over Ni-NTA
column. Coomassie-stained SDS-PAGE of flow through, washes, and elutions are shown (left).
Elution fractions in lanes 7-11 were combined and concentrated, shown right. Apparent
improvement in purity in the concentrated solution can be attributed to the concentration method
using a 1 00-kDa MWCO filter, which allows smaller impurities to flow through. In addition,
PglB dispersity becomes more homogenous during concentration, removing the higher order
oligomers and thus decreasing intensities of bands above 82 kDa.
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Another alteration that significantly affected the purification was replacement of the His6
tag (native to the pET24a(+) vector) with a His10 tag. This change was made during expression
optimization, and thus all purification optimization heretofore described was performed with the
His 10 tag. However, it is mentioned because lengthening the His-tag did cause a clear increase in
the affinity of PglB for the Ni-NTA resin. For this reason, much higher imidazole concentrations
are used in column washes than are considered typical, and similarly very high imidazole is
required to elute all the bound PglB from the resin (up to 600 mM from 300 mM used with the
His6 tag). In fact, using the typical concentration of 300 mM imidazole for elution recovers only
a fraction of the bound PglB. Accordingly, very little protein remained in the flow through and
washes based on gel analysis (Figure 7B) and activity assays. The batchbinding changes resulted
in a final value fold-purification of approximately 500 (Table 3), relative to the -50-fold
purification values achieved before batchbinding optimization and increasing imidazole in
elution buffer.
Buffer Exchange
It has been observed that PgIB activity is rapidly lost after elution from the Ni-NTA
column due to prolonged exposure to very high imidazole concentration. Dialysis, which was
previously used to exchange the buffer and remove the imidazole after elution, proceeded too
slowly for PglB to maintain activity. Therefore, an alternative method was used to exchange
buffer: a HiTrap desalting column (G.E. Healthcare) was used immediately after elution to
replace the elution buffer with one that lacked imidazole. However, use of the desalting column
diluted the protein and caused significant loss of activity. Next, an Amicon Ultra I 00-kDa
MWCO cellulose filter was used, which concentrates the fractions containing PglB, and also
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serves as a method to exchange the buffer and remove the imidazole (Figure 7B). While the
molecular weight of PglB (82 kDa) is below the molecular-weight cut-off of 100 kDa, the mass
is high enough that there is virtually no PglB lost in the filtrate. This may in part be due to the
presence of the DDM detergent micelle surrounding PglB. In contrast, the DDM detergent
micelle alone (without PglB bound) flows through the 100 kDa-MWCO filter despite the
reasonably large size of the DDM micelle (- 50 kDa) [34]. This selectivity is very advantageous
because it allows the protein to be concentrated without simultaneously concentrating the
detergent to a degree that is deleterious to the protein stability. In addition, the loss of lower
molecular-weight impurities is consistently observed when using these high molecular-weight
cut-off filters presumably due to the fact that these contaminants can pass through the filter.
In summary, this method of buffer exchange results in negligible loss of activity whereas
dialysis of a PglB solution overnight at 4'C results in complete loss of enzyme activity. In fact, it
was found that PglB solutions lose activity when dialyzed overnight, even in the absence of
imidazole. Thus, it is likely that the dialysis procedure was a cause of activity loss in Pg1B in
addition to the high imidazole. Using the 1 00-kDa MWCO Amicon filter, Ni-NTA-purified PglB
is concentrated and buffer-exchanged to roughly 10 pM in 50 mM HEPES pH 7.5, 100 mM
NaCl, 30% glycerol, 0.01% DDM. This solution is distributed into aliquots and stored at -801C
and, under these conditions, remains stable for at least two months (Figure 8).
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Figure 8: Activity of PglB over multiple days post-purification.
Pure PglB (shown in Figure 7B) was distributed into aliquots and stored at -80 0C. An aliquot
from this batch was used for each activity measurement shown.
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PglB Purification protocol
1 L culture yields ~ 25 grams of cells
All steps performed on ice or at 4'C
Purification of-3.5 gram pellet:
1. Resuspension: Remove pellet from -80'C storage. Add Buffer 1 at a volume for ~ 0.1
grams of pellet weight per mL. Agitate to resuspend. Add protease inhibitor cocktail
solution, DNase and lysozyme at product manual recommended concentrations. Agitate
solution gently for ~1 hour.
2. Lysis: Sonication of lysis solution on ice:
a. Between rounds of sonication lysis solution should be cooled on ice and
periodically inverted to mix.
b. 3 rounds of sonication at the following settings: Time: 1 min, Amplitude: 50%,
Pulse: 1 second on/l second off.
3. Differential centrifugation, Round I: 8000 x g, 40C, 35'
4. Decant supernatant. Save supernatant. Pellet can be discarded (or sample saved for blot
analysis).
5. Differential centrifugation, Round 2: 150000 x g 4*C, 60'
6. Decant supernatant. Save pellet (contains crude cell envelope fraction, or "CEF").
Supernatant may be discarded (or sample saved for blot analysis).
7. CEF salt wash: Quantitatively transfer cell pellet to homogenizer. Use spatula to transfer
as much of the pellet as possible. Then add 2 mL Buffer 2 to centrifuge tube. Scrape
bottom of centrifuge tube to resuspend remaining CEF. Add this solution to homogenizer
containing rest of the CEF. Homogenize cell pellet in a final volume of 35 mL of Buffer
2 (33 mL added, after the 2 mL wash).
8. Differential centrifugation, Round 3: return homogenized CEF to centrifuge tube. Spin, at
150000 x g 40C, 60'
9. Decant supernatant. Save pellet (contains washed cell envelope fraction, or "CEF").
Supernatant may be discarded (or sample saved for blot analysis).
10. Transfer washed CEF quantitatively to homogenizer. Use 2 mL of Buffer 3 to wash CEF
remaining in centrifuge tube. Add this solution to homogenizer containing dry CEF
pellet.
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11. [Sample may be homogenized, aliquotted, and frozen at -80' at this point and purification
continued at a later date. To continue, thaw stored CEF on ice, pour into homogenizer,
wash container with 200 p.L of buffer and combine with neat CEF solution.]
12. Solubilization of washed CEF:
a. Homogenize CEF at for a concentration of 10 mg/mL protein
b. Add 1/10 volume of 5% DDM solution, -> protein: detergent ratio of 2
c. Re-homogenize
d. Vortex 2 minutes
e. Dilute 1:3 in Buffer 3 for a final concentration of 30% glycerol, 0.17% DDM, 20 mM
imidazole, and 3.3 mg/mL protein)
13. Differential centrifugation, Round 4: spin at 100000 x g, 41C, 60'.
14. Decant supernatant. Save supernatant. Pellet may be discarded.
15. Batchbinding to Ni-NTA: 1-2 mL Ni-NTA resin equilibrated in 50 mM HEPES pH 7.5,
30% glycerol, 20 mM imidazole, 0.0 1% DDM. Add supernatant to equilibrated resin and
gently agitate overnight.
16. Ni-NTA purification: let each wash or elution fraction completely flow through before
adding the following fraction.
a. Flow through of solution over gravity flow filter.
b. Wash 1: 1 x ~ 25 mL Buffer 4 + 20 mM imidazole.
c. Wash 2: 3 x I mL Buffer 4 + 80 mM imidazole.
d. Elution A: 6 x 0.5 mL fractions with Buffer 5 + 300 mM imidazole
e. Elution B: 6 x 0.5 mL fractions with Buffer 5 + 600 mM imidazole
17. Measure activity of elution fractions (or use SDS-PAGE) to determine fractions
containing protein.
18. Concentrate and buffer exchange using 100 -kDa concentrator, exchange into Buffer 5
19. Storage of solution in aliquots at -80'C.
Buffer 1: 50 mM HEPES, pH 7.5; 10% glycerol, 100 mM NaCl.
Buffer 2: 50 mM HEPES, pH 7.5; 10% glycerol, 250 mM NaCl, 250 mM KCl.
Buffer 3: 50 mM HEPES pH 7.5, 30% glycerol, 20 mM imidazole.
Buffer 4: 50 mM HEPES pH 7.5, 20% glycerol, 300 mM NaCl, 0.0 1% DDM
Buffer 5: 50 mM HEPES pH 7.5, 30% glycerol, 100 mM NaCl, 0.01% DDM
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Discussion and Conclusion
The purification values shown in Table 3 were recorded for a 3.6 g cell pellet, which
represents roughly one seventh of the cell weight obtained on average from one liter of culture
using auto-induction. The 0.6 mg protein remaining at this point is > 95% purified PglB as
judged by SDS-PAGE (Figure 7B). Thus, we estimate that per liter of culture, using auto-
induction expression and the optimized purification conditions, 1-5 mg pure PglB is obtained.
This represents a 100-fold increase in levels of pure, stable PglB relative to pre-optimized levels,
which were estimated to be -50 pg per liter of culture. Importantly, multiple PglB preparations
have been completed using the current optimized protocol, demonstrating the reproducibility of
yields obtained, and indicating that the values shown in Table 3 are representative of an average
purification.
Nonetheless, the optimized procedure for purifying PglB is far more time-consuming
than purification of most soluble proteins. The obligatory steps of isolating and processing the E.
coli membrane fraction add considerable time and effort to the purification process. Additionally,
a greater emphasis is placed on maintaining the protein at a cold temperature, working rapidly,
and following protocols strictly. Furthermore, optimized quantities of membrane proteins often
seem scant relative to typical yields for soluble proteins. These difficulties, however, are well-
recognized by those intending to express and purify an uncharacterized membrane protein, and
there are many thorough reviews that provide an overview of these challenges and potential
solutions [35-38]. While optimizing PglB expression and purification, several additional
obstacles and solutions were encountered, and it is hoped that these may be beneficial for non-
specialists to consider when commencing such an effort.
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Ironically, it proved challenging to navigate the abundant options available that have
potential to improve the expression or stability of a membrane protein. Various cell lines, fusion
tags, expression-culture additives, detergent alternatives, protein stabilizers, and countless other
products and methods have reported instances of success in handling of certain membrane
proteins. Yet, there are very few guarantees, and optimizing most steps remains an empirical
process. In the case of PglB, it proved to be more time-efficient and economical to begin
optimization of each step with a limited range of commonly used conditions and expand based
on those results, when necessary. Deciding on a standard for sufficiency is useful, and when a
step is particularly problematic, it may be practical to allot a specific amount of time to the task.
If progress is not made by the end of the time period, perhaps it is wiser to try another route or
target entirely.
It was also found helpful to develop a clear strategy from the onset, and to begin with the
first step of the procedure. Once the first step of the procedure has been optimized, the next step
of the procedure should only then be addressed, because conditions used at each step in
expression and purification can have unpredictable results on those that follow.
Along the same lines, one should carefully choose the specific construct to optimize.
Ideally it should be the same construct that will be used for anticipated future experiments. An
optimal procedure for expression and purification for a protein in one vector can be significantly
different in another vector, or when adding or exchanging the expression tag. The importance of
designing a systematic procedure for optimization and an objective measure of comparison
cannot be underestimated. The inevitably qualitative nature of many aspects of protein
biochemistry-resulting from variability in individual transformation colonies, expression
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cultures, loading of gels and western-blot transfers-multiplies the uncertainty of qualitative
judgments.
The presented optimization of PgLB expression and purification was performed with the
ultimate purpose of kinetic and mechanistic characterization, rather than crystallographic studies.
Implications of this goal include a primary interest in obtaining high quantities of pure, active,
and stable protein. In contrast, crystallography-driven optimizations often prioritize obtaining
monodisperse, concentrated protein, which are absolute requirements for obtaining a crystal
structure.
Because the goal of the presented procedure is biochemical, SDS-PAGE and western
blots alone represent poor methods for comparing the optimal conditions for expression and
purification of the enzyme. While a condition used in a purification step may yield a bright band
on a western blot, it may be unfavorable for activity yields. If constructs with tags of various
sizes are screened, the differences in molecular weight can be a perplexing factor to account for
in gel densitometry measurements. Additionally, expression tags can have effects on structure,
activity and monodispersity of the enzyme, which cannot be accounted for using SDS-PAGE.
Purifying a protein based on specific activity and yields allows a more rigorous and precise
measure of the most efficient purification condition to use for each step.
However, the requirement for a quantitative activity assay can be problematic, as activity
assays are enzyme-specific, and reagents and equipment can make the assays laborious or
expensive to perform frequently. Undeniably, in the developing field of membrane-protein
biology, most information acquired is important and useful even if lacking in certain
methodological precision. Though, while it may be exciting to speculate on results from
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experiments and techniques available, it is equally important to be conscientious of the questions
that these experiments leave unanswered.
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Materials and Methods
Vectors and cloning
The PglB gene was amplified by PCR from the C. jejuni genome NCTC 11168 [39,40]. Primers
used in the PCR encoded a BamHI site at the N-terminus prior to the start codon and His10-
UGA-XhoI on the C-terminus prior to the native stop codon. The PCR product was purified and
digested with BamHI and XhoI (New England Biolabs, NEB) and ligated into the corresponding
sites in the pET24a(+) vector (Invitrogen) using T4 DNA ligase (NEB) and standard molecular
biology procedures. The resulting vector was sequenced and then transformed using
manufacturer-supplied protocols into BL21 (DE3) RIL E. coli competent cells (Agilent) for
expression. Additional vectors screened for expression of PglB with alternate fusion tags include
pGEX with Glutathione-S-transferase (GST) (GE Healthcare), pMAL-c2X with MBP (NEB),
pET SUMO with SUMO (Invitrogen), pET Trx with Thioredoxin (EMD Millipore), and pGBH
with GB1 [23] (Table I).
Protein Expression
Pre-optimized expression was carried out according to the following procedure except when
specifically noted: 5-mL solutions of LB at 25g/L were at 37 0C, until reaching an O.D.= 0.6-0.8.
At this point the temperature was turned to 16'C and cultures were induced by adding IPTG to a
final concentration of 1 mM. Cultures were left to shake overnight. The following day, cells were
harvested and lysed according to the conditions described below. Competent cells screened
included BL21 (DE3) RIL, BL21 (DE3) Gold, BL21 (DE3) RP, BL21 (DE3) pLys (all BL21
strains from Agilent), Rosetta 2 (DE3) (Novagen), Rosetta gami-2 (DE3) (Novagen), and C41
(Lucigen). In contrast, the optimized expression procedure involves using auto-induction media
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ZYM-5052, a high-density growth media [29]. For auto-induction expression, one liter of auto-
induction media was made up in a 6-liter flask to allow adequate aeration of the cultures. 10 g
tryptone and 5 g yeast extract were combined with 960 mL of deionized water and autoclaved.
Once the media had cooled, Kanamycin and Chloramphenicol were added for final
concentrations of 100 pg/mL and 170 gg/mL, respectively. Just before inoculation, the following
media components were added:
* 25 mL of 40X Salt Solution: 1 M Na2HPO 4, 1 M KH2PO 4 , 2 M NH4Cl, 0.2 M Na 2 SO 4
0 20 mL of 50X 5052: 25% glycerol (v/v), 2.5% glucose (w/v), 10% a-lactose
monohydrate (w/v)
0 0.2 mL of 1 OOOX trace metals
9 2 mL of 1M MgSO 4
This gives the final composition of ZYM-5052: 1% N-Z-amine (tryptone), 0.5% yeast extract, 25
mM Na2HPO 4, 25 mM KH 2PO 4, 50 mM NH 4Cl, 5 mM Na2 SO 4 , 2 mM MgSO 4 , 0.2X trace
metals, 0.5% glycerol, 0.05% glucose, 0.2% lactose. Optimized expression is carried out by
inoculating the 1 L auto-induction media with a 5-mL culture grown from a recent transformation
of the PglB vector into BL21 (DE3) RIL. The inoculated media is grown at 37*C for 4-5 hours
shaking at 200 RPM. The temperature is then turned down to 16'C and cultures are left shaking
at 200 RPM overnight. The following day, cultures are harvested and cell pellets are weighed
and stored at -80*C until purification.
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Activity Assay
The Pg1B activity assay has been described in detail elsewhere [41]. Briefly, to a tube of
radiolabeled substrate, Und-PP-Bac-[ 3H]GalNAc, DMSO (10 pL), 2X PglB Assay Buffer
containing 100 mM HEPES, pH 7.5 / 280 mM sucrose / 2.4% (v/v) Triton X-100 (100 gL), 1 M
MnCl2 (2 pL), H2 0 (73 pL), and 5 pL PglB fraction are combined. The assay is initiated by the
addition of 10 pL of a 2 mM stock of the peptide Acetyl-DQNAT-pNF in DMSO [42]. Time
points of the reaction are taken by quenching aliquots of the reaction in biphasic solutions of
3:2:1 CHCl3: MeOH: 4 mM MgCl 2 (1.2 mL). The aqueous layer is then extracted and the organic
layer washed twice with theoretical upper phase (TUP) with salt (2 x 600 pL). The aqueous layer
and washes are combined and mixed with 5 mL of scintillation fluid (Ecolite, MP Biomedicals).
The organic layer was mixed with 5 mL of scintillation fluid (OptiFluor, Perkin Elmer) and all
fractions are subjected to scintillation counting.
Protein Quantification
Total protein in each of the purification fractions is estimated using the Bio-Rad protein assay
(Bio-Rad, #500-0006) according to the manufacturer-supplied protocol. Bovine Serum Albumin
(BSA) standard (Thermo Scientific Pierce) is used to create a standard curve. Fractions are taken
during each step of the purification from a given cell pellet and stored at -80*C. Upon purifying
to the desired end-point, the protein quantities for all samples are measured at the same time to
minimize error. Pure PglB protein is quantified by measuring the absorbance at 280 nm and
using an extinction coefficient of 117,300 M' cm~1 (for T7-PglB-Hisio).
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Cell lysis
All steps of purification are performed on ice or at 40C. A cell pellet of 3-5 g in weight is thawed
on ice and resuspended in 50 mM HEPES pH 7.5, 10% glycerol, 100 mM NaCl for 0.1 grams of
cell pellet per mL. Protease inhibitor cocktail solution, EDTA-free (Calbiochem) and hen-egg
lysozyme powder (Amresco) is added for I pL/mL and 1 mg/mL, respectively. Mixture is
agitated gently for -1 hour. Cell lysis is performed by sonication (Sonics Vibracell, VC 505
(500 watts) & VC 750 (750 watts)). Sonication is performed on ice for 3 x 1 min at 50%
amplitude, pulsing at 1 s on/I s off, and with breaks between cycles to prevent warming of the
mixture. Lysates are centrifuged at 8000 x g, 4"C for 35 minutes to remove unlysed cells and
insoluble cell debris. The supernatant (cleared lysate) is decanted and pellet is discarded.
Isolation of Cell-Envelope Fraction (CEF)
The cleared lysate is centrifuged at 150000 x g, 4*C for 60 minutes. After the spin, the
supernatant is discarded. The pelleted fraction (the CEF) is transferred as quantitatively as
possible to a Pyrex homogenizer using a small spatula. Two mL of high-salt buffer (50 mM
HEPES pH 7.5, 10% glycerol, 250 mM NaCl, 250 mM KCl) is then added to the centrifuge tube
and the remaining CEF is resuspended by gently scraping the bottom of the tube with the spatula.
This wash solution is added to the homogenizer containing the rest of the CEF. The CEF is
homogenized in a final volume of 35 mL of the high-salt buffer (33 mL added, after the 2 mL
wash). The homogenized CEF is returned to the centrifuge tube and this solution is centrifuged at
150000 x g, 4"C for 60 minutes. Again, the supernatant is discarded. The pellet, containing the
washed CEF, is again transferred and homogenized in 5-10 mL of 50 mM HEPES pH 7.5, 30%
glycerol, 20 mM imidazole. This washed CEF fraction is either stored at -80 0C or purification is
continued.
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Extraction of membrane proteins from cell membrane
The optimization procedure for PglB solubilization from the membrane is modeled after one
used previously for the yeast oligosaccharyl transferase [32]. Washed CEF is solubilized by
homogenizing in 50 mM HEPES pH 7.5, 30% glycerol, 20 mM imidazole in a volume that
roughly yields a final concentration of 10 mg total protein per mL. The 5% DDM detergent
solution (in 50 mM HEPES pH 7.5) is diluted 1:10 in the homogenized CEF volume for a final
concentration of 0.5% detergent for solubilization. This 0.5% (w/v) concentration corresponds to
roughly 200X CMC of DDM (IOOX CMC of Triton X-100, and 9X CMC of OG, also screened
at 0.5%) [34]. This solution is re-homogenized thoroughly, and the solution is vortexed at the
maximum setting for two minutes. The solution is then diluted 1:3 in 50 mM HEPES pH 7.5,
30% glycerol, 20 mM imidazole, giving a final concentration of 50 mM HEPES pH 7.5, 30%
glycerol, 0.17% DDM, 20 mM imidazole, and roughly 3.3 mg/mL protein. The solubilized CEF
is centrifuged at 100000 x g, 4'C for 60 minutes. The supernatant is decanted into a clean, pre-
chilled 50-mL conical tube for further purification, and the pellet is discarded.
Ni-NTA purification
The supernatant, containing the solubilized membrane-proteins, is added to Ni-NTA agarose
resin (Qiagen) that has been pre-equilibrated in 50 mM HEPES pH 7.5, 30% glycerol, 20 mM
imidazole, 0.0 1% DDM. The protein solution is gently agitated overnight with the resin. Ni-NTA
purification is carried out with Buffer M (50 mM HEPES pH 7.5, 20% glycerol, 300 mM NaCl,
0.0 1% DDM) plus the specified amount of imidazole used for washes and Buffer E (50 mM
HEPES pH 7.5, 30% glycerol, 100 mM NaCl, 0.01% DDM) plus specified imidazole used for
90
elutions. Batchbinding solution is allowed to flow through a disposable gravity-filtration column
(BioRad). The following fractions are collected: Flow through, Wash A: 1 x 25 mL Buffer M +
40 mM imidazole. Wash B: 3 x 1 mL Buffer M + 100 mM imidazole, Elution A: 6 x 0.5 mL
fractions of Buffer E + 300 mM imidazole, Elution B: 6 x 0.5 mL Buffer E + 600 mM
imidazole. Five microliters of every other elution is removed and used to determine the location
of the active PglB using the activity assay. Fractions containing most activity are combined. The
combined solution is concentrated and buffer is exchanged using an Amicon Ultra- 100K
centrifugal filter (Millipore) into Buffer E (no imidazole). SDS-PAGE is used to verify purity
and then the concentration of the pure PglB solution is quantified using UV-absorbance at A =
280 nm. The solution is then divided into aliquots and stored at -80'C.
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CHAPTER 3:
SEQUENCE-DRIVEN BIOINFORMATIC ANALYSIS OF THE
EVOLUTIONARY DIVERSITY OF
OLIGOSACCHARYL TRANSFERASES
The majority of the data in this chapter has been published in:
Jaffee, M.B. and Imperiali, B. (2011) Exploiting topological constraints to reveal buried
sequence motifs in the membrane-bound N-linked oligosaccharyl transferases. Biochemistry.
50(35):7557-67.
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Summary
In an effort to learn more about the functionally relevant regions of PglB/STT3-specifically, to
investigate the importance of the transmembrane domain for function-the sequences for several
divergent STT3 homologs were analyzed with a range of bioinformatic software programs. It
was noted that the topology predicted for STT3 homologs is conserved. However, the sequences
of the transmembrane helices are highly divergent, preventing recognition of potential conserved
motifs in full-length sequence alignments. To circumvent this issue, a computer program was
developed to parse each STT3 sequence according to predicted topology and group the
sequences of topologically related regions from each homolog. Alignments were then made from
each group of sequence segments individually. For example, the sequence of the first predicted
cytoplasmic loop from each STT3 homolog would comprise one group. This analysis was
performed using 28 homologs from evolutionarily distant organisms ranging from humans to
yeast to bacteria and archaea. The results show that several soluble loops between
transmembrane helices contain strictly conserved motifs, suggesting a critical role of the
transmembrane region in PglB/STT3 function. Sequence and topological analysis was
supplemented by comparison of the secondary structure of the loops containing the conserved
motifs. Secondary-structure predictions indicate the motifs share a conserved local structure,
further demonstrating the importance of these loops. On a general methodological level, these
studies establish the utility of combining topology prediction and sequence analysis for exposing
buried pockets of homology in large membrane proteins.
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Introduction
The C. jejuni OTase PglB comprises a single 82-kDa protein that shows homology to the
catalytic subunit of the eukaryotic OTase, called Stt3 [2,3]. Both have a similar predicted
architecture, with 11-13 transmembrane domains in the N-terminal region followed by a C-
terminal soluble domain (Figure 1). The soluble domain projects into the periplasmic space (or
ER lumen in eukaryotes) and contains the distinctive Stt3 signature motif: WWDxG. However,
sequence identity between PglB and Stt3 is low (17.9%), and apart from the aforementioned
motif, little conservation had been clearly demonstrated between PglB and other Stt3s at the time
of these studies.
TMHMM topology probabilities for PgB
1.2!
S0.6
042 IIEI04
02 10 0 300 400 500 600700N-terminus PgB protein sequence ---- ------ C-terminus
transmembrane - Inside - outside -
N-term - residue - 400 Residue - 400 - C-term
-11-13 TM helices Soluble, globular domain
-C-terminus
N-termInus
Figure 1: Translation of topological probabilities to a picture of protein architecture.
Top: Graphical representation of the topology prediction for PglB. TMHMM algorithm uses
sequence data to predict location of each residue as transmembrane, inside (cytoplasmic), or
outside (luminal or extracellular). Cartoon (bottom) depicts the architecture predicted by the
graph above, with multiple transmembrane domains followed by a C-terminal globular domain.
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At the time this research was performed, little was understood of the structure-activity
relationship of STT3/OTase. Crystal structures existed only for the C-terminal soluble domains
of PglB (C. jejuni) and Pyrococcusfuriosus Stt3. It was expected that the soluble domain
contained the catalytic site, since the only known conserved and essential motif at the time
(WWDxG) appears in this region. Also, the soluble domain alone is relatively simple to express
and crystallize, accounting for the available structural data for this region alone [4-6]. In contrast,
the many N-terminal transmembrane domains make the full-length enzyme very intractable for
in vitro and structural studies (Figure 1). Yet the soluble domain by itself is neither functional
nor capable of binding substrate, limiting the interpretability of the structural data [5,6].
Nonetheless, defining the residues required for OTase function presented a potential
starting point for investigation of the structural prerequisites for catalysis. Therefore, although
lacking activity, additional residues were suggested to function in OTase catalysis based on the
structural data from the soluble domains of P. furiosus STT3 and C. jejuni PglB. The structure of
the P. furiosus soluble domain shows an aspartic acid and a lysine (separated by two residues,
DxxK) that appear to interact with the WWDxG motif (Figure 2). Researchers showed that
mutating these residues led to decreased OTase activity, indicating their potential importance for
enzyme function [5]. However, the general frequency of the DxxK pattern makes it difficult to
define homologous residues in other Stt3 congeners using sequence analysis alone; thus, the
level of conservation throughout evolutionarily diverse Stt3s could not be clearly established.
Some additional loosely conserved residues were shown to display decreased glycosylation when
mutated [4-6]. These studies generated interesting hypotheses about the importance of additional
regions of the OTase, though the lack of strict conservation and quantitative biochemical studies
complicated efforts to define the role of these regions in the catalysis of glycan transfer.
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Figure 2: Pymol representation of crystal structure of P. furiosus Stt3 soluble domain.
(PDB: 2zai, 2.7 A resolution, [5]). The left image shows the full soluble domain and the right
image shows a region of interest enlarged for clarity. Shown as sticks are the residues comprising
the WWDxG motif and the aspartate and lysine from the proposed DxxK motif. Orange dashed
lines show approximate distances for the following: N-terminus and the second tryptophan in the
WWDxG motif (13.3 A), aspartate from DxxK and the first tryptophan in WWDxG (3.1 A), and
lysine from DxxK and the tyrosine situated in the 'x' position of WWDxG (5.6 A).
In contrast, there existed no direct investigation of the significance of the transmembrane
region of PglB and other Stt3 proteins. This region is predicted to be significant in catalysis due
to the highly hydrophobic, and membrane-associated, undecaprenyldiphosphate-linked substrates
that the OTases act upon. In addition, the crystal structure of the P. furiosus Stt3 soluble domain
shows the WWDxG residues in close proximity to the N-terminus (the N-terminus being the
native site connecting the soluble domain to the transmembrane region) (Figure 2). The location
of the WWDxG in the structure suggests these residues are interacting with atoms located on or
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near the surface of the membrane bilayer, implying that residues within the transmembrane
domain interact with the expected site of catalysis [5].
In order to investigate the transmembrane domain of the enzyme directly, sequence
alignments of diverse Stt3 homologs were created. However, as mentioned above, alignment of
full-length Stt3 sequences failed to expose any homology in the transmembrane region. It was
hypothesized that some regions of local conservation may exist within the predicted
transmembrane domain, but in general, these regions are not well defined due to the large size of
the protein and the low overall sequence conservation. In other words, divergence of surrounding
transmembrane helices may create a background noise that prevents detection of intervening
conserved motifs. To test this hypothesis, computational topology predictions, which predict
whether a residue in a protein sequence appears inside or outside of the membrane, were
assembled for several Stt3 proteins (Figure 1). The Stt3 topology predictions were used to
narrow regions of focus, for example, to the amino-acid sequence of a specific loop between two
transmembrane domains. Sequence analysis was then performed on these localized segments
(Figure 3).
In order to expand this analysis to a set of 28 non-redundant Stt3 sequences, which
included 13 eukaryotes, 7 archaea, and 8 bacteria, a program was developed which accepts a list
of homologous protein sequences and the related topology predictions. The program returns the
sequence from each homolog that corresponds to a specific topological feature (e.g. the first TM
sequence, or the third loop of each sequence). This method allowed topology-driven sequence
analysis of a large number of Stt3 sequences, which would have been prohibitively onerous to
evaluate manually. Using this program, substantial homology was identified between PglB and
other Stt3s in the N-terminal transmembrane region of the protein, with several motifs that
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appear between the transmembrane helices in predicted periplasmic soluble loops. Remarkably,
these motifs exhibit strict conservation from bacteria to humans. The secondary structure of the
sequence regions surrounding the motifs was analyzed as well; predictions showed that local
secondary-structure surrounding the motifs are conserved, further supporting the expected
importance of these motifs. In addition to identifying conserved motifs in the OTase enzyme
prior to the availability of supporting structural data [7], the following analysis clearly
demonstrates the utility of combining topology prediction and sequence analysis to identify
conserved, functional motifs in large membrane proteins.
R145SfTxxGxxD'5 2
A.thaliana - I SR SVAGSY(D
C.elegans YTSRSVAGSYD
C.jejuni YYNRTMSGYYD
D.melanogaster - - SRSVAGSYD
H.sapiens - I SR SVAGSYD
Mmusculus - I SR SVAGSYD
M.voltae - FVKTVAGFSD
P.furosus - K I I S I FGYNE
S.cerevisiase - - SR SVAGSYD
W.succinogenes YYNRTMAGYYD
Z.ievis - - SRSVAGSYD
INxxS/T-INxE316
A.thalana SKY I P I I ASVSEHOPPTWP
C.elegans K I H IPI I ASVSEHOPTTWV
C.Jejuni FMYFNVNQT I OEVENVDLS
D.melanogasterK I H I P I I ASVSEHOPTTWF
H.sapiens KNN I P I I ASVSEIHQPTTWS
M.musculusKNN I P I I ASVSEHOPTTWS
M.vottaeTGWPNVLTTVSE LDTASL -
P.furiosus YQSTOVYET VOE LAKTDWMG
S.cerevisaeK I H I P I IASVSEHQPVSWP
W.succinogenes LHFYSVVQT I REASTLSLE
Z.aevisKNNI Pl I ASVSEHOPTTWS
Allows construction of single topology
model for all OTases
Motif:
L/xxxDxY/F
Motif,
R-S/TxxGxxD
Motlf-x
lNxxS/T-I1x
Soluble
- domain:
425-713
Signature
sequence:
W457WDxG 461
Conservation Conseration
22346 5)4 5 3444710
Figure 3: Representation summarizing the topology-based sequence analysis performed on
Stt3 homologs.
The sequence segments corresponding to individual predicted loops (1 t, 2 d, etc.) were isolated
from several Stt3-homologs. These segments were then aligned, at times revealing conserved
residues. Pockets of conservation were then used to construct a revised topology map common to
all OTases.
101
Conserved loop motifs discovered by alignment of
individual predicted loops for many OTase homoloas
L/lxxxD54xY/F
A~thaiana I KYESV HEFDPY FNYRVTQFLSKN
C.Oeas VRFES I GHEFLPWFNYRATHHMVH
Cjejni F NNQLM 1 SNOGY AF AEGAROM I AG
D.melanogaster IRFESI HEFDPVFNYRATAYMVQN
Hsapiens LRFESV HEFDPYFNYRTTRFLAEE
M.mucuiusLRFESV HEFDPT FNYRTTRFLAEE
M.voltae DNGRMYt TALOP YYLRMSENYLEN
P.furiosus ---. KYFSDPDTF YHFEIYKLVLKE
S~cerevisiae IKFES i HEFDPVFNYRATKYLVNN
W.succinogenos HKGILMiNTNDGYVYAEGARDL IAG
Zisevis LRFESV HEFbP FNYRTTRFL TEE
Conservation
Results
Predicted topologies are similar for PgB and Stt3 homologs
Much of the following analysis was motivated by observed similarities between topology
predictions for STT3 homologs. Topology predictions for Stt3 homologs, including PglB,
indicate a conserved overall structural arrangement. Stt3 homologs share a large N-terminal
multi-transmembrane domain, followed by a C-terminal soluble domain (Figure 1). Graphical
depictions of predicted topologies are displayed in Figure 4 for select Stt3 homologs, chosen to
represent the evolutionary diversity of the protein.
It should be noted that the predicted number of transmembrane helices varies from 11-13
amongst sequences from various organisms. However, topology predictions vary subtly
according the specific algorithm used in analysis, which leaves uncertainty about whether the
number of transmembrane domains in STT3 homologs varies or whether some predictions are
incorrect. Some sequences are also predicted to contain a transmembrane domain near the middle
of the C-terminal soluble domain, although the majority of these are predicted to simply contain
a hydrophobic region at this position. The latter scenario is almost certainly the correct one, as
indicated by many studies of the soluble domain [5,8-10]. However, this discrepancy
demonstrates the tentative nature of topology predictions, which often differ depending on the
specific algorithm used, and thus are used only as a guide for investigating protein topology. The
topology prediction server TMHMM was used throughout the present analysis [11].
Closer inspection of the topology diagrams reveals the consistent presence of two
sizeable loops (> 40 residues) located in similar regions of each of the Stt3 topology predictions.
One loop of roughly 50 residues appears consistently after the first transmembrane domain; a
second loop of roughly 40 residues appears 2-3 transmembrane domains before the start of the
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soluble domain (Figure 4). Investigation of the sequences corresponding to the first loop reveals
a prominently conserved aspartic acid (residue D54 in PglB). While other groups have suggested
the existence of conserved residues, a systematic investigation of potential regions of
conservation or their functional significance has not been previously carried out [4,9]. Indeed,
such investigations are hindered by the difficulty of detecting small motifs within the context of
the large and variable full-length sequence. Utilizing the conserved topology of Stt3 homologs,
sequences corresponding to a specific topological feature of each Stt3 protein were extracted,
and then sequence analysis was confined to these sections. To systematize the approach, a
computer program was developed to automatically extract the sequence corresponding to a given
topological feature for a series of 28 divergent Stt3 homologs (Table 1).
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Figure 4. Sequence-based topology predictions for several Stt3 homologs.
The predictions shown are for archaea (M. voltae), bacteria (C. jejuni, Pg1B), fungi (S.
cerevisiae) and a mammal (H. sapiens). The protein sequence from N- to C-terminus is
represented along the x-axis, and the y-axis shows the probability that a given residue appears
within a transmembrane domain or outside the membrane. The tall blocks represent predicted
transmembrane domains. Predictions and illustrations were generated by the Transmembrane
Hidden Markov Model (TMHMM) topology prediction program [11]. Note: The trace running
horizontally along the top of the graph is included in the program output to designate upon which
side of the membrane a soluble section is predicted to appear (i.e. cytoplasmic is blue or luminal,
pink). For the figure shown, this trace can be disregarded, as these predictions tend to be highly
inaccurate when processing sequences with many consecutive predicted transmembrane helices.
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Table 1: Identities of sequences used in all bioinformatic analysis.
Domain Gone entfIer Organilm
eukaryota gil1 322489lemblCAA96722.1 Saccharomyces cerevisiae
archaea gill 1497941 IreflNP_069165.11 Archaeoglobus fulgidus DSM 4304
archaea gi|l5669720refINP_248533.11 Methanocaldococcus jannaschii DSM 2661
archaea gii87045854igblABD1 7750.11 Methanococcus voltae
archaea gi|l340452001reflYP_001096686.1I Methanococcus maripaludis C5
archaea gill 500121891gbIABR54641.11 Methanococcus vannielii SB
archaea gi|2614023681reflYP_003246592.11 Methanocaldococcus vulcanius M7
eukaryota gi|2814856061refINP001 164010.11 Rattus norvegicus homolog B
eukaryota gill48226196IrefINP001083986.11 Xenopus laevis homolog A
eukaryota gil2119656981gbEEB00894.11 Toxoplasma gondii ME49
eukaryota gill 21904152lgblEAY09105.11 Trichomonas vaginalis G3
bacteria gil86153042lreflZP_01071247.11 Campylobacter jejuni HB93-13
eukaryota gil3081591141gblEFO61662.11 Giardia lamblia P15
eukaryota gil127799903|gblAAH48348.21 Homo sapiens homolog A
eukaryota gil55154464gblAAH85313.11 Mus musculus homolog A
eukaryota gil30851502|gblAAH52433.11 Mus musculus homolog B
eukaryota gil238881972|gblEEQ4561 0.11 Candida albicans WO-1
archaea gil189765281reflNP_577885.1| Pyrococcus furiosus DSM 3638
eukaryota gil1 8419993|reflNP_568380.11 Arabidopsis thaliana
eukaryota gil529357gblAAC24442.1 Caenorhabditis elegans
bacteria gil253510784lgblEES89443.1| Helicobacter canadensis MIT 98-5491
eukaryota gil17738187|refINP_524494.1I Drosophila melanogaster
bacteria gil345564991refNP_906314.11 Wolinella succinogenes DSM 1740
bacteria gil3077214321reflYP_-003892572.1| Sulfurimonas autotrophica DSM 16294
bacteria gil2243736601reflYP_002608032.1 Nautilia profundicola AmH
bacteria gil2l98683191gblACL48654.1I Desulfovibrio desulfuricans ATCC 27774
bacteria gil325066002IgbADY74009.1I Desulfurobacterium thermolithotrophum DSM 11699
bacteria gil3l71148261gbIADU97316.11 Thermovibrio ammonificans HB-1
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Identfi cation of conserved motifs
The sequence analysis revealed strong conservation in several Stt3 inter-TM loops, which
is not easily detected when the full-length Stt3 sequences are aligned. Alignments of these motifs
are shown for PglB (C. jejuni) and other key Stt3 homologs in Figure 5. The first
transmembrane helix contains a conserved arginine residue (residue R29 in PglB). The first loop
(which appears in the lumen in eukaryotic Stt3s and the periplasm of the C. jejuni PglB) contains
the [L/I]xx[D 54]x[Y/F] motif. The third loop in the ER lumen or the periplasm contains the
[R/K][S/T]xx[G 14]xx[D 12] motif, and the seventh loop contains the [I/V]xxx[S/T][I/V]x[E 316]
motif. A topology model, shown in Figure 6, was constructed based on a combination of
topology predictions for Stt3 homologs and the conserved motifs, and is used to indicate the
locations of the identified motifs.
R
Afulgidus - - - - - - LMLAV I LFALAVRFQNFGE IFDSGI YY
A.thalianaNVLSVL I LVL I GVLAFS I RLFSV I KYESV I HEF
C.albicansVLLKVI IFISIAGAAISSRLFSVIRFESI IHEF
C.elegansTLLTIVVLALAWFVGFASRLFAIVRFESI IHEF
C.jejuni - -- LFAMI I LAYVFSVFCRFYWVWNASEFNE-Y
C.lari ----- I LI LAFAFSVLCRLYWVAWASEFYE -F
D.desulfuicans A LF L V VAL IVP LGLGLF VR LNDVPVWE KH KALF
D.melanogasterSLITFAILLIAWLAGFSSRLFAVIRFESI IHEF
D.thermolithotrophumLI L LL VS I II PIT IGLYVRFDDLRVWEKYKNQF
G.lamblIaRPLAL IGMI F I GALAFFCRLMSV I RYETV I HEF
H.canadensisGLDF I SFSFRNLKNQLF IRLTSHSFFWHFVLLF
H.sapiensTLLKLL I LSMAAVLSFSTRLFAVLRFESVIHEF
M.jannaschi--KVFLI ILMLMFVSFQLRAQTADMKFAQDNEF
M.maripaludis- -KLI LI I LF IGMMSFQIRAQTADMPFAEDSQY
M.musculus.ATLLKLL I LSMAAVLSFSTRLFAVLRFESV IHEF
M.musculus.BSLLSFTI LFLAWLAGFSSRLFAVIRFESI IHEF
M.vannielii- -KLFLI ILFIGLMSFQIRAQTADMEFTE-SSY
M.voltae- -KT ILI I IFLAFLSFQMRAQTADMGFTTNEQY
M.vulcanius - - K I AL I VLLLMFMSFQLRAQTADMKFAQGNEF
N.profundicola - -AFVLISFAYVFATAVRYYYFSWASGIKE-F
P.furosusTVLAFLVVLAFAAYGFYIRHLTAGKY ------ F
R.norvegicusSLLSFTI LFLAWLAGFSSRLFAVIRFESI IHEF
S.autotrophicaALFLVVAL I VPLGLGLFVRLNDVPVWEKHKALF
S.cerevisiaeTILKLVIFVAIFGAAISSRLFAVIKFESI IHEF
T.ammonificansALFLVVAL IVPLGLGLFVRLNDVPVWEKHKALF
T.gondiPVVEVAALLVIFVLCFCIRQFAVIRYESVIHEF
T.vaginalisKTIQLLIVILSCILSVLIRLFSNVINEPIIHEF
W.succinogenes - - -DI GLAL L LF LFALGARLAWVVDFGAYEE - F
Z.aevisTLLKLLI LSMAAI LSFSTRLFSVLRFESVIHEF
Conservation - -
L/IxxxD x
Afulgidus - - -- I YYTGYDSYYHMRLVEVMVKE
A.thaliana I KYESV I HEFDPYFNYRVTQF LSKN
C.albicans I RFES I I HEFDPWFNFRATKYLVTH
C.elegansVRFES II HEFDPWFNYRATHHMVQH
C.jejuniFNNQLMI I SNDGYAFAEGARDMI AG
D.desulfurcans LGSQWL LATHDAYHWVAGAEG I GLA
D.melanogaster I R F E S I I H E F D PWFN YRAT AYMVQN
D.thermolithotrophumY EDR P L F T SYD AF F F AR YGK EY LNG
Glamblia I RYETV I HEFDPYFQYKSTLYLNEK
H.canadensis FENTL I LTSYDSYFYAKGAKEFL - -
H.sapiens LRFESV I HEFDPYFNYRTTRFLAEE
M.jannaschiiEHGRMYL LALDPYYYLRLSEN LYNN
M.maripaludisDNGRMYLTALDPYYYLRLTENYQNS
M.musculus.ALRFESV I HEFDPYFNYRTTRFLAEE
M.musculus.B IRF ES I I HEFDPWFNYRSTHH LASH
M.vannieliiENGRMYLTGLDPYYYLRQSENY LNS
M.voltaeDNGRMY LTALDPYYYLRMSENY LEN
M.vulcaniusEHGRMYL I A I DPYYYLRLAENLYDH
N.profundicolaWHGTLM I NNVDGYYYAAGAKELLNN
P.furiosus - - -- KYFSDPDTFYHFE I YKLVLKE
R.norvegicus I RFES I I HEFDPWFNYRSTHH LASH
S.autotrophica FNGQFM I NTNDGY IWAEGARDLLSG
S.cerevisiae I KFES I I HEFDPWFNYRATKYLVNN
T.gondli IRYESVIHEFDPYFNYRTTTYLAKE
T.vaginalisVINEPI IHEFDPHFNWRCSQYIDQH
W.succinogenesHKG I LMI NTNDGYYYAEGARDL I AG
Z.aevis LRFESV I HEFDPYFNYRTTRF LTEE
Conservation A L
106
149 1b
R/K-S/T-xxG xxD
Afulgidus -VWKTVLGQADHHA - -
A.thaliana - I SRSVAGSYDNEAVA
C.albicans - - SRSVAGSYDNEA I A
C.elegansYTSRSVAGSYDNEGI -
Cjejuni YYNRTMSGYYDTDMLV
D.desufuricans F LART L LGYYDTD LVT
D.melanogaster - - SRSVAGSYDNEG I A
D.thermolithotrophum - LVRTS I ARFDTDS LN
GlambliaF I QRSVAGSYDNESSS
H.canadensis FYQRNGVGYFDTDML I
H.sapiens - I SRSVAGSYDNEG I -
M.jannaschil - LYKTCAGFADTP I FIE
M.maripaludisL I YKTSAGFSDTP I F -
M.musculus.A - I SRSVAGSYDNEG I A
M.musculus.B - - SRSVAGSFDNEG I A
M.vannieliiL LLYKTSGGFADTN ---
M.votae -FVKTVAGF SDTP - - -
M.vulcanius - LYKTCAGFADTP I - -
N.profundicola -YNRTMVGYYDTDM- -
P.furiosus - K I I SIFGYNELEAF L
R.norvegicus - - SRSVAGSFDNEG I A
S.autotrophicaYYNRTMAGYYDTD - --
S.cerevisiae - - SRSVAGSYDNEA I A
T.gondiiYMSRSVAGSYDNEAV -
T.vaginalisF I SRSVAGSYDYEC I -
W.succinogenes YYNRTMAGYYDTDM - -
Z.laevis - - SRSVAGSYDNEG I A
Conservation .
2 316
INxxS/T-INxE
A.fulgidusFGAN I YLPT I SEARSLQ IF
A.thaliana SKY I P I I ASVSEHQPPTWP
C.albicansK I H I P i I ASVSEHQPTAWP
C.elegans K I HIP I ASVSEHQPTTWV
C.JjuniFMYFNVNOT I QEVENVD LS
D.desufurdcans LMYPSVAQS I I EVQDL SFA
D.melanogasterK I H I P I I ASVSEHQPTTWF
D.thermolithotrophumGGFPNVFMS I SEAKHFD I -
G.amblaKRIFNIP I VASVAEHOPTVWS
H.canadensis F I YASVVES I LETSKANFT
H.sapiens KNN I P I I ASVSEHQPTTWS
M.jannaschiiTGWPNVYTTVAE L AKPSSW
M.marpaudisTGWPNVYTTVSELA I PTF -
M.musculus.AKNN I P I I ASVSEHQPTTWS
M.musculus.BK I H I P I I ASVSEHQPTTWV
M.vannieliiVGWPNVFTTVSELAVPTV -
M.vottasTGWPNVLTTVSELDTASL -
M.vulcaniusSGWPNVYTTVSELAKPSSW
N.profundIcola LHFYNVSKT I REASO I PFD
P.furosusYQSTQVYETVQE LAKTDWG
R.norvegicus K IH I P I I ASVSEHOPTTWV
S.autotrophica LHFFTVMQTVREAGH I PFE
S.cerevisiaeK I HI P11 ASVSEHQPVSWP
T.gondiiTKYLP I [ASVSEHQPATWA
T.vaginalisTKN I P I I ASVAEHQPSSWS
W.succinogenes LHFYSVVQT I REASTLSLE
Z.IaevisKNN I P I ASVSEHOPTTWS
Conservation o , -
4/b
D
A.fulgidusEYSVMSWDYGNWI LY- VSKKAVVCNN--
A.thallanaDDKVASWDYGYQTTA - -MANRTV I VDNNT
C.albicanSDAKVMAVWWDYGYQ I GG - -MADRTTLVDNNT
C.elegansDARVMSWWDYGYQO AG- -MANRTTLVDNNT
C.jejuniEDYVVTWDYGYPVRY -YSDVKT LVDGGK
D.desuluricansDSMLWLWWDWGYAAHY - -FAHRAT I ADGAQ
D.melanogasterDARVMSWWD YGYQ I AG - -MANRTTLVDNNT
D.thermolithotrophumNSWI WTVWDYGTA I EY - -LAGRAVFHDGQS
G.lambliaTAKVASWDYGYQ I NQ - - I GNKTT LADGLT
H.canadensisQDVAFVWDYGYALEY - -FTQAQTLLHGGR
Heapiens DAKVMSWWDYGYQ I TA - -MANRT I LVDNNT
M.jannaschliNSV I TCWVDNGH I YTY - -EARRMVTFDGGS
MImarIpaIudisNSVVTCWWDNGH I YTW- - ATRKMVTFDGGS
M.muscuus.ADAKVMSWWDYGYQ I TA - - MANRT I LVDNNT
M.musculus.BHARVMSWWDYGYQ I AG- -MANRTTLVDNNT
M.vannielIlNAVVTCAWWDNGH I YTW- - ATRKMVTFDGGS
M.voltaeNSVVTCWWVDNGH I YTW- -KTDRMVTFDGSS
M.vulcaniusNSV I TCWWDNGH I YTY - - EARRMVTFDGGS
N.profundicola EDYVVTWWDYGYP I RY - -YAGTKT LVDGGK
P.furosus YSTAT SWWDYGYWI ESS L LGQRRASADGGH
R.norvegicusHARVMSWDYGYQI AG --MANRT T LVONNT
S.autotrophicaDDYV I SWVDYGYP I RY - - YADVKT L ADGGK
S.cerevisiaeDSKVAAWDYGYQIGG- -MADRTTLVDNNT
T.gondilRAR I MSWVDYGYQATA - -MGNRTVLVDNNT
T.vaginalis DO K VMSWD YGYQ I T S - - MGGRGCMADGN T
W.succinogenes EDYVMAWWDYGYGLRY --YSDVKT L I DGAK
Z.aevisDAKVMSWDYGYQ I TA --MANRT I LVDNNT
Conservation UuJ I a.. i~um -
Figure 5: Alignments for highly conserved regions of OTase sequences.
All 28 homologs listed are listed in Table 1. Top left alignment shows a conserved arginine
within the first transmembrane domain. The corresponding residue number in PglB (C. jejuni) is
designated in superscript. Alignments and conservation histograms shown were made using
Jalview multiple alignment editor. (doi: 10.1093/bioinformatics/btpO33). Histogram shading:
light to dark designates most to least conserved. Alignment conservation calculation uses the
MAAFT method of multiple sequence alignment (Livingstone, C. D., Barton, G. J. (1993)
CAMBIOS 9: 745-756).
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Motif:.
L/lxxxD"xY!F
Motif:
RIK-5/TxxG' 4xxD'6
R
Motif
NxxS/T-INxE3"1
Soluble domain
425-713
Signature sequence:
W45IWDxGx4
N
Figure 6: Topology model of PglB showing locations of conserved motifs.
Model is based on a combination of topology prediction programs (see Methods) and
conservation of loop regions, and agrees with topology of the C. lari crystal structure. Thirteen
transmembrane helices are followed by a globular domain located in the periplasm. Predicted
locations of identified motifs are indicated by arrows. The N-terminus is located in the
cytoplasm.
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Assessing structural conservation in loops
Sequence analysis of the various Stt3 proteins provided strong predictive data that these
regions are fundamentally involved in PglB function. However, the motifs consisted of one to
three highly conserved residues interspersed with stretches of residues with little or no
conservation. Additionally, these motifs are short and potentially difficult to identify within a
loop. For example, the first major loop contains a D-x-Y/F/W motif, in which the aspartate is
invariably conserved. But it is not improbable that several Stt3 homologs will show several
appearances of this motif pattern appearing in the first luminal loop.
Therefore, to supplement the sequence alignments, the series of Stt3 homolog sequences
for the two largest loops were submitted to the free online software program NetSurfP, which
predicts a protein's secondary structure and level of accessibility from the sequence [12]. While
NetSurfP is less well-known than several alternative programs available for this purpose, the
program both allows input of a list of sequences at a single time and the output data can easily be
parsed to provide visually informative graphs, which makes for simpler comparison and
detection of patterns.
The conserved Stt3 motifs invariably appear in the same loops relative to the remainder
of the protein. Therefore, it is expected that the motif-containing loops exhibit secondary-
structure conservation in this region in order to structurally situate the motif into a functional
position. In other words, is likely that the location of the motif within the loop will fall in the
same location with respect to the secondary structure of the loop (e.g. the motif may appear
continually in a coil between two alpha helices, etc.). As a result, the secondary structure pattern
presumably provides an alternate way to quickly identify the motif of interest with high
confidence. Additionally, the conservation of secondary structure can also be informative of the
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flexibility, and thus potential mobility of the loop, in the OTase reaction. Finally, a conserved
secondary structural pattern can function as an additional way to refine the predicted border
residues of the loops and help identify additional regions in the loops that are critical for
function.
The sequences for two of the predicted loop regions were analyzed for all of the Stt3
homologs used to make the alignments. The two loops analyzed included the first soluble loop
containing the highly conserved aspartate (in the motif D-x-F/Y/W, D54 in C. jejuni) and the
large soluble loop toward the C-terminus of the transmembrane region (containing the motif S/T-
I/V-x-E, E3 16 in C. jejuni). These two loops, both ranging from 30 to 100 residues, are both long
enough to get a meaningful prediction of structure (in contrast to the roughlyl 0-residue R-S/T-
xx-G-xx-D -containing loop) and yet these two soluble loops are short enough to identify subtle
patterns and variations. Graphs of the secondary structure predictions for the first loop are shown
in Figure 7 for several representative organisms across the evolutionary spectrum. The graphs
for all Stt3 homologs involved in the sequence analysis are shown at the end of this section
(Figures 9 and 10).
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-p(a-Hefix) -p(f-Sheet) p(coI) C. jejun; 33-77
V W Wy A S F N E Y F P N N L M I I N 0 YA F A E G A R D M IA 0 F 1 1 P 11 0 L
D. thermolithotrophum 27-117
M vo/tae:57-129
NADMGFTTNESYLOVFSDONGRMYLTALCPYYYLRMSENYLENGHTOC LKN I GOOVPWDSYKYGPTGARAT
S. cerevisiae: 28-81
A S S R LF A V K F E S I H E F W F N Y R A T K Y L V N N S F Y K F L N W F 0 D R T A Y P L 0 R
Figure 7: Secondary structure predictions for first major conserved loop in several Stt3
homologs.
The x-axis shows the protein sequence for the first conserved loop of the homologs lsited. The y-
axis gives the calculated probability (p) for each residue that it is located within an alpha helix
(blue line), beta strand (red line), or coil (green line). The conserved aspartate in the D-x-W/F/Y
motif is underlined for reference.
The known motifs are useful in comparing the secondary structure predictions, because
they create anchor points around which to align the graphs. The graphs are based both on the
topology prediction of the length of the loop as well as the prediction of secondary structure. The
combination of predictions from several programs increases the associated error. This ambiguity
makes it difficult to determine whether a given graph may be representing, for example, the first
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or latter half of the loop sequence. It is important to recognize that the presence of a given
section of secondary structure in some graphs and not others does not necessarily imply a lack of
structural conservation. As noted above, the accuracy of these graphs is not only dependent on
the accuracy of the secondary-structure predictions but also on the topology predictions of the
length of the loop region. Since nature rarely adheres to convenient categories such as
membrane, inside, or outside in location, the situation is often complicated when the borders of
the protein loop are not well defined. A comparison of two highly similar bacterial OTase
sequences from C. jejuni and W. succinogenes highlights how similar sequences can produce
highly variable results. Figure 8 demonstrates this principle making use of the C. lari structural
model (PDB 3RCE, [7]).
The structure in Figure 8 shows the region encompassed by the first conserved loop for
C. jejuni and for W. succinogenes. The W succinogenes predicted 'loop region' (Figure 8D)
includes an additional section of an alpha helix that appears to lie atop the membrane and then
merge with the following TM helix. Thus, although these sequences are virtually identical, it is
clear that the topology prediction may differ for each in defining the precise borders of 'loop'
versus 'TM helix', as the structural border between these two defined categories is inherently
unclear.
The conserved residues, however, can be used to clarify this potential complication. For
example, in the graphs shown in Figure 7, there is considerable variation at first glance.
However, the appearance of the D-x-W/Y/F motif is underlined in each sequence. Using this
anchor point, a clear pattern becomes visible. The motif consistently appears at the start of a
clearly defined alpha helical segment, which is invariably bordered on both sides by a short
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region of coil structure, which is then interspersed with short occurrences of backbone structure
in the form of beta strand or alpha helix.
A. C. jejun 33.77 -p(a-Hefix) p(P-Sheet) p(coUl)
VWW A SEFN EYF F NNQL M IiS NDG Y A FAE GA RDM IAG F HQPN OL S
W succinogenes. 42-103
A Y E E F L H K G I L M I N T N G Y Y Y E 0 A R 0 L I A G F H Q E N D L S P L H T P L 5 L L T A W L Y H L T P F S L E
B. ~SolubleSdoma C.D.
Residues 33-77 Residues 33-106
Membrane
helices
Figure 8: Example of one source of ambiguity in topology predictions: when a helix is both
'soluble' and integral-membrane'.
(A) Secondary-structure predictions for first transmembrane loop in C. jejuni and W.
succinogenes, are highly similar, showing the formation of 1-2 strong helical regions. Though
the sequences are highly similar, the prediction for where the soluble loop transitions into a
transmembrane helix differs for each protein (ranges of graphs, part A). The large, well-defined
helices in this loop account for the inconsistency. Both predicted ranges are mapped onto the C.
lari X-ray crystal structure shown in (B). The range predicted to be 'soluble' for C. jejuni is
shown in (C); the region predicted to be 'soluble' for W succinogenes is shown in (D). The
fusing of the second helix in the loop with the following TM helix is shown and accounts for
variability in predictions.
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The graphs can also be interpreted generally as a prediction of structural rigidity versus
flexibility (alpha helix or beta strand represent formation of rigidity through peptide backbone
bonds, while coils are generally more disordered, or flexible, and less confined by energetic
nadirs formed by secondary-structure bonding). Consequently, the invariable presence of some
secondary-structure order indicates that the region of the loop containing the motif is
constrained, and any movement involving this unit is expected to be tightly controlled.
The first loop, as noted above, is predicted to contain a high content of alpha-helix and
beta-sheet structural order, which implies a general ordered nature. In contrast, the second large
loop in the transmembrane region, which contains the motif S/T-I/V-x-E, consistently is
predicted to contain a high degree of disorder. The predictions for the sequences comprising this
loop consistently have high coil content interrupted by 1-2 precipitous drops in coil toward the
center of the loop. The conserved motif unfailingly appears in one of these sudden, brief
appearances of secondary-structural order, and at times is predicted to be an alpha-helix and
other times predicted to be a beta-sheet. This prediction is in agreement with the available
structural data, in which a large portion of this loop is unresolved in the crystal structure [7]. The
conservation of the general size and secondary structure composition of this loop, in addition to
the presence of the conserved motif, implicates this region in a critical motion for catalysis,
perhaps in substrate binding or release. The secondary-structure predictions for these two large
loops are shown for all 28 Stt3 homologs in the following pages. Figure 9 shows predictions for
Loop 1 containing the conserved motif L/I-xxx-D-x-Y/F/W and Figure 10 shows predictions
luminal/periplasmic loop 5 containing the conserved motif S/T-V/I-x-E.
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For Figure 9, sections 9A, 9B, and 9C respectively appear on the three pages immediately
following the current one.
Figure 9: Secondary-structure predictions for regions of Stt3 sequences predicted to
correspond to the first soluble loop containing the conserved L/I-xxx-D-x-Y/F/W motif.
Along the x-axis runs the protein sequence predicted for this region (residue numbers indicated
next to species name) and the y-axis gives the probability that each residue is part of a coil
(green), helix (blue), or P-sheet (red). Loop 1 contains the highly conserved motif L/I-xxx-D-x-
Y/F/W in Stt3 homologs (see Figure 6). The location of the aspartate in the motif is highlighted
with a purple star. The graphs are group according to kingdom: (A) eukaryote, (B) bacteria, (C)
archaeal.
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Figure 9A: Eukaryotic Stt3 homologs
Eukaryota (Loop 1, I/L-xxx-D*-x-F/Y/W)
H sapiens: 38-85
I. norvegicus: 82-134
M. musculus -
HomologA: 38-83
.1. musculus-
HomologB: 81-133
X laevis: 38-83
D. metanogasrer:- 31-89
A. thaliana: 42-88
C. albicans: 42-90
S. cerevisiae: 28-81
G. lamblia: 31-104
r. vaginalis: 31-104
.gondli: 82-149
p(a-Helix) -p(f-Sheet) p(coil)
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Figure 9B: Bacterial Stt3 homologs
T. ammonificans: 28-107
D. thermelithotrophum: 27-117
N. profundicola: 35-107
W. succinogenes: 42:103
C. jejwni: 33-77
S. autotrophica: 33-112
D. desulfuricans: 91-155
H canadensis: 100-137
Bacteria (Loop 1, I/L-xxx-D*-x-F/W)
&VL A.~I
LV..W..i..±.
k 'A
p(o-Heix) -p(f-Sheet) p(coHI)
117
Figure 9C: Archaeal Stt3 homologs
A.fulgidus: 21-94
P.furiosus: 46-87
M. vannieii: 38-140
.. vuicanius: 38-144
M.annaschi: 45-119
M. voltae: 57-129
M. maripaUdus: 38-112
Archaea (Loop 1, I/L-xxx-D*-x-F/YIW)
(A N,
-p(a-Helix) -p(f3-Sheet) "-P(coiI)
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For Figure 10, sections 10A, 10B, and 10C respectively appear on the three pages immediately
following the current one.
Figure 10: Secondary-structure predictions for regions of Stt3 sequences predicted to
correspond to the soluble loop containing the conserved S/T-I/V-x-E motif.
Along the x-axis runs the protein sequence predicted for this region (residue numbers indicated
next to species name) and the y-axis gives the probability that each residue is part of a coil
(green), helix (blue), or P-sheet (red). Loop 5 contains the highly conserved motif S/T-I/V-x-E in
Stt3 homologs (see Figure 6). The location of the glutamate in the motif is highlighted with a
purple star. The graphs are group according to kingdom: (A) eukaryote, (B) bacteria, (C)
archaeal.
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Figure 1OA: Eukaryotic Stt3 homologs
Eukaryota (Loop 5, S/T-V/I-x-E*)
I. norvegicus: 371-411
S. cerevisiae: 321-359
X laevis: 319-363
/
AA4&AZ2\ 6~LL T. gondii: 365-404
T. vaginalls: 313-350
H sapiens: 319-363
M. musculus -
HomologA: 319-363
C. albicans: 327-367
C elegams: 321-361
<A
(N
G. lamblia: 327-366
M. musculus -
HomologB: 370-410
A. thallana: 325-370
D. melanogaster: 320-360
~~Lv
-p(a-Hefix) -p(P-Sheet) p(coil)
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Figure 1OB: Bacterial Stt3 homologs
Bacteria (Loop 5, S/T-V/I-x-E*)
S. autotrophica: 291:335
C. jejuni: 280-331
H canadensis: 354-399
I~4LA
N. profundicola: 288:332
D. desulfuricans: 391:437
W succinogenes: 290:338
T. ammonificans: 260-292 D. thermollthotrophum: 267-305
p(a-Heix) -p(f-Sheet) p(coil)
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Figure 10C: Archaeal Stt3 homologs
Archaea (Loop 5, S/T-V/I-x-E )
M. annieUl: 292-346
M. voae: 328-375
v v I m A a P L L c 5 0 G P v T v c 0 A t c t
A.fulgidus:275-306
P. furiosus: 325 -370O
V~~~~~~ t* Y Y k0 0 v v y v x 6
V1V~
At0 Q V 5 t A A T w t I 1 5 1 1 1
i IT 10 Pv Iv P1". 1 TA
M. vulcanius:: 369-417
M. maripaUdus: 293-339
.jannaschi: 381430
-p(a-Helix) -p(P-Sheet) p(coil)
122
Conclusions
In recent years, it has become abundantly clear that the conserved loop segments between
transmembrane domains often play a fundamental role in substrate recognition and/or catalysis in
integral membrane proteins [13-16]. However, it is particularly difficult to observe sequence
conservation in these regions because motifs may be embedded within transmembrane regions
that have diverged considerably through evolution, thereby complicating sequence alignments.
Demonstrated here is a straightforward method for defining these buried regions of conservation
applied to the complex integral-membrane OTase PglB. Topology predictions are generated for a
list of homologous sequences using freely available software; a designed algorithm then parses
each sequence by topological feature. These sequence segments are then more fruitful for
detecting regions of conservation through sequence alignment. The systematic nature of the
method allows for position-specific sequence analysis of a large number of divergent sequences
of a given protein, which is crucial for determining the extent and significance of proposed
motifs. These results expose the extraordinary level of conservation that exists in Stt3 homologs
from bacteria through humans. Conservation over this evolutionary span implies that these
regions play an essential role in the OTase activity.
With the breadth of computational prediction programs currently available, information
on a protein can be gleamed without entering a laboratory. While the predictions generated will
generally require experimental validation in order to be accepted, the predictions can also make
evident the experiments that will likely be successful in providing results.
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Materials and Methods
Bioinformatic analysis
Sequences of Stt3 homologs were chosen by searching NCBI Entrez Protein Database for 'Stt3'
and selecting Stt3 homologs from evolutionarily diverse organisms. The collated set of 28 non-
redundant sequences (Table 1) were subjected to topology prediction analysis via the TMHMM
2.0 server (http://www.cbs.dtu.dk/services/TMHMM/) [11]. Batch topology output was run
through our 'TMH.py' program, which was written in Python code (all codes provided in Figure
5). The 'TMH' program parsed the topology prediction data and returned output files with each
Stt3 GenBank Identifier (gi) number and the predicted sequence ranges for the appropriate
topological location (i.e. inside (cytoplasmic), outside, or transmembrane). Each output file and
the Stt3-sequence file were directed to our 'Extract.py' program, which extracted the region of
the sequence corresponding to the specified range indicated for a topological characteristic. The
final output file for a specific topological feature showed, for each Stt3 sequence, the gi number
followed by the sequence range and its corresponding sequence (e.g. >1322489 [1:9]
MGSDRSCV \n >1322489 [100:116] ALRNWLGLPIDIRNVC, etc.). Sequence analysis was
carried out by selecting a feature of each Stt3 (e.g. the first 'inside loop' prediction) and aligning
the corresponding sequences using MAFFT [17]. The alignments were used to identify
conserved motifs within the given feature. The alignments were then manually adjusted for those
Stt3 sequences in which the conserved motif did not appear exactly within the residue range
predicted by TMHMM, but in a proximal region.
For secondary structure predictions, the same extracted fragments for the two major TM
loops were input as a list in Fasta format to NetSurfP (http://www.cbs.dtu.dk/services/NetSurfP/)
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[E12]. The output contained a probability for each residue assessing that whether it is contained in
an alpha-helix, beta-sheet, or coil. These probabilities were graphed in Excel.
Summary of topology sequence-extraction programs
1. Download list of desired FASTA sequences from Entrez, call this file 'fastas.txt'
2. Input fastas.txt to TMHMM topology prediction and select 'extensive output without graphics',
name output file predicts.txt
3. Run TMHMM.py with command as follows:
python TMHMMinside.py predicts.txt insideranges.txt
the output file 'inputranges.txt' will have a list that looks like the following:
1322489 1 8
1322489 100 115
1322489 162 171
etc... where the first number is the gi,
the second number is the beginning residue of the inside range,
and the third is the last residue of the range
When the ranges for all of the inside-predicted regions for gi 1322489 are listed,
the inside regions for the next gi (sequence) are listed, etc
4. Run extract2.py with command as follows:
python extract2.py fastas.txt inside-ranges.txt inside seqs.txt
The output file 'insideseqs.txt will have a list that looks like the following:
>1322489 [1:9]
MGSDRSCV
>1322489 [100:116]
ALRNWLGLPIDIRNVC
etc... giving sequences for all the ranges listed in 'inside ranges.txt'
5. Repeat from step 3 replacing 'inside' at all points with 'outside' or 'TMhelix'
e.g. TMHMMoutside.py, outside ranges.txt, etc.
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#Program 1: TMH.py
#extracts topology prediction data from TMHMM output
#takes in topology results and extracts the gi number and ranges in the sequences predicted to be TMhelix (or inside, or #outside,
by changing 'TMhelix' to appropriate
S
import sys
if len(sys.argv) == 1:
print "Error: Must input a file name"; sys.exito
else:
fn = sys.argv[1]
fh = open(ft)
lines = th.readlines()
output = sys.argv[2]
sys.stdout = open(output, 'a')
seqs=[]
r = "
for line in lines:
string = line
if len(string) > 1:
if string[2]='':
m= I
splat = string.split()j = splat[O]
j = j.split('')
gi =j[l]
if splat[2] =='outside':
a = splat[3]
a = int(a)
a=a-2
if a< 1:
a= 1
b = splat[4]
b = int(b)
b=b+2
print gi, a, b
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#Program 2: Extract.py
#first input- takes in list of fasta sequences and removes newline
#second input- file output from TMHMM program with gi and its range for a specific topological section
#output- prints the gi, the range, and the sequence corresponding to that range
import sys
if len(sys.argv) = 1:
print "Error: Must input a file name"; sys.exito
else:
fh = sys.argv[I]
seq = sys.argv[2]
fh = open(fh)
lines = fh.readlines()
output = sys.argv[3]
sys.stdout = open(output, 'a')
seqs=[]
gi =
for line in lines:
if line[O] =='>':
seqs.append(gi)
r= "
line = line.split('I')
gi = line[I]
gi = gi+'
else:
line = line.rstrip("\n")
line = str(line)
gi+=line
seqs = seqs[1:]
fh = open(seq)
linez = fh.readlines()
for i in linez:
line = i.split( )
gi = line[O]
rangel = line[l]
if rangel < 0:
rangel = 1
range2 = line[2]
rangel, range2= int(rangel), int(range2)
rangel = rangel - 1
for j in seqs:
k = j.split('_')
if gi == k[0]:
sec = k[ 1]
#range2 = len(sec)
secl = sec[rangel:range2]
rangel, range2 = rangel +1, range2 +1
rangel, range2 = str(rangel), str(range2)
print'>' + gi, '[' + rangeI + ':' + range2 +
print secI
Figure 11: Python code for programs developed to parse and group sequence data
according to predicted topological constraints.
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CHAPTER 4:
BIOCHEMICAL VALIDATION AND CHARACTERIZATION
OF SEQUENCE MOTIFS CONSERVED IN
OLIGOSACCHARYL TRANSFERASES
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Summary
The topology-driven sequence analysis discussed in Chapter 3 identified three highly conserved
motifs present in the inter-transmembrane loops of oligosaccharyl transferases. This chapter
discusses the mutagenesis, expression, activity, and limited proteolysis studies performed on
PglB to determine whether key residues in the loop regions of PglB/Stt3s are required for
function. The level of specificity required at these sites was further investigated by mutating the
key residues to amino acids with similar properties to the native residue. Finally, partially active
mutants were analyzed using a substrate rescue assay to determine potential involvement in
substrate binding. Recent suggestions of a conserved DxxK motif based on the P.furiosus
soluble-domain crystal structure were investigated in a similar manner by mutating and assaying
appearances of this DxxK pattern in the PglB soluble domain. Coincident to the publication of
this date, a structure of the full-length PglB was published [Lizak, C. et al (2011) Nature 474,
350-355]. Both the following biochemical studies and structural data have strongly verified the
functional importance of the predicted motifs in catalysis.
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Introduction
The previous chapter discusses a strategy used to simplify detection of conserved motifs
in transmembrane proteins. When applied to the sequences for PglB and a range of Stt3
homologs, several strongly conserved motifs are revealed. Prior to detection of these motifs, very
little conservation had been definitively demonstrated in Stt3 homologs, excepting the WWDxG
motif present in the soluble domain of the enzyme. The publication of the structure of the soluble
domain from the P. furiosus Stt3 had led to speculation that an aspartic acid and lysine
(separated by two non-conserved residues, called DxxK) are conserved and may be involved in
catalysis. However, the general frequency of the DxxK pattern makes it difficult to define
homologous residues in other Stt3 congeners using sequence analysis alone.
To investigate the hypothesis of an essential DxxK motif in PglB, the three appearances
of this sequence pattern in the soluble domain of PglB were mutated and each mutant was
assessed in a similar way to the loop mutants. A small number of additional conserved regions
had also been suggested that showed decreased glycosylation when mutated; however, the
conservation demonstrated was relatively low [1-3]. All of these studies generated interesting
hypotheses about the importance of additional regions of the OTase; although the lack of
quantitative biochemical studies complicated efforts to define the role of these regions in the
catalysis of glycan transfer.
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Figure 1: Topology model of PgIB showing locations of mutants.
Model is based on a combination of topology prediction programs and conservation of loop
regions (Chapter 3) and agrees with topology of the C. lari crystal structure [4]. The N-terminus
is located in the cytoplasm, along with the two loops containing non-conserved residues that
were mutated to serve as positive controls.
Figure 1 shows a topology model of PglB with the approximate locations of the mutants
described in this chapter. To experimentally examine the functional relevance of the loop motifs
and the presence of an essential DxxK motif, key residues in the PglB gene were mutated and the
resulting mutant constructs were transformed into and expressed in E. coli. In addition, several
residues were mutated which were predicted to be in cytoplasmic loops and which showed no
detectable conservation (Figure 1). These mutants (K124A and K351A) served as controls for
loop-residue essentiality. The recombinant mutant proteins were purified as CEFs. Western blots
were run on all CEF mutant fractions to show that each mutant was expressed at a level
qualitatively similar to wild-type PglB. Fractions of the CEFs were then subjected to kinetic
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analysis using a highly specific assay for PglB activity. Most mutants were assayed with time
points ranging from one minute to three hours; those which failed to show turnover after three
hours were subjected to a time-course that extended overnight. Several of the mutants showed a
complete loss of activity, while others showed only a partial loss. Loop mutant controls and
several of the DxxK-candidate mutants showed wild-type activity levels. The structural integrity
of the mutants relative to the wild type was probed using limited proteolysis in order to establish
that the observed loss of activity for a given mutant was not the result of misfolding or large
structural changes.
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Figure 2: Pg1B-catalyzed N-glycosylation reaction in C. jejuni.
PglB transfers the heptasaccharide GlcGalNac 5Bac (where Bac is Bacillosamine, or 2, 4-diacetamido-
2,4,6-trideoxylglucose) from undecaprenyl pyrophosphate to asparagine side chains that appear in the
sequon D/E-X1 -N-X2-S/T, in which X, and X2 can be any residue other than proline.
To characterize the role of some of these mutations in PglB catalysis (Figure 2), an assay
was designed to investigate differential effects of substrate concentration on the reaction rates. It
was reasoned that the mutational effects would be most sensitive to the concentration of the
undecaprenyldiphosphate-linked glycan substrate in cases where the altered residues directly
impacted interactions with this substrate. Therefore, in order to establish whether the mutations
influenced the binding of the glycan substrate, the effect of increasing glycosyl donor substrate
135
concentration on catalysis was assessed. Results show that effects of certain mutations are
directly correlated with substrate concentration; the effect of the mutation becomes distinctly less
severe as the concentration of sugar substrate is increased. This substrate correlation provides
further biochemical insight into the potential importance of these residues in the binding of the
polyprenyldiphosphate-linked glycan.
Coincident with completion of these studies, a 3.4-A resolution crystal structure was
published for the PglB homolog from Campylobacter lari [4]. This structure represents a
remarkable leap forward in our understanding of the structure and topology of the OTases. The
crystal structure provides strong evidence that the aforementioned loop motifs are critical for
catalysis and enzyme activity in vivo. The complementary biochemical evidence described in
this chapter demonstrates the importance of the transmembrane region of PglB and indeed all
Stt3 proteins for OTase function.
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Results
Mutational and kinetic characterization of residues in conserved motifs
In order to investigate the importance of the three motifs in catalysis, site-directed
mutagenesis was performed on several conserved residues in PglB. As negative controls, residues
(K124 and K351) that would be predicted to appear in non-conserved loop regions were also
mutated (Figure 1). All candidate residues were mutated to alanine, and each acidic residue was
additionally mutated to its amide-containing complement (Asn for Asp, Gln for Glu), and/or its
acidic complement residue (Asp for Glu, or vice versa).
In addition, the proposal that a DxxK motif is required for OT catalysis was investigated [2].
The crystal structure of the soluble domain of P. furiosus Stt3 suggests a role for an aspartic acid
and a lysine, separated by two residues, fifty residues C-terminal to the signature WWDxG motif;
when mutated, a decrease in OTase activity was previously observed [2]. The natural frequency of
the aspartic acid and lysine residues and thus the DxxK pattern within the PglB sequence makes it
difficult to surmise functionally equivalent residues in other Stt3 sequences. PglB has three
appearances of DxxK in the C-terminal soluble domain: D475xxK 478, D5 19xxK5 2 2, and D5 5 3 xxK55 6
To establish whether a functionally conserved DxxK motif exists in PglB, each aspartic acid and
lysine within these DxxKs were mutated to alanine and analyzed along with the loop mutations.
All mutants were overexpressed in E. coli, as described in Materials and Methods. A wild
type (WT) PglB strain and a strain containing the empty expression vector (referred to as the
'blank') served as the positive and negative controls, respectively. All mutants and WT were
expressed with an N-terminal T7-tag and a C-terminal Hisio-tag. Mutant cultures were purified to
the point of 'washed CEF' (see Chapter 2), so each mutant solution was expected to contain the
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integral-membrane proteins and associated lipids only. Ideally, each mutant enzyme would be
purified to homogeneity for quantification; however, the unstable nature of membrane proteins
upon solubilization and purification can result in a source of error with unpredictable effects on
activity measurements. Thus, it was considered preferable to use the mutant and wild-type enzymes
in the more stable cell envelope fractions and to establish similar enzyme concentrations by using
western blot analysis. A fraction of each semi-pure mutant CEF was run on a western blot alongside
the WT and blank. Immunostaining with the anti-His and anti-T7 antibodies confirmed comparable
expression levels of PglB in the fractions assayed and that the full-length gene was being expressed.
(Figure 3).
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Figure 3: Western blots of PglB wild-type and mutant CEFs show similar expression levels.
All blots include a negative control ('Blank CEF') and a positive wild-type Pg1B control. Western
blots were visualized using the anti-tetra-His antibody (which also recognizes the C-terminal Hisio
tag) as well as the T7-tag antibody (which recognizes the N-terminal T7 tag of each protein).
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The activities of PglB and each of the mutants were measured using a radioactivity-based
assay, which measures transfer of a radiolabeled glycan from the undecaprenyldiphosphate carrier
to a peptide bearing the Pg1B consensus sequence (see Materials and Methods). Results from
activity assays for Pg1B enzymes with mutations in conserved loop motifs and the first DxxK motif
are shown in Figure 4. Activity assays for mutants showing wild-type levels of activity along with
extended time points for loop mutants are shown in Figure 5. Mutant activity results are
summarized in Table 1. Mutants were divided into broad categories based on relative activity level,
as follows: WT-level activity (+++), decreased activity (++), activity detectable only with overnight
incubation (+), or no detected activity (-).
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Figure 4: PglB activity assays performed on CEFs of loop mutants.
Each assay set included a negative control ('Blank CEF') and a positive Pg1B control (WT). Each
plot indicates the mutants assayed in the legend. Shown here are those with mutations in the
conserved loop motifs and the D475xxK motif.
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Figure 5: Activity data for soluble-domain mutants and extended time points for loop
mutants.
Assays for negative-control mutants K124A and K351A are also shown along with those for the
D"19xxK and D" 3xxK mutants.
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Table 1: Relative activity and locations of PgIB mutants.
Activity was considered null (-) if no activity is seen over the blank CEF background, +++ if levels
are comparable to wild type (WT), ++ if levels are distinctly lower than WT, and + if levels are
detected only with overnight incubation.
Mutant Location Activity
Blank CEF ---
WT --- +++
R29A between TM domains 1 & 2 -
D54A between TM domains 1 & 2 -
D54E between TM domains 1 & 2 -
D54N between TM domains 1 & 2 -
K124A between TM domains 2 & 3 +++
R145A between TM domains 3 & 4 +
D152A between TM domains 3 & 4 -
D152E between TM domains 3 & 4 ++
E316A between TM domains 7 & 8 +
E316D between TM domains 7 & 8 ++
E316Q between TM domains 7 & 8 -
K351A between TM domains 10 & 11 +++
D475A soluble domain ++
D475E soluble domain ++
K478A soluble domain ++
D519A soluble domain +++
K522A soluble domain +++
D553A soluble domain +++
K556A soluble domain +++
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Mutants maintain tertiary structure
Mutants that showed a decrease or loss in activity were analyzed by limited proteolysis,
which examines the possibility that the mutation causes a loss in activity by disrupting folding of
the mutant. Figure 6 shows western-blot degradation profiles for wild-type PglB and all mutants.
Before protease is added (time 0) the bands of the major digestion products are already visible at
very low levels, perhaps due to endogenous E. coli protease activity. Over time, individual bands
appear or change in intensity to give a characteristic profile, which was used to establish structural
integrity in mutants with loss of activity. As can be seen in Figure 6, all mutants display similar
degradation profiles to the wild-type protein. Limited proteolysis cannot provide conclusive
evidence that the mutants are as stable as the WT enzyme or that the mutants are capable of
adopting an active conformation. However, the presence of a clear time-dependent degradation
profile is a strong indicator that on a global, tertiary level the mutant enzymes adopt a WT-like fold.
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Figure 6: Probing effects of mutations on PgIB tertiary structure using limited proteolysis.
Mutants were assayed in sets, each accompanied by wild-type PglB for comparison. Anti-His
western blot analysis was performed on fractions of the reaction quenched at 0, 5, 10, 30, 60, and
180 minutes. Arrows indicate the location of the full-length PglB band at the start of the reaction.
Numbers to the left of wild-type blots indicate molecular weights (kDa) of standards.
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Correlation of mutation effects with concentration of Und-PP-disaccharide substrate
It was determined that the effect of mutants D I52E, E3 16D, and D475A and D475E are
inversely correlated with concentration of Und-PP-glycan substrate: at increasing substrate
concentrations, the mutant rates approached the wild-type rate (Figure 7). Initial mutant enzyme
assays (Figures 4, 5) were performed in the presence of saturating peptide substrate (50 x apparent
Km) and a relatively low concentration of radiolabeled disaccharide substrate (0.0 1x apparent Km),
which causes the measured rates to be highly sensitive to changes in binding efficiency of
undecaprenyldiphosphate-disaccharide and insensitive to changes in peptide binding. The initial
assay was constructed in this manner to test the hypothesis that the conserved loop motifs, given the
acidic nature of many key residues, might be involved in metal-ion mediated binding of the
diphosphate in the glycosyl donor substrate since PglB is known to require divalent cations
(generally Mn(II) or Mg(II)) for activity. Then, in order to establish whether the mutations
influenced the binding of the undecaprenyldiphosphate-linked glycan, we assessed the effect of
increasing glycosyl donor substrate concentration on catalysis. The initial rates for these mutants
were measured at three separate concentrations of this substrate: 0.01, 0.1, and 1.0 pM (Figure 7).
Initial western blot analyses ensured that a similar level of each PglB construct was
expressed, providing confidence such that mutants could be reliably grouped into broad categories
based on activity levels (Table 1). However, to further characterize the partially active mutants by
directly comparing initial turnover rates, a more precise western blotting method was used to
quantify relative levels of protein (see Materials and Methods). It was determined that levels of all
mutants were very similar, with a maximum concentration difference of +1.7-fold relative to WT
(Figure 8, Table 2). The relative level of each mutant in CEF measured by western blot analyses
was reproducible, allowing determination and correction of any effects on rate comparisons.
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Figure 7: Partial rescue of mutant activity with increasing sugar-substrate concentrations.
Average initial rates for low-activity PglB mutants assayed at three concentrations of
polyprenyldiphosphate disaccharide substrate (0.01, 0.1, and 1.0 gM). Percent of WT rate for
each mutant is determined at each concentration, with the average rate of WT set to 100%. Inset:
magnification of R145A, D152E, and E316A values for clarity. Rate values shown are corrected
for small variations in concentration, as determined by quantitative western blot analysis. Raw
rate data can be found in the Table 2.
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Figure 8: Quantitative western blotting of mutants with partial activity loss.
Quantitative blotting was performed to ensure observed activity losses are not significantly
influenced by differences in enzyme concentration. Average fold differences in activity were
used to correct for variations when measuring relative rate data at varying substrate
concentrations. As indicated in the legend below the blot, lanes 1-8 show mutant CEFs and lanes
9-14 show various levels of pure, quantified Pg1B. The intensities of the varied amounts of pure
protein are used to derive a standard curve (upper right). This curve was used to estimate the
quantities of protein in the CEFs shown in the blot. Fold differences in enzyme levels are shown
in the bar graph on the bottom right. Error bars indicate the standard error from averages of
multiple western blots.
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Table 2: Activity of mutants relative to wild-type at various sugar-substrate concentrations.
Percent of wild-type rate at varied concentrations of polyprenyldiphosphate-disaccharide
substrate are shown for mutants tested. Left table contains numbers derived directly from
measured rates. Right table contains numbers that have been corrected for concentration
variation as measured by quantitative western blot.
% of WT rate,
directly from measured rates
0.01 pM 0.1 pM I pM
WT 100 100 100
R145A 0.15 0.24 0.37
D152E 4.2 7.4 9.7
E316A 0.3 0.8 1.0
E316D
D475A
D475E
K478A
4.6
18.1
33.5
45.4
18.2
28.3
34.4
40.5
27.0
44.5
48.4
36.4
% of WT rate,
corrected for concentration differences
0.01 pM 0.1 pM 1.0 pM
WT 100 100 100
R145A 0.13 0.15 0.23
D152E 3.2 5.8 j 7.6
E316A c.2 0.4 0.6
E316D 3 11 17
D475A 10 21 33
D475E 17 25 36
K478A 25 31 28
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Discussion
Interpretation of Pg/B mutants in context of kinetic and structural data.
The bioinformatic and biochemical data that we report can now be framed in the context of
the recent structure analysis of the Stt3 homolog from C. lari, also designated as PglB [4]. In this
structure, the conserved acidic residues in each loop motif (D56, D154, and E319 of the C. lari
PglB) are proposed to form a pocket that accommodates a divalent magnesium cation and the
nucleophilic asparagine. In these structural studies, the essentiality of these residues is supported by
use of an in vivo glycosylation assay, which exploits the gel shift observed upon glycosylation.
The biochemical results that we present provide a more detailed characterization of the
residues implicated by the structure, and additionally expose critical residues that are not made
evident by the structural data. The aspartic acid in the [L/I]xx[D54]x[Y/F] motif (D54) can be set
apart from the other two implicated acidic residues (D152 and E316) by the in vitro activity
measurements. In particular, D152 and E3 16 can both be mutated to their acidic counterparts
(D1 52E and E3 16D) and still retain activity, albeit at a notably decreased level. This indicates the
primary role that the negative charge plays at these sites, as the alanine mutations at these sites
show minimal activity, and E316Q showed no activity. In contrast, with D54, we observe that when
mutated to alanine, asparagine, or glutamic acid, activity is completely eliminated. This establishes
D54 as highly specific for its role in function with respect to both charge and size and suggests a
pivotal role in catalysis.
It is also observed that the effects of certain mutations can be directly correlated with
substrate concentration; the effect of the mutation becomes less pronounced as the concentration of
the glycosyl donor substrate is increased. For example, this is observed with D152E and E316D
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(Figure 7). For other mutations, including D54 and K478A the increased Und-PP-Bac-GalNAc
substrate concentration had little effect. This substrate correlation analysis suggests that these
residues are implicated in the binding of the polyprenyldiphosphate-linked glycan. This trend is
consistent with the reported structural analysis, which suggests that these residues coordinate to the
divalent cation, and the hypothesis that the divalent cation is further involved in coordinating the
disphosphate of the glycan substrate. Further biochemical analyses using more complex glycosyl
donor substrates may help determine the relative effect of the mutations on substrate binding and
catalysis.
With respect to the [R/K][S/T]xx[G 49 ]xx[D 5 2] motif, we find that R145 and D152, when
individually mutated to alanine, lead to an almost complete loss of PglB activity. Mutation of D152
to a glutamate restores partial activity. In this context, a fundamental role for the aspartic acid at
the +2 position to the D152 (D154 in C. jejuni PglB, D156 in C. lari PglB) has been proposed [4].
Specifically, this pair of aspartic acids is proposed to represent a 'DxD' motif that is characteristic
in the glycosyltransferase superfamily GT-C [4-6]. However, the alignments derived from our
topology-guided motif analysis suggest that the sequence characteristics in this region of the OTase
are not definitively conserved across evolution. Indeed, it is evident from our alignment of the motif
(Figure 9A) that the residue +2 to the defined motif is a glutamic acid in almost fifty percent of
homologs examined, and this residue is a proline in the seven archaeal homologs that were analyzed
in this study. Site-directed mutagenesis data are not yet available to evaluate the kinetic significance
of the second aspartic acid in the DxD motif in PglB and the natural frequency of the generic and
variable motif leaves significant room for further exploration. Therefore the association with the
characteristic GT-C superfamily motif may not be clear.
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R-S/T-xx-G-xx-D--x-D
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Figure 9: Relative conservation of residues within and surrounding conserved motifs.
A. Alignment of sequences containing OTase motif in second transmembrane loop R-S/T-xx-G-xx-
D152 (orange outline). The proposed overlapping motif D152X-D is included in alignment (aspartate
at position +2 is highlighted yellow). B. Alignment of first appearance of D-xx-K pattern (D47 ,
K478) in soluble domain of Pg1B and analogous positions in other OTases. Aspartate 475 is
highlighted in orange and lysine 478 is highlighted yellow.
Interestingly, the arginine (R29) in C. jejuni PglB that appears at the C-terminus of the first
transmembrane helix is also conserved and essential: when mutated to alanine, activity is
eliminated. In view of this data alone, the role that this arginine may play in Pg1B function is not
obvious. However, when the equivalent residue (R31) is examined in the C. lari structure one
observes that this arginine side chain appears to be in direct contact with threonine 148 (or T146 in
C. jejuni PglB). In this context, we note that this position is highly conserved as a hydroxyamino
acid (either a serine or threonine) throughout our 28 examined Stt3 homologs and appears in the
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[R/K][S/T]xx[G14 9]xx[D1 5 2] motif in the third transmembrane loop (Figure 1). This apparent
interaction again highlights the unique ability of this topology-guided sequence analysis to reveal
residues key to enzyme function. The high conservation of this hydroxyamino acid and its apparent
interaction with the essential arginine in the first transmembrane helix allows us to propose that
these residues may be involved in mediating in a conformational shift of the enzyme, as the
interaction represents a clear link between the catalytic site and an integral membrane helix. In the
future, it will be very interesting to gain a structural analysis of other substrate-bound forms of the
enzyme to determine the likelihood of this scenario.
Interpretation ofDxxK mutants in context of kinetic and structural data
Of the three appearances of DxxK sequon in the PglB soluble domain, mutations in D475
and K478 negatively impacted PglB activity, while [D 5 ' 9xxK 522]and [D5 5 xxK 556] alanine mutants
showed levels comparable to wild type (Figure 4). The effect on D475A was more significant than
that on K478A (Figure 4), which calls the proposed DxxK motif into question. Considering the
enhanced impact of D475A relative to K478A, and the additional fact that this aspartic acid is
highly conserved throughout all OTases while the lysine is not (Figure 9B), it appears that a 'DxxK
motif is not playing an essential role in OTase activity. However, the high level of conservation of
D475 and the clear impact of the mutation on activity indicates that this residue is likely involved
the OTase function. Interestingly, an increase in the concentration of the polyprenyldisphosphate-
linked glycan in the assay steadily attenuated the effect of D475A and D475E on activity, while no
such trend is seen for K478A (Figure 7). As in the case of D152 and E3 16, this trend suggests that
mutation at these sites affects the ability of PglB to bind the polyprenyldiphosphate glycan
substrate.
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Mutants maintain tertiary structure
Limited proteolysis represents powerful tool for identifying flexible, exposed regions of
proteins and for studying how tertiary structure (and thus susceptibility to proteolysis) is affected by
mutations, substrate presence and many other factors [7-11]. Mutants that showed a decrease or loss
in activity were analyzed by limited proteolysis to establish that activity loss is not due to
misfolding (see Materials and Methods), and all mutants assayed display similar degradation
profiles to the wild-type protein (Figure 6). In addition to reinforcing that the mutants that are
analyzed are properly folded, it was of interest to determine the precise location of proteolysis. The
three major C-terminal degradation products appear at roughly 50, 30, and 23 kDa, which provides
a rough approximation of the cut site. To further narrow the location of the proteolysis sites, N-
terminal Edman degradation sequencing of the digestion bands was performed.
Using the N-terminal sequencing data and the estimated molecular weights of the fragments,
it was determined that the enzyme was being proteolyzed at G33 l/S332 (''I" cut site') and
Y467/S468 ( 2nd cut site'), yielding C-terminal fragments of 45.5 and 29.3 kDa, respectively.
Figure 10 shows the location of the analogous residues in a model of the C.lari PglB X-ray
structure [4]. The first cut site appears at the C-terminal end of a large loop between two
transmembrane domains (Figure 10B, C). In the C. lari structure, this loop appears as a highly
disordered coil, with the N-terminal half of the loop unresolved [4]. In comparison, the second cut
site appears in the soluble domain 4-5 residues C-terminal to the WWDxG motif. In the C.lari PglB
structure, this site does not stand out as obviously accessible to solvent as it appears to be shielded
by a nearby helix (Figure 10D). Interestingly, however, the analogous site in the structure of the P.
furiosus Stt3 soluble domain shows this site immediately preceding a coiled region of high disorder
which was not solved with the rest of the structure (Figure 10D, [2]).
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A.PgIB from C. lari (PDB: 3RCE)
Disordered
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Soluble domain from P. furlosus Stt3 (PDB: 2ZAI)
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coil (residues not
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Figure 10: N-terminal sequencing of degradation products reveals sites of protease
susceptibility.
Predicted cut sites are colored red and the WWDxG motif residues are shown as sticks for
reference. A. Model of crystal structure of PglB from C. lari (PDB: 3RCE, [4]) highlighting
predicted locations of digestion. B. The region containing the first cut site is expanded for clarity.
The loop residues N-terminal to the 1 cut site are colored light orange. The dotted line denotes
the unresolved residues in the loop. C. Cartoon topology model of PglB, highlighting the general
location of the first cut site. D. (left) Region containing the second cut site in PglB. The loop C-
terminal to the cut site is colored light orange. Shown to the right is the analogous position in a
model of the crystal structure of the soluble domain of Stt3 from P. furiosus (PDB: 2ZAI, [2]).
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The structure of the C. lari PglB posits this observation in a structural context and correlates
susceptibility to proteolysis with the proposed flexibility and exposure of these regions. The first
proteolysis site appears just after the exposed loop 5, designated as EL5, which is noted as highly
disordered in the C. lari structure [4]. Interestingly, while both of these sites appear in coils
adjacent to catalytically important sites, neither site appears prominently exposed in the crystal
structure. Nonetheless, the dramatic preference for these proteolysis sites is shown clearly by the
discrete banding pattern indicated by western blot. It is possible that these sites become exposed in
an alternate conformation of PglB, which may provide insight into structural changes implicated in
substrate binding and release. Indeed, it was proposed that this conformational change would
involve movement of EL5 [4]. Also, the striking conservation of the WWDxG motif, combined
with its proximity to a preferential proteolytic cut site, may indicate that this helix is involved in
this conformational change, in addition to the proposed role in peptide/protein substrate binding [4].
The second cut site occurs just after the WWDxG motif, N-terminal to a coil connecting two
helices. As noted above and in Figure 10D, this site appears relatively shielded from solvent in the
C. lari crystal structure, while in the P. furiosus soluble-domain structure the predicted cut site
borders a highly disordered, unresolved coil. Though highly speculative, this distinction of this
region in the C. lari and P. furiosus structures, combined with apparent proteolytic activity at this
site, may suggest involvement of this region in a conformational change. Undoubtedly, since the P.
furiosus structure is solved as a soluble domain alone, the observed conformations are expected to
be less representative of reality than the C. lari full-length structure because many of the native
intramolecular interactions are unable to form. Nevertheless, the two clearly distinct physical states
of this region in two structures, combined with the apparent proteolysis (and thus exposure to
solvent) at this site, increases the conceivability that the disordered state represents a native
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conformation of the enzyme. Conversely, an alternative explanation is that this region only
becomes accessible when specific interactions between the soluble and the transmembrane domains
are disrupted. Once the first cut in the inter-transmembrane loop is made, a majority of the
transmembrane helices are separated from the soluble domain, potentially disrupting these
interactions and exposing the second site for proteases to act upon.
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Conclusion
In recent years, it has become abundantly clear that the conserved loop segments between
transmembrane domains often play a fundamental role in substrate recognition and/or catalysis
[12-15]. However, it is particularly difficult to observe sequence conservation in these regions
because motifs may be embedded within transmembrane regions that have diverged
considerably, thereby complicating sequence alignments. Demonstrated here is a straightforward
method for defining these buried regions of conservation applied to the complex integral-
membrane OTase PglB. Topology predictions are generated for a list of homologous sequences
using freely available software; a designed algorithm then parses each sequence by topological
feature. These sequence segments are then more fruitful for detecting regions of conservation
through sequence alignment. The systematic nature of the method allows for position-specific
sequence analysis of a large number of divergent sequences of a given protein, which is crucial
for determining the extent and significance of proposed motifs. These results expose the
extraordinary level of conservation that exists in Stt3 homologs from bacteria through humans.
Conservation over this evolutionary span implies that these regions play an essential role in the
OTase activity. The biochemical data verifies that in PglB, many of these residues are essential
for enzyme activity, and through limited proteolysis experiments it is shown that activity loss in
mutated PglB is not caused by major structural changes. These combined data indicate a direct
involvement of these motifs in protein function.
The publication of a medium-resolution structure of the C. lari PglB in 2011 indicates
that these motifs are centrally involved in catalysis [4]. Thus, the structural data, combined with
the independently acquired alignments and biochemical data, provide compelling evidence for
the roles of these motifs in OTase catalysis. Much biochemical work remains to investigate the
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details of the catalysis. In this context, the limited proteolysis approach will be useful for
ascertaining whether the E5 loop is flexible in the presence, as well as the absence, of each
substrate, and thus may provide insight into the dynamics of these regions accompanying
substrate binding, catalysis, and substrate release. Ultimately, similar studies on eukaryotic
OTases will be essential for relating the prokaryotic OTase studies to OTase catalysis
universally.
The structural studies now provide an excellent framework for developing new
experiments to investigate N-linked glycosylation. Yet, the importance of quantitative, in vitro
biochemical assays with defined quantities of pure substrates and precise measurements of
enzymatic rates cannot be overstated. Based on the C. lari PglB structure a mechanism for
nucleophilic activation of the asparagine nitrogen has been proposed [4]. A challenge in the
future will be to acquire structural and biochemical data that are complementary and consistent
with specific mechanistic proposals. Currently, the structural data provides valuable information
on the residues that are likely to be involved in catalysis, however at the present structural
resolution of 3.4 A, it is not feasible to identify specific hydrogen bonding networks or, in fact
even distinguish between the nitrogen and carbonyl oxygen of the nucleophilic asparagine
amide. Furthermore, due to the crystallization conditions, the C. lari PglB structure was acquired
at a pH of 9.4, where activity is very low [16]. Lastly, as the structure was solved in the presence
of only the peptide substrate, the site of polyprenyldiphosphate-glycan binding, the order of
binding and release of substrates and products, and nature of potential conformational changes,
remain to be assessed. These data are required for the development of hypotheses concerning the
mechanistic details of the reaction. The structural and biochemical data, when in agreement, will
provide an important foundation for unraveling the details of this intricate cellular process.
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Materials and Methods
Mutant production, expression, and purification
The QuikChange (Agilent) protocol was used to generate mutations in the PglB gene, and
all mutant genes were sequenced to verify specificity and accuracy of mutagenesis. All mutants
and wild type PglB were expressed in a pET24a(+) vector from Novagen. All constructs were
transformed into BL2 1 -CodonPlus-RIL cells (Stratagene) and grown in 1 L of culture overnight.
Cell cultures were harvested by centrifugation, washed in lysis buffer (50 mM HEPES, pH 7.5,
100 mM NaCl, 10% glycerol), re-pelleted, and frozen at -80 'C until needed. For the preparation
of Cell Envelope Fractions (CEFs), cell pellets of equal weight were resuspended in 40 mL lysis
buffer with the addition of 40 pg hen egg-white lysozyme (EMD Chemicals) and 40 pL EDTA-
free Protease Inhibitor Cocktail III (CalBiochem). Cell suspensions were incubated at 4C with
gentle rocking for one hour and then lysed using sonication with cooling on ice. Specifically,
three one-minute sets of one-second pulses at 50% amplitude, with five-minute intervals between
each set were employed. Lysates were centrifuged at 6,000 x g for 30 minutes to remove
insoluble debris, and the supernatant was then centrifuged at 100,000 x g for 1 hour to pellet the
CEF. The resulting supernatant was discarded and the CEF was homogenized in 35 mL of high
salt buffer (50 mM HEPES, pH 7.5, 250 mM NaCl, 250 mM KCl, 20% glycerol), incubated at 4
4C with gentle rocking for 1 hour, then pelleted again. Washed CEFs were homogenized in 10
mL of lysis buffer and stored at -80 0C until further use.
For western blot analysis, 8 pL samples of CEF (diluted 1:40 in 50 mM HEPES, pH
7.5) were mixed with 2 pL of 5X SDS reducing buffer and boiled for 5 minutes. Five pL of this
solution was added to each lane of a 4-15% Tris-HCl pre-stacked gradient gel (BioRad) . Gels
were run at 150 volts for one hour. Protein was then transferred at 120 volts for 2 hours to a
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nitrocellulose membrane. Membranes were blocked for at least one hour in a solution of 5%
BSA in TBS-T, then incubated for 1 hour in a solution of either: 1) T7 antibody conjugated to
alkaline phosphatase diluted 1:10,000 in TBS-T (EMD4Biosciences), washed with three one-
minute washes in TBS-T and a single one-minute wash in TBS and then developed using the 1-
STEP BCIP/NBT (5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium) developing
solution (Thermo Scientific) for roughly 10 seconds or until staining became visible, at which
point the nitrocellulose membrane was washed thoroughly with deionized water, or 2) Tetra His
antibody, BSA-free (Qiagen) at 0.1 gg/ml in TBS-T, followed by a three one-minute washes in
TBS-T, one-hour incubation in Anti-mouse alkaline phosphatase-conjugated secondary antibody
produced in goat (Sigma Aldrich), three one-minute washes in TBS-T and a single one-minute
wash in TBS, and development with the alkaline-phosphatase substrate 1-STEP NBT/BCIP. For
quantitative western blot analysis, the process was carried out similarly except with optimization
of CEF dilution factor to achieve intensities in the range of those of the purified PglB.
Ultimately, CEFs were diluted 1:100 and compared against a set of pure PglB internal
standards, which had been quantified by measuring ultraviolet absorption at 280 nm. After
staining, the nitrocellulose blots were allowed to dry for 10 minutes and then were immediately
scanned at 1200 dpi and analyzed using Adobe Photoshop densitometry software. To maximize
reliability, sample preparation and western blot analysis were repeated in triplicate, the data were
combined and the average relative quantities used. A representative western blot and standard
graph are shown in Figure 8.
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PglB Activity Assays
A survey of activity measurements for PglB and all PglB mutants was carried out as
described previously [17]. Briefly, 10 ptL of DMSO was added to a tube containing 6 pmol of
dried radiolabeled undecaprenyl-PP-Bac-[3H]GalNAc of specific activity 15 pCi/nmol. The tube
was then vortexed and sonicated (water bath) to resuspend the substrate. Then, 100 pL of 2X
assay buffer (280 mM sucrose, 2.4% Triton X-100 (v/v), and 100 mM HEPES at pH 7.5), 2 pL
of 1 M MnCl2, and 5 pL of PglB CEF were added and the volume brought to a total of 190 pL
with water. Reactions were initiated by the addition of 10 pL of 1 mM peptide substrate (Ac-
DQNAT-p-NF-NH2; where p-NF is para-nitro-phenylalanine) dissolved in DMSO [18]. Aliquots
of the reaction mixture were removed at specified time intervals and quenched in 1 mL of 3:2
chloroform/methanol + 200 pL of 4 mM MgCl 2 . The aqueous layer was extracted, and the
organic layer was washed twice with 300 pL of pure solvent upper phase (3% chloroform, 49%
methanol, and 48% water with 100 mM KCl). The aqueous extracts were combined and mixed
with 5 mL of EcoLite scintillation fluid (MP Biomedicals), the organic phase was mixed with 5
mL of OPTI-FLUOR scintillation fluid (Perkin Elmer), and all fractions were subjected to
scintillation counting. All assays were carried out in duplicate or triplicate.
Synthesis of lipid-linked sugar substrate at three specific activities
For rate comparison assays at varying concentrations of sugar substrate, radiolabeled
undecaprenyldiphosphate-disaccharide (Und-PP-Bac-GalNAc) was synthesized at specific
activities of 0.15, 1.5, and 15 pCi/nmol, according to procedures described previously [17]. Each
PglB assay performed (using one aliquot of Und-PP-Bac-GalNAc) contained the same level of
tritium, but depending on the specific activity a single assay would contain 0.01, 0.1, or 1.0 pM
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sugar substrate, which represents roughly 0.01x, 0.1x, and 1x Km (app) of the Und-PP-Bac-
GalNAc substrate in the PglB reaction [19]. The three different specific activities of the sugar
substrates were desirable because the reactions would contain varied concentrations of total
substrate, but the handling of very high or very low levels of radioactivity would be avoided.
The starting substrates for synthesis include the UDP-GalNAc (tritium-labeled), UDP-
Bac, Und-OH, and ATP. The enzymes used include the SM kinase [20], PglC (purified to CEF),
and PglA. It was determined that roughly 20 assays of lipid-linked disaccharide would be carried
out at each of the three log units of varied substrate concentration: 20 reactions at Km(app) (1
pM), 20 reactions at 0.1x KM(app) (0.1 pM), and 20 reactions at 0.01x KM(app) (0.01 pM). The
manufacturer-supplied specific activity of the pure radiolabeled stock of UDP-GalNAc was 15
Ci/mmol, or 15 pCi/nmol, with 1 ptCi (Curie) = 2.22 x 106 DPM. Since each reaction contains
200 pL total volume, and 20 reactions of each concentration of 1, 0.1, and 0.01 pM substrate was
required, it can be calculated that for the 1 pM batch of reactions 40 nmol radiolabeled product is
required (200 pmol/reaction vial), for the 0.1 pM batch, 4 nmol substrate is required, and for
0.01 pM batch a total of 0.4 nmol would be required.
For the lowest concentration substrate (0.01 x KM(app) product/tube), the radiolabeled
UDP-GalNAc was not diluted with any unlabeled UDP-GalNAc. Thus, 0.4 nmol of UDP-
GalNAc (specific activity of 15 pCi/nmol, containing 6 pCi) was collected for each of the three
reactions. For the 0.1 x KM(app) reactions, a volume containing 3.6 nmol of a known
concentration of unlabeled UDP-GalNAc was added to the hot solution, rendering its specific
activity 1.5 jCi/nmol. The same was done with the lx KM(app) UDP-GalNAc solution, except
this time a volume containing 39.6 nmol unlabeled UDP-GalNAc was added in order to give a
specific activity of 0.15 jCi/nmol. Thus, each reaction contained the same level of radiolabeled
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UDP-GalNAc, the total UDP-GalNAc concentration was varied. The stoichiometric levels of
other reaction components were adjusted accordingly in order to maximize turnover of the UDP-
GalNAc solution.
The final product was purified over HPLC. The reaction aliquots for each specific activity
batch contained roughly 66,600 DPM, which represented 2 pmol, 20 pmol, or 200 pmol labeled
substrate for the reactions performed with 15, 1.5, and 0.15 pCi/nmol specific activities,
respectively. When resuspended to the reaction concentration of 200 ptL, this provided a
concentration of 0.01 piM, 0.1 pM, and 1 pM Und-PP-Bac-GalNac, respectively.
A summary of the specific reaction plan is as follows:
Km for disaccharide - 1 IM
Specific activity of undiluted hot GalNAc: 15 pCi/nmol
1. 1X hot UDP-GalNAc (for 10 nM concentration in assay with 100K DPM)
-50 nmol Und-P
-20 pL 5 mM UDP-Bac
-20 pL .025 pM UDP-GalNAc (specific activity 15 pCi/nmol)
2. 1 OX dilution of hot UDP-GalNAc (for 1 OX increase in concentration in assay (0.1 pM) with
lOOK DPM)
-50 nmol Und-P
-20 pL 5 mM UDP-Bac
-20 pL .25 pM UDP-GalNAc (specific activity 1.5 pCi/nmol)
3. 1 OOX dilution of hot UDP-GalNAc (for 1 OX increase in concentration in assay(1 pM) with
lOOK DPM)
-50 nmol Und-P
-20 gL 5 mM UDP-Bac
-20 pL 2.5 pM UDP-GalNAc (specific activity 150 nCi/nmol)
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Limited Proteolysis
Digestion profiles of wild-type Pg1B using trypsin, a-chymotrypsin, and proteinase K
were compared, with proteinase K showing the clearest production of discrete proteolytic
fragments. The incubation time, temperature, and the ratio of PglB to protease were optimized,
such that the time-dependent production of discrete proteolytic fragments could be clearly
viewed by applying His-tagged western blot analysis. The His-tag antibody was used because the
location of the His-tag at the C-terminus of the soluble domain resulted in a more readily
identifiable degradation profile. Proteolytic assays were performed at room temperature on CEF
fractions that were diluted 1:40 in 50 mM HEPES, pH 7.5. Two pL of 0.1 mg/mL of Proteinase
K (in 4 mM MgCl2) were added to 160 pL of diluted CEF. Aliquots of 20 pL were quenched
into 3 pL of 100 mM PMSF (phenylmethylsulfonyl chloride) in ethanol, at time points of 0, 5,
10, 30, 60, and 180 minutes.
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CHAPTER 5:
DESIGN AND DEVELOPMENT OF LRET-BASED SYSTEM TO
INVESTIGATE DYNAMICS OF PGLB CATALYSIS
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in this chapter.
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Summary
The following chapter describes the design and assembly of components required for obtaining a
system to investigate key features of the OTase enzymatic reaction; these key features include
order of substrate binding, the sites on the enzyme involved in substrate-binding and release, and
the nature of potential conformational changes occurring upon substrate binding and catalysis.
Toward these goals, the improved levels of stable PglB are used as a foundation for developing a
system to measure informative distances using LRET. The strategy devised includes expression
of PglB with a genetically encoded lanthanide-binding tag (LBT). Cysteine-containing peptide
substrates were synthesized, purified, and labeled, which will allow intermolecular LRET
measurements between the LBT-Tb3+ complex and the peptide substrate. In addition, the site-
specific insertion of cysteine allows the expressed enzyme to be labeled with a thiol-specific dye
that may act as an LRET acceptor, and the complex of LBT-Tb3+ functions as a partner donor.
As a result of the following efforts, proof of concept has now shown with the measurement of
LRET between LBT-PglB and a acceptor-labeled substrate peptide. The system is now being
applied to an archaeal OTase, AglB, and additional comparative studies are expected to continue
under the direction of a fellow graduate student, Michelle Chang. In summary, a system has been
successfully designed and developed to measure dynamic changes and interactions involved in
the OTase reaction, which are unattainable using X-ray crystallography.
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Introduction
In the past several years, remarkable advances have been made toward better
understanding the reaction catalyzed by OTases. Importantly, significant sequence homology has
been revealed in OTases throughout all evolutionary domains of life; as a result, the single-
subunit OTase PglB from C. jejuni has been firmly established as a prototypical model of the
conserved enzymatic reaction. Structural models of the enzyme have provided a wealth of
knowledge on the manner in which the conserved regions of the protein join to form a predicted
active site.
However, fundamental aspects of the OTase reaction remain to be determined. The
structural data available for PglB shows a single conformation of the enzyme at a resolution of
3.5A, an alkaline pH, and in a detergent micelle, which differs from the native state in the
membrane and at neutral or acidic pH. As with any crystal structure, it is difficult to discern from
the structural data alone whether the enzyme has adopted a native, active conformation when
crystallizing. The substrate-binding requirements are unknown, and accordingly it is unclear
whether the substrates bind in a specific order, whether binding order is random, and which
chemical groups on the substrates function in binding and catalysis. Also unknown is the
location on the enzyme that the glycan substrate binds or whether the peptide bound in the
crystal structure is representative of the native state of binding. In the case that the saccharide
substrate binds before the peptide substrate, saturation of the enzyme with the peptide substrate
alone may facilitate a non-native conformation. While key regions of the enzyme have been
defined, the function of each of these regions remains to be determined; it is not known whether
the critical residues in these regions are involved in substrate-binding, catalysis, structural
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organization, or a combination. Other major unresolved factors include the role of the required
divalent cation and the nature or existence of conformational changes.
The recent availability of a stable and purified PglB enzyme in reasonable quantities and
determination of structural regions composing the OTase active site provide new tools to guide
experimental design in studying these factors [1-3]. A series of steps were carried out to develop
a system to examine substrate binding and the nature of potential conformational changes
involved in PglB catalysis. A luminescent spectroscopic approach was preferred because it
allows for sensitive measurements and low perturbation of the active enzyme in vitro, which are
important conditions for studying dynamic enzymatic processes.
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Figure 1: Jablonski diagram representing fluorescent and phosphorescent emission.
On the y-axis energy (E) is representative. So through S2 represent electronic states, T1 is a triplet
state. The purple arrow represents absorbance, the red arrow represents fluorescent decay and the
orange arrow represents phosphorescent decay. The squiggly arrows represent non-radiative
processes: the green arrow is internal conversion, the brown arrow is intersystem crossing, and
the blue arrow is vibrational relaxation.
Specifically, luminescence resonance energy transfer (LRET) will be used to investigate
the aforementioned characteristics of the PglB enzymatic reaction. As opposed to fluorescence
transfer (FRET), LRET includes emission via phosphorescence as well as fluorescence (hence
the all-encompassing term 'luminescence'). The term LRET is often used in the context of
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lanthanide emission [4]. Lanthanides ions, when excited at the appropriate wavelength, will emit
energy via phosphorescent emission. As represented by a Jablonski diagram in Figure 1,
absorbance of energy results in excitation of an electron form a ground state to an excited state.
In addition to non-radiative decay mechanisms (internal conversion and vibrational relaxation),
emission of light via luminescence accounts for the loss of energy of the electron as it returns to
the ground state. When the decay occurs from the a singlet state to the singlet ground state, the
emission of light is defined as fluorescence; when the energy first undergoes intersystem
crossing to a triplet state and decays from a triplet state to the singlet ground state, the emission
of light is defined as phosphorescence.
There are several differences between LRET and FRET. Lanthanides do not inherently
result in improved brightness of the emission relative to that of fluorophores, as quantum yields
and extinction are unrelated to the form of emission. However, phosphorescent molecules or
atoms (such as lanthanides) have longer Stokes' shifts and lifetimes relative to fluorophores.
These qualities result in a dramatically reduced background signal, because the phosphorescent
emission can be measured after a time delay during which the shorter-lived auto-fluorescence
has already decayed [5]. Furthermore, unlike the polarized mission from fluorogenic molecules,
emission from lanthanide ions is radial. The dipole orientation factor K depends on the relative
orientation of the two fluorophore; emission from fluorescent molecules is polarized, which
affects the level of energy transfer and thus the FOrster radius Ro (Equation 1). Generally, the
dipole orientation factor K is estimated as 2/3 based on an assumption that both molecules are
freely rotating in solution causing isotropic emission. Often one or both fluorophores is fixed and
is not free to rotate, which makes the assumption of isotropic emission invalid and thus
introduces error into calculation of Ro. Thus, the radial (unpolarized) emission from lanthanide
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ions results in a reduced error in the determination of RO. In calculation of Ro, Qo is the quantum
yield of the donor in the absence of acceptor, I is the spectral overlap integral, n is the refractive
index of the medium, and NA is Avogadro's number.
6_ 9 0 (InlO) K2 j
0  128 1 5 n 4N N(
The reduction in background and the improved accuracy of RO effectively improves the
accuracy of LRET measurements relative to those of FRET. Reduced background gives an
improved normalized signal and, because the Ro-value is included in calculation of distance
measurements (r-values) from transfer efficiency (E), LRET effectively improves the accuracy of
the distances calculated (Equation 2). This improved accuracy lends the calculated values to
more plausible biological interpretation and results in better agreement with crystallographic
measurements.
1E (2)
RO
Resonant energy transfer measurements are made using the enzyme in solution. Enzyme
activity can be monitored which eliminates any uncertainty as to whether the obtained data is
representative of the active enzyme. This gives the resonant energy transfer technique an
advantage over X-ray crystallography. LRET is capable of measuring intra- and inter-protein
interactions and distances, thus providing structural information that can support, clarify, and
supplement crystallographic data. Significantly, LRET is capable of providing time-resolved
information about the dynamics of the enzymatic reaction (e.g. conformational changes upon
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substrate binding) in a single experiment [6,7], which cannot be obtained from crystallographic
data.
C
LBT-PgIB
construct
280 nm
280nm 3. Luminescence
1. Absorbance ,
2. Energy transfer
Figure 2: Sensitization of Tb3 + by the LBT.
The topology cartoon of PglB shows the LBT bound to the lanthanide ion, Tb 3 . The complex is
irradiated with UV light, and after a millisecond-lifetime phosphorescent light is emitted.
Expansion of the LBT shows the amino acids chelating and sensitizing Tb3+. The tryptophan,
when excited by incoming UV light, transfers energy of its excited electronic state to the nearby
Tb3+, which then emits light at specific discrete wavelengths. Importantly, the LBT residues
protect Tb3+ from exposure to water molecules, which quench the luminescence. LBT figure
taken from [8].
In order for lanthanide ions in aqueous solution to absorb energy from light, a sensitizer
is required; the sensitizer is a molecule that chelates the ion and first absorbs the applied light,
ultimately transferring the energy to the ion. The lanthanide-binding tag (LBT) consists of 20
amino acids and binds and sensitizes lanthanide ions (such as Terbium ion (Tb 3+)), forming a
luminescent composite (Figure 2) [9,10]. The LBT was chosen to act as the donor in the
following LRET experiments for several reasons, in addition to the favorable properties of
lanthanide emission discussed above. First, a major challenge for LRET-type experiments is the
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site-specific labeling of two locations on the protein with different fluorophores. The LBT is
genetically encoded, which eliminates half of that challenge. Second, LBT-lanthanide complexes
have very narrow and discrete emission bands, enhancing specificity of LRET. Third, LRET
between LBT-lanthanide emission and known acceptor fluorophores exhibits a large transfer
distance, which ensures detection of an intermembrane region even if it is located at a relatively
large distance from the LBT.
In order to measure intermolecular distances between PgIB and the peptide substrate,
which can provide information on the location and order of substrate binding, a peptide
containing the glycosylation consensus sequence was synthesized with a cysteine residue
included. The cysteine was then site-specifically labeled using a thiol-reactive LRET acceptor
dye. Similarly, cysteine mutations or insertions can be made in locations throughout the enzyme
that are predicted to be informative. If the mutants express and show WT-level activity, then
thiol-specific labeling can again be used to create a functional donor-acceptor pair. In this way,
both inter- and intra-molecular LRET measurements can be made (Figure 3).
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Figure 3: Simple illustration of the planned LRET experiments.
The LBT, genetically encoded on the N-terminus of the Pg1B gene, acts as a donor when
lanthanide ion (Tb 3 ) is added to the solution. The unpolarized lanthanide emission can engage in
LRET with a dye that is specifically labeled via the thiol group on a unique cysteine. For
intermolecular LRET measurements, the cysteine is included in the substrate peptide sequence.
For intramolecular LRET measurements, cysteine residues are individually mutated into specific
locations in the PglB sequence.
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Results
Expression of LBT-PglB construct
The first step in developing the LRET system described above involved constructing and
expressing a well-behaved LBT-PgIB fusion construct. This task was expected to be relatively
simple and rapid for several reasons. As seen in Chapter 2 of this thesis, much time had been
spent optimizing the expression levels of PglB and the resulting yields were comfortably within a
workable range. The LBT was developed and characterized extensively by previous Imperiali lab
members who had successfully expressed LBT fusions [8-13]. Additionally, the LBT is only 20
amino acids in length (shown below), making it seem unlikely that fusion to PglB would alter
previously established properties of PgIB.
LBT amino-acid sequence: GPGYIDTNNDGWYEGDELLA
Therefore, it was surprising when LBT-PglB initially showed very poor expression.
Despite the small size of the LBT, encoding the LBT sequence at the N-terminus of PgIB led to
dramatically reduced yields relative to T7-PgIB (Figure 4A). The construct that was initially
tested encoded LBT-PglB-HislO in pET24a(+) and is denoted LBT-PglB-l (Table 1).
Troubleshooting started with changing parameters that are known to cause general problems in
protein expression. The vectors were re-sequenced to ensure no mutations were at fault. Vectors
were re-transformed into a fresh batch of competent cells. Media components involved in
making autoinduction media (see Chapter 2) were replaced along with antibiotic solutions. Even
a new pET24a(+) carrier vector was obtained and the LBT-PglB sequence was moved to the new
vector, but to no avail. All efforts resulted in the same deficient expression of LBT-PglB.
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Construct name Components & restriction sites' Notes
LBT-PglB-1 Ndel-ATG-LBT-BamHI-PglB-His I O-STOP-XhoI Poor expression
LBT-Ubiq Ndel-ATG-His6-LBT-BamHI-ubiquitin-STOP-XhoI
TEV-LBT-PglB Ndel-ATG-TEV-LBT-BamHI-PglB-His I O-STOP-XhoI
LBT-PgIB NdeI-ATG-LBT(optimized)-BamHI-PgB-His 10- STOP-XhoI Best expression
1. Unless otherwise noted, all constructs are made within a pET24a(+) vector.
Table 1: Summary of major vectors discussed in this chapter.
Upon reviewing earlier studies, it was found that a test expression carried out a year
previous had shown reasonable expression of the LBT-PglB; however, this construct had
contained a TEV sequence after the start codon but before the LBT sequence due to the cloning
strategy. This TEV sequence had since been removed, as it contained no ostensible purpose.
Despite a lack of comprehension of any positive impact the resulting from a preceding TEV
sequence, few other obvious options remained. (Discussed below, measurements had been made
that indicated that the N-terminus was preferable to the C-terminus for LRET measurements,
ruling out this option.) Therefore, the TEV-LBT-PglB construct was re-made (Figure 4C, Table
1). Surprisingly, the insertion of the TEV sequence before the LBT sequence led to improved
expression levels (Figure 4B).
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Figure 4: Poor initial expression of LBT-PglB and improvements with N-terminal insertion
of TEV sequence.
Activity results of cleared lysates for LBT-PglB (A) or TEV-LBT-PglB (B) and T7-PglB after
growing, lysing, and preparing both samples in parallel. Discrepancy in activity levels in A and
B result from preparation and weight of initial cell pellets used. In each case, T7-PglB was grown
and prepared alongside the LBT-PglB or TEV-LBT-PglB construct such that each comparison
internally represents a comparison of the same fraction of cell pellet. (C) Diagram showing the
location of the start codon relative to the LBT-PglB construct and the location of the inserted
TEV sequence.
Literature searches led to the development of several hypotheses to explain the observed
improvement in expression at the mere insertion of a 6-amino acid TEV sequence (ASENLY).
Several studies by the Isaksson group in the Netherlands provided anecdotal and general
evidence that several codons immediately following the start codon in a gene significantly
affected expression levels in E. coli. An early study showed that a simple change of the +3 codon
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from GAG to GAA (both coding for glutamic acid) in the ginS gene results in a four-fold
expression improvement [14]. The observation was further investigated, showing that high-
expressing genes show a statistically significant overrepresentation of certain codons at early
sites after the start codon and mutational analysis implicated ribosome binding and translation
initiation as mediators of this effect [14-18]. In E. coli, several codons immediately 3' to the start
codon (+2, +3, +5, +7) are significantly more likely to be enriched in adenines than guanines
[15]. Synthetic constructs with varied codon composition further showed that increasing the
adenine content led to improvements in expression of up to 20-fold [18].
Construct First five codons
+1 +2 +3 +4 +5
TEV - LBT - PgIB ATG - GCT - TCT - GAA - AAC
LBT - PgIB-1 ATG - GGT - CCG - GGC -TTC
T7 - PgIB ATG - GCT - AGC -ATG - ACT
Table 2: Comparison of nucleotide content of the four codons following the start codon for
several constructs discussed.
Table 2 shows the first five codons (in which the start codon is +1) for T7-PglB, LBT-
PgIB-1, and TEV-LBT-PglB. Comparison of the codon composition of this segment highlights
the over-abundance of guanines and lack of adenines following the N-terminal start codon in
LBT-PglB- 1. In contrast, T7-PglB and TEV-LBT-PglB can be seen to have adenines present and
significantly fewer guanines, and no sequential guanines. This observation was encouraging
because it indicated that the reason for the low levels of LBT-PglB expression may be due to
codon composition in the early codons 3' to the start codon.
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Several other lines of reasoning can be used to support this hypothesis. The relatively low
publicity received from the papers published by the Isaksson lab can be understood in light of the
fact that determinants of expression level are accepted as being diverse, unpredictable, and
poorly understood. Heterologous expression of proteins in E. coli is accepted as an empirical
endeavor. Certain factors may generally influence the expression level of a protein one way or
another, such as localization, complex folding, poor solubility, and others; however, these
principles are guidelines and there exist many unknown reasons why some proteins are toxic or
inefficiently expressed in E. coli [19-21]. Therefore, empirical screens of conditions or fusion
tags is often the immediate course of action when a protein shows poor heterologous expression.
Fusion tags are frequently used in expressing and purifying proteins in E. coli and are
often themselves foreign to E. coli [22]. Importantly, these tags are commonly developed
empirically; therefore, those that are frequently used have been observed to express well in E.
coli and likely have unrecognized qualities that lead to efficient expression such as high adenine-
content in the early codons. One example to consider is the His-tag, which is very frequently
used in protein expression and purification and often is placed at the N-terminus of the gene. The
two histidine codons, CAC and CAT, are both notably lacking in guanines and each contain an
adenosine. Therefore, initiating synthesis with a His-tag would likely shield codon effects to
some degree if gene has guanine-rich early codons. In contrast to the empirical success of certain
fusion tags (which likely are unknowingly selected for properties such as a beneficial early
codon composition), the LBT sequence is based on an amino acid sequence synthesized using
SPPS and evolved to optimally bind lanthanides [8]. Therefore, expression of the sequence did
not contribute to selection. Expression of the LBT-protein fusions in the past included a His6-tag
at the N-terminus and the proteins have been small and soluble and otherwise well-expressed, so
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early codons, if unfavorable for translation initiation, would not be likely to greatly influence
expression [9,11,12].
A final compelling piece of evidence was discovered in a very recent Nature publication
from the Weissman lab at the University of California in San Francisco (UCSF) [23]. The study
sought to investigate the reasons behind the non-uniform speed at which ribosomes translate a
linear RNA substrate. It has been frequently reasoned that relative abundance of tRNAs for each
codons causes ribosomes to stall at certain regions of the transcript that have a high
concentration of the 'rare codons'. The authors did a bacterial genome-wide analysis using
ribosome profiling, or deep sequencing of ribosome-protected mRNA fragments and showed
that, surprisingly, codon bias was not associated with ribosome occupation of certain sites. The
pauses in translation resulted, rather, when the ribosome encountered Shine-Dalgamo-(SD)-like
features within coding sequences [23].
The Shine-Dalgarno (SD)-sequence plays a primary role in translation initiation in
bacteria. The sequence is a purine-rich region located roughly 9 nucleotides upstream of the start
codon on the mRNA transcript. A sequence at the 3'-end of the 16S rRNA base pairs with part or
all of the complementary the SD-sequence. (In E. coli, the complementary rRNA sequence is
ACCUCCUUA.) The SD-sequence adheres loosely to the motif UAAGGAGGU, but anywhere
from 3 to 9 nucleotides base pair with the 16S rRNA 3'terminal sequence. The degree of
complementarity affects initiation efficiency, and this factor is used as one way to regulate levels
of expression of individual proteins in bacteria. Importantly, if the length of complementarity is
very long and precise, ribosomes will bind to mRNA too tightly, disturbing the migration of the
ribosome.
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1 I I I I
1 ATGGGGCCTGGGTTCATCGATACCAATAACGATGGTTGGATCGAAGGGGATGAACTGCTGGCGGGATCCATG 72
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1 ATGAAACTGATTTTCATCGATACCAATAACGATGGCTGGATCGAAGGCGATGAACTGCTGGCCATTGGATCCATG 75
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Figure 5: LBT before and after optimization of nucleotide content.
The corresponding amino-acid sequence is shown below each of the nucleotide sequences.
Thus, the association of ribosome stalling with appearances of SD-like sequences is not
difficult to understand [23]. Generally, the ribosome translates the RNA transcript at steady-
state, but upon encountering and binding to a site of significant complementarity, a counter-force
is introduced, and the binding energy of the base pairs must be overcome for the ribosome to
continue moving along the transcript. The phenomenon is not frame-specific, as the ribosome
base-pairing occurs upstream of the start codon (thus upstream of the ribosomal 'A-site'.
Additional evidence that SD-like sequences caused ribosome stalling was provided by the ability
to change the translation speed of a gene by introducing or eliminating SD-like clusters without
changing the encoded amino-acid sequence. Importantly, it was observed and explained that SD-
like sequences that appeared closest to the N-terminus resulted in the most suppression of
translation [23].
With the above study in mind, the LBT nucleotide sequence was scanned for potentially
troublesome regions. In fact, it appeared that there were multiple regions containing clusters of
purines (Figure 5). It was determined that the nucleotide sequence of the LBT had not been
codon optimized when the gene was initially synthesized. The LBT has been fused to multiple
protein constructs (generally preceded by a His-tag) and is frequently used in the Imperiali lab.
Therefore, it seemed beneficial to optimize the nucleotide composition of the LBT. Optimizing
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the sequence and re-expressing LBT-PgB tests the hypothesis that the early codon composition
of the LBT is the cause of the poor LBT-PglB expression observed. In addition, the optimized
vector construct will be helpful to future users of the LBT in the case that optimization
successfully improves expression. Indeed, as shown in Figure 6, the optimized LBT-PglB
showed restored expression levels with comparable activity to the T7-PgIB enzyme.
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Figure 6: Purification of stocks of T7-PgIB and LBT-PgB.
SDS-PAGE (10%, Tris-Glycine) showing A. T7-PglB purification fractions, B. LBT-PglB
purification fractions, and C. the final stock solutions after combining protein-containing elutions
from each construct, concentration and buffer exchange. The first lane of each gel contains the
Precision Plus Protein Unstained Standard ladder (Bio-rad) with labeled molecular weights in
kDa. After normalizing the concentration for the fractions in part C., activity assays were carried
out (D). As previously observed, the LBT-PglB construct shows robust activity, which is only
slightly less than that of T7-PglB.
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Optimization of LBT-PglB luminescence
With a well-expressed, active, and stable LBT-PglB in hand, the luminescent studies
were initiated. However, unexpected obstacles once again presented themselves, delaying the
ultimate measurements, though providing important and relevant lessons that will be critical to
keep in mind in future experiments involving the LBT.
The first task involved validating that the LBT-PglB protein expressed was functioning as
expected with regard to luminescence intensity and lifetimes. It was thought that it may be useful
to have a well-behaved, soluble LBT-fusion protein for use as an internal comparison when
measuring basic binding and luminescent parameters for PglIB. Former members of the lab used
a LBT-ubiquitin fusion for characterization and development of LBT properties and the protein
construct is conveniently well-expressed, soluble, and previously charaterized [11,24]. A large
stock of His6-LBT-Ubiquitin was expressed, purified, aliquotted, and stored at -80 0C for use as a
standard comparison when measuring LBT-PglB photophysical properties. Figure 7 shows the
SDS-PAGE results of the purification. Bands above the 11 .6-kDa molecular weight of LBT-
ubiquitin stained on the anti-His western blot, appear in multiples of 11.6 kDa, and are apparent
on pictures of SDS-PAGE results from earlier purifications by former lab members (see Landon
Martin, dissertation); thus these bands are expected to represent higher-order oligomers rather
than impurities. The lifetime was determined for this stock of pure LBT-ubiquitin, which agreed
with previous measurements of the LBT-Tb'+ lifetime (Figure 8D) [10].
184
First purification over Ni-NTA column Anti-His western
+_F e smons FT washes *Aons
sLBT-ubiquitin: 1
11.8 kDa1
Second batchbind improved purity
FT washes elutions
sLBT-ubiquitin:
11.8 kDa
Figure 7: Expression and purification of an LBT-ubiquitin standard.
First purification on Ni-NTA resin showed impurities in the elutions (top left, Coomassie-
stained). The anti-His western blot (top right) verified that the major band was His6-LBT-
ubiquitin. Repeating Ni-NTA batchbind of elutions resulted in improved purity (bottom left).
Arrows indicate His6-LBT-ubiquitin monomer band.
It was expected that the LBT on two different proteins should give highly similar
luminescence intensities upon titration with Tb3+. This property would make it possible to
precisely measure the concentration of the enzyme in solution without doing a full titration, as
the addition of a given amount of Tb3+ should correspond to a specific intensity. A standard
internal comparison would be required to control for potential instrument or lamp fluctuations
however. The available LBT-ubiquitin was expected to provide this internal comparison in the
measurements of concentrations of PglB in pure and semi-pure solutions. Thus, LBT-ubiquitin
was titrated with Tb3+ at three concentrations and the luminescent data were recorded (Figure 8).
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Figure 8: Measurements of LBT-Ubiquitin intensities and lifetime.
Terbium ion titrations of LBT-Ubiquitin at 3 pM (A), 1.5 pM (B), and 0.5 gM (C). D: Lifetime
measurement of LBT-ubiquitin bound to Tb3+ at 544 nm agrees with previous measurements
made independently of the LBT-Tb 3 lifetime [10]. The data was fit to a monoexponential
equation in which I(t) is the intensity of emission at time t, 1(0) is the initial emission intensity, t
= time, and T is the lifetime, determined from the equation fit.
Additionally, LBT-ubiquitin was expected to serve as a standard for determining effects
of buffer components on LBT-Tb3+ intensities. As PglB is a membrane protein, detergent and
potentially additional stabilizing agents and salts may enhance monodispersion of LBT-PglB in
solution. As a result, the effects of increasing concentrations of several cations, glycerol, and
DDM on LBT-Ubiquitin luminescence were determined (Figure 9).
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Figure 9: Effects of buffer components on LBT-Ubiquitin luminescence intensities.
Addition of increasing Mg 2+ (A) and Ca2+ (B) into a solution of LBT-Ubiquitin saturated with
Tb3+ results in steadily decreasing signal intensity. (C) Presence of both 0.01% DDM and 25%
glycerol in minimal buffer (10 mM HEPES, pH 7.4, 100 mM NaCl) results in an improved LBT-
Ubiquitin luminescent signal relative to minimal buffer with levels of either or both DDM and
glycerol decreased.
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It can be seen in Figure 9 that addition of higher levels of cations leads to a decrease in
luminescence intensities measured for LBT-Ubiquitin. This is expected to be due to competition
with Tb3+ binding to the LBT when a high level of competing cation relative to Tb3+ is added.
The addition of non-Tb3+ cations was measured because PglB requires a (generally divalent)
cation for activity which can be substituted by Tb3+ (Figure 10). Therefore, it is hoped that
providing a low level of divalent cation to solutions of LBT-PgB would out-compete Tb3+ for
binding to PgIB cation-binding site and allow added Tb3+ to bind primarily to the LBT site.
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Figure 10: Tb3+ can satisfy cation requirement for T7-Pg1B activity.
Michaelis-Menten binding curves were determined using the activity (left) and luminescence
intensity (right) for a range of Tb3+ concentrations. The constant in the denominator represents
the estimated binding constant in pM. The above measurements were made using PglB without
LBT; thus, an amino acid capable of sensitizing Tb3+ is most likely present near the cation-
binding site.
Upon purifying the optimized LBT-PgIB, it was surprising to note that a concentration
measured using UV spectroscopy did not give expected luminescence intensities.
Confoundingly, the titrations showed that the enzyme was saturated at expected concentrations,
ensuring that the concentration measurements from UV absorbance are correct (Figure 11). (As
Tb3+ has low nM binding affinity for LBT, when the LBT is present at micromolar
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concentrations Tb3+ can be titrated into the protein solution, such that each Tb3+ atom added
binds LBT until all LBT is bound, at which point the luminescence will no longer increase with
further addition of Tb3 +.) Not only did the intensities fail to correspond to those expected based
on the LBT-ubiquitin standards, but the intensities were extremely low. With the low level of
intensity observed, luminescent measurements would carry a high degree of error. Therefore,
experiments were carried out in order to optimize the luminescent signal measured for LBT-
PglB. In addition, investigations were begun to determine the reason for the discrepancy in
signals for LBT-PglB and LBT-ubiquitin at the same concentrations of protein and Tb3+
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Figure 11: LBT-PglB shows relatively low luminescence intensities.
In order to determine the role of the phosphorimeter program settings on intensities, Dr.
Andrew Krueger of the Imperiali lab systematically varied several major parameters and
compared the emission intensities (Figure 12). A protein construct of EGF (Epidermal Growth
Factor) fused to an LBT labeled with a Europium sensitizer was used in these experiments; thus,
concentrations of Europium are noted rather than Terbium [25]. Based on the measurements, Dr.
189
Krueger concluded that changing the delay time does not affect emission intensities, which he
reasoned may be due to having flash lamp rather than a pulse laser. Increasing the sample
window (amount of time for data collection after flash) increases the intensity of the signal as
well as background without any beneficial effect on signal to noise (S/N). Lastly, Dr. Krueger
observed that increasing the number of flashes (the number of times pulse is repeated and
emission data collected at each point, then combined) improved intensities of signal much more
than intensities of noise, thus improving the S/N ratio.
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Figure 12: Effects of varying phosphorimeter parameters on luminescence intensity
(courtesy of Dr. Andrew Krueger).
LBT-EGF was used to demonstrate effects on intensity when varying gating delay, sample
window, and number flashes (clockwise from top left). The (cs 124) refers to the LBT labeled
with a Europium. sensitizer.
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Based on measurements made by Dr. Krueger, the number of flashes in a program was
considered the most beneficial parameter to increase in order to improve intensities of
luminescent intensities measured. Indeed, when this parameter was varied for LBT-Ubiquitin in
the presence of saturating Tb3+, the signal-to-noise was improved greatly. The same was
observed for LBT-PglB at non-saturating and then saturating Tb3+ (Figure 13).
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Figure 13: Improvement in luminescent intensities measured for LBT-Ubiquitin and LBT-
PgIB when the number of flashes is increased.
Increasing the number of flashes used when making luminescent measurements thus
appeared to universally improve intensities measured for LBT-fusion proteins in the presence of
Tb3+. However, it was still apparent that when instrumental parameters were held constant,
luminescent intensities measured for LBT-PglB differed from those of LBT-ubiquitin. At this
time, an additional LBT-fusion protein had been introduced: LBT-AglB. AglB, an archaeal
OTase, would be expected to work within the LRET framework similarly to PglB, and
measurements made using both OTases are expected to provide more information and legitimacy
to analysis of data. Another graduate student in the Imperiali lab, Michelle Chang, had expressed
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and stored solutions of LBT-AgIB. Thus, a comparison of luminescent intensities for three LBT
fusions was made. Equal concentrations of LBT-AglB, LBT-PglB, and LBT-ubiquitin were
made up in identical buffer solutions, and titrations were carried out for each protein identically
(Figure 14). It can be seen that each LBT-fusion protein approaches saturation of luminescence
at roughly 5 ptM, verifying that the concentration of each protein is also roughly 5 pM. But the
intensities for each fusion protein upon addition of increasing Tb3+ vary tremendously, with
LBT-AglB showing the highest, followed by LBT-ubiquitin, and LBT-PglB showing the lowest
(Figure 14).
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Figure 14: Comparison of luminescent intensities of three proteins fused to LBT.
Equimolar concentrations (5 pM) of LBT-PglB (A), LBT-AglB (B), and LBT-Ubiquitin (C) in
the presence of 10 mM HEPES, pH 7.4, 100 mM NaCl, 5% glycerol, 0.5 mM MgCl 2 were
titrated with Tb3+. Titrations were performed on the same day using the same stock solutions of
Tb3+ to minimize error. Intensity versus [Tb3+] is shown for all three constructs in (D) for
comparison. Michelle Chang of the Imperiali lab provided data for LBT-AglB.
The data shown in Figure 14 are extremely important because they overturn the
previously held assumption that the LBT luminescence intensity is not affected by the identity of
its fusion partner. In fact, the fusion identity matters greatly, though the reasons are not entirely
understood. Some effects can be explained by the presence or absence of a cation-binding site
within the fusion protein. Indeed, Figure 15 shows that the addition of Mg 2+ suppresses LBT-
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ubiquitin luminescence intensity (also seen in Figure 9). In contrast, final addition of 50 gM
MnCl2 deeply enhanced the LBT-PglB signal.
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PgIB + 0.5 mM Mg2+
-5.1 IM+ 50 pM Cl2
--5.1
3.8
-2.5
-1.11
0.47
-0.13
-- 0
I
3000
- LBT-Ubiquitin + 0.13 vM
Th3+
2500
LBT-Ubiquitin + 0.13 pM
Th3+ + 0.5 mM MgC2
2000
-- LBT-Ubiquitin
1500
1000
A.
12000
10000
8000
,6000
4000
2000
0
580 600
Figure 15: Additional data from luminescent titration experiments shown in Figure 14.
(Left) LBT-PglB titration is identical to that in Figure 14 except includes data from a final
measurement made upon addition of 50 pM Mn2 +. (Right) Before performing the titration shown
in Figure 14, LBT-Ubiquitin luminescence was measured first in minimal buffer (10 mM
HEPES pH 7.4, 100 mM NaCl, 5% glycerol), second after addition of 0.13 pM Tb3+, and third
after the addition of 0.5 mM MgC 2. (The spectrum measured with both 0.13 ptM Tb 3 and 0.5
mM MgCl2 is the same as the 0.13 pM Tb3+ spectrum shown in Figure 14 for LBT-ubiquitin).
In view of the above results, it became clear that LBT-Ubiquitin does not provide a
reliable standard for determining the effect of buffer components on LBT-PglB luminescence
intensities. Therefore, solutions of LBT-PglB were directly used to determine the optimal
conditions for LBT-PglB luminescence (Figures 16, 17, 18). Ultimately, it was determined that
LBT-PglB gives optimal luminescent intenties in the presence of 10 mM HEPES pH 7.4, 100
mM NaCl, 5% glycerol, 0.1% DDM, and 100 RM MgCl 2. In these conditions, and using a
program with the number of flashes set to at least 300, luminescence intensities were roughly
ten-fold higher than before optimization.
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Figure 16: Comparison of LBT-PgIB luminescence intensities and lifetime-curve fits in the
presence of three buffers.
Buffer A = 10 mM HEPES, pH 7.4, 100 mM NaCl, 5% glycerol; Buffer B = 10 mM HEPES, pH
7.4, 100 mM NaCl, 25% glycerol; Buffer C = 10 mM HEPES, pH 7.4, 100 mM NaCl, 5%
glycerol, 0.01% DDM. Buffer C gives the most accurate curve fit for lifetime (A) and greatest
luminscence intensity (B). It is the presence of DDM in Buffer C that accounts for the
enhancement, which is verified by the improvement of the signals for Buffer A and Buffer B
when 0.01% (final) DDM is directly added to the solutions (C, D).
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Figure 17: Effect of detergent identity and concentration on luminescence intensity of LBT-
PglB in presence of Tb3 *.
(A) One solution of LBT-PglB with saturating Tb3+ was divided into three aliquots and equal
volumes were added to each aliquot to give a final detergent concentration of 0.01 % DDM, 0.1
% DDM, or 0.1 % OG. The luminscent intensities and lifetimes (541 nm) were then measured
for each solution.
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Figure 18: Effect of cation identity and concentration on LBT-PglB luminescence.
(A) To a solution of LBT-PglB and saturating Tb3+, aliquots of MgCl2 were added to give a final
concentration of 100 ptM, followed by 200 pM, and finally an aliquot of MnCl2 was added to
give a final cation concentration of 200 pLM MgCl2 and 30 gM MnCl2. (B) Order of cation
addition is reversed to ensure presence of one cation is not influencing effect of second. 50 pM
MnCl2 added, followed by 100 IM MgC12
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Insertion of cysteine mutations to allow labeling of PglB with thiol-reactive acceptor dye
The two native, non-conserved cysteines in PglB were mutated to serine so that single
cysteines could be inserted at choice locations for site-specific labeling of the enzyme (this
construct was designated LBT-PglB-CxxC, representing the LBT-PglB with C28S and C408S
mutations). The double-cysteine mutant was shown to be active and expressed at wild-type levels
(Figure 19).
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Figure 19: Mutating native cysteines in Pg1B to serine.
Construction of PglB construct with both native cysteines mutated to serines shows WT-level
expression and activity. Left: Coomassie-stained SDS-PAGE and western blots with antibodies
to N-terminal tag (T7) and C-terminal tag (Hisio) indicate that the mutations do not significantly
alter the recombinant expression levels of PglB produced. Right: Activity assay results for equal
concentrations of WT-PglB and PglB-CxxC show that the cysteine mutations do not significantly
affect PglB activity.
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Locations for six cysteine insertions were chosen based on multiple criteria: first, the sites
should be accessible to labeling (solvent exposure) and unconstrained (to accommodate Bodipy-
dye); second, the predicted measurements at the mutations sites should be informative (in terms
of donor-acceptor distance as well as containing regions of conserved loops); third, the precise
residues that are mutated or neighboring a cysteine insertion should show low conservation of to
avoid significant disruption of activity or structure. Assessment of these criteria was made based
on existing structural and biochemical data.
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Figure 20: Efficiency (E) of LRET as a function of Tb 3 (donor) and Bodipy-TMR
(acceptor) distance (r).
The Ro value between this donor-acceptor pair has been determined to be 50.9 A. For a narrow
range above and below Ro the curve is approximately linear and the signal can be measured with
reasonable precision, as a small change in distance results in a significant change in signal, or
efficiency. As the distance from RO increases, the precision of the measurement drops off rapidly,
as the efficiency becomes less sensitive to small changes in distance.
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Additionally, the acceptor dye will ideally be placed within a given range of distances.
Accurate measurements can only be made when the acceptor and donor are within a short
difference from the Ro-value, or the value at which the LRET efficiency is 50 percent of the
maximum, and which is specific to a given donor-acceptor pair. As the difference between Ro
and the acceptor-donor distance increases, the LRET efficiency decreases or increases at a rate of
1/r 6 , where r is the distance between donor and acceptor (Figure 20). Importantly, the labeled
peptide is useful even if its binding site does not fall within the specified range; while specific
distances could not be ascertained, the change in LRET for the case in which the peptide is
unbound versus bound is almost certainly great enough to detect the presence of absence of
binding. Thus, the requirements for peptide binding or lack thereof may be investigated.
However, the thiol-reactive dye chosen to function as an acceptor, Bodipy-TMR maleimide, has
been used in combination with the LBT in LRET experiments in the past and the Ro has been
determined as 50.9A (Figure 21, [10]). Prior use of the dyes in an LRET experiment and
determination of RO simplifies the following analysis and provides confidence that measurements
made will be informative. Based on the structural data available, it is possible to estimate an
expected range of distances, and the Ro falls conveniently toward the center of this range.
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Figure 21: Structure and photophysical properties of LRET pair.
A. Depiction of the LBT bound to Tb3+. B. Structure of Bodipy-TMR. C. The excitation
(absorption) spectrum for Bodipy-TMR (circles), the emission spectrum of LBT-Tb3+ (smooth
line) and the extent of overlap.
The structure of the C. lari PglB was used to ascertain that the Bodipy-TMR label is an
appropriate LRET acceptor for the range of distances expected. In addition, the structure was
informative in choosing suitable locations for placement of cysteine mutations, which should be
close enough to Ro to make informative measurements (Figure 22). However, these
measurements are enormously approximate for several reasons. First, the PglB structure is only
resolved to 3.4 A, immediately adding a high degree of error. Additionally, while the sequences
of PglB from C. jejuni and C. lari are highly similar, they are not identical and residues at some
of the mutation sites differ between the two proteins; thus, the location of residues in the C. lari
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structure may not accurately represent the exact situation in the C. jejuni PglB. Finally, the
measurements are made between the site of mutation and the N-terminal LBT extension modeled
onto the PglB structure. In fact, the mutation sites provide the unique handles for conjugation to
Bodipy-TMR. The error increases as the size of the Bodipy-TMR is the component whose
distance from the LBT matters, and it is unknown the degree to which the LBT model represents
its actual position when expressed on the N-terminus of PglB.
Mutation Location r (A) E
1 F58C externaIop) 45 0.68
2 W88C ELI 44 0.71
3 M147C EL2 37 0.87
4 F308C EL5 61 0.25
5 N319C ELS 47 0.62
6 Y467C WWDYG' helix 57 0.37
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Figure 22: Sites of cysteines mutated into PglB to act as handles for LRET acceptor.
(A): Table listing the residues that were mutated to cysteines (in separate constructs) and the
general location of the protein in which they appear. The measurements were made in Pymol
between an LBT model at the N-terminus of PglB and each residue. (B) Efficiency (E) of LRET
as a function of Tb 3 (donor) and Bodipy-TMR (acceptor) distance (r), also shown in Figure 20.
(C): Snapshot of a model of the C. lari crystal structure shown in Pymol. The sections of the
protein in which the cysteines mutations appear are colored to coordinate with the identifiers
listed in the last column of the table on the right.
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Nonetheless, the chosen locations span a range of estimated distances within 10-15 A of
the RO value, increasing the likelihood that one or several will fall within an informative
measurement range. Even when precise distances cannot be accurately obtained, conformational
changes can be detected if the helix or loop containing the labeled cysteine undergoes a motion
from a distance of relatively low LRET efficiency to one of high efficiency. The cysteine-
mutants chosen were constructed by site-specifically mutating the LBT-PglB-CxxC construct,
providing unique handles to conjugate Bodipy-TMR.
Synthesis and labeling of cysteine-containing peptide substrates of PglB
In order to measure intermolecular LRET to gain information on location and order of
substrate binding, a substrate peptide (SP) containing a cysteine was synthesized to allow thiol-
specific labeling. A negative control (NC) peptide was also synthesized, which also contains a
cysteine and similar amino acid content, but lacks the consensus sequence. These peptides are
shown in Figure 23. The cysteine was added C-terminal to the consensus sequence in SP (and
close to the C-terminus in NC) because rough distance measurements of the N-terminus (location
of LBT) to the peptide bound in the C. lari structure indicates that this distance is closer to the
Ro-value than the distance between the N-terminus of the bound peptide and the N-terminus of
the PglIB structure (Figure 24).
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Figure 23: Two peptides synthesized for intermolecular LRET studies.
Top panel shows the substrate peptide, which contains the PglB consensus sequence as well as a
cysteine to provide a unique thiol group for labeling. Bottom panel shows the negative control
peptide, which also contains a cysteine for labeling. This peptide resembles the substrate peptide
in size, charge, and amino acid content, but lacks the consensus sequence required for
glycosylation by PglB.
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Figure 24: Distance measurements determine the preferred location of cysteines in
substrate peptide and site-specific mutagenesis.
Left: Depiction of the C.lari PglB crystal structure showing the bound peptide (N-terminus
closest to the bottom in this figure) in green sticks. The structure of the LBT is modeled at the N-
terminus of the protein (green) representing where it is genetically encoded. The measurement
indicates a distance of 49 A between the Tb 3 and the C-terminus of the peptide. The orange star
represents the location the Bodipy-TMR is expected to label a cysteine. Though the measurement
is a rough approximation, it falls in the nearby range to the Ro value for the LBT-Tb 3 complex
and Bodipy-TMR LRET pair, 50.9 A [10]. Right: Analogous figure to left, but in contrast the
location of an inserted cysteine for labeling and intramolecular LRET studies is being assessed.
Measurement and picture made in Pymol, PglB structure, PDB:3RCE [3], LBT structure, PDB:
1TJB, [8].
These peptides were synthesized by SPPS, purified by HPLC, and verified by MALDI-
MS analysis. Pure peptides were subsequently labeled with Bodipy-TMR, re-purified using
HPLC, and re-verified with MALDI-MS (Figures 25, 26). Luminescent measurements were
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performed to ensure that these peptides showed predictable behavior with virtually no non-
specific emission resulting from 280 nm excitation after a 50-gs delay and high overlap between
the LBT-PglB absorbance and the Bodipy-TMR peptide (Figure 27). Stocks of each were stored
in aliquots at -80'C for upcoming LRET experiments. Control assays showed that the negative
control peptide was indeed inactive and that the labeled substrate peptide shows similar activity
levels to the unlabeled substrate (Figure 28).
Substrate peptide
Ac-GDQNATYCG-NH2
991.8 Da
= 968.4 (neutral mass)
+ 23 (Na')
Mass (m/z)
aS
Negative Control peptide
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=1005.4 (neutral mass)
+ 23 (Na+)
[ - TM1 'T M 
Mass (m/z)
Figure 25: MALDI-MS validation of masses of peptides for LRET studies.
Left: Mass spectrum of substrate peptide solution with a major peak at 991.8 Da. Right: Mass
spectrum of the negative-control peptide with a major peak at 1028.8 Da.
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Figure 26: HPLC purification of Bodipy-TMR labeled peptides.
Bodipy-TMR absorbs at 544 nm (red), indicating the peaks containing the Bodipy-TMR. Peptide
absorbs at 280 nm (grey). The left-most peak represents unlabeled peptide, the center peak
represents labeled peptide, and the right-most peak corresponds to TCEP-adduct with the dye (all
determined using MALDI-MS).
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Figure 27: Bodipy-TMR is a favorable LRET acceptor to LBT-Tb 3 donor luminescence.
Left: Bodipy-TMR conjugated to a cysteine-containing peptide substrate shows high background
luminescence due to non-specific excitation by 280 nm light, which decreases the signal: noise
ratio in typical FRET experiments. After a 50 pis time delay, the background signal is virtually
eliminated, which demonstrates the benefit of LRET over FRET due to the longer lifetime of
several milliseconds. Right: Overlap of LBT-Tb3+ emission with Bodipy-TMR-thiol conjugate
absorbance. The maximum emission of LBT-Tb 3 at 544 nm due to excitement at 280 nm
overlaps well with the absorbance maximum Bodipy-TMR-thiol conjugate.
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Figure 28: PglB activity assays in presence of substrate and negative-control peptides.
Left: PglB activity assay shows that the negative-control peptide lacks activity, as expected.
Right: Bodipy-labeled substrate peptide (SP) shows similar rates to the peptide typically used in
PglB assays, indicating that the Bodipy conjugate does not significantly impede binding or
catalysis.
Initial LRET measurements
With the above components assembled, initial LRET measurements were made between
LBT-PglB and the labeled substrate peptide. The labeled substrate peptide (designated 'SP') was
titrated into a solution of LBT-PglB saturated with Tb 3 . Emission spectra were recorded and the
relative emission at the emission maximum for BODIPY-TMR (572 nm) shows corresponding
increases, indicating energy transfer is occurring (Figure 29). The increase in emission intensity
at 572 nm saturates when all LBT-PglB is bound by labeled peptide, and the intensity at 572 nm
can be plotted against the concentration of BODIPY-TMR SP to give a binding constant (Figure
29). The binding constant calculated below was in good agreement with activity-based
determinations of binding constants for the Ac-DQNAT substrate peptide to PglB, which
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average 1 pM. The agreement between these values is a good indication that the LRET measured
is representing native binding behavior of the substrate peptide to the enzyme.
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Figure 29: Increase and saturation acceptor emission.
(Left) Labeled substrate peptide was added in increasing amounts, resulting in signal saturation at
572 nm (emission maximum for Bodipy-TMR). The increasing intensities can be graphed versus
substrate concentration to approximate the binding constant of the peptide to LBT-PglB (right).
The curve gives a rough fit that estimates the binding constant at 0.77 pM, which agrees with
other estimates averaging 1 pM.
In order to translate the LRET measurements into distance measurements, lifetime
measurements were made in addition to measuring emission spectra upon addition of increasing
concentrations of labeled-SP (Figure 30). The corresponding decrease in lifetime is visible and
the saturation of the lifetime change can also be observed. By comparing the lifetime
measurements for LBT-PglB with saturating Tb 3 to LBT-PglB with saturating Tb3+ in the
presence of labeled SP (with labeled SP contributing roughly half of the signal to the measured
lifetime, determined by coefficients for each parameter in the biexponential curve), distance
measurements can be obtained (Figure 30). The lifetime values are used to calculate a transfer
efficiency, which is then used along with the known R0 value of 50.9 A to calculate the distance r
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(see Methods). The measurements shown in Figure 30 result in calculated distance values that
agree with expectations based on measurements made using the PDB file for the C. lari PgIB.
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Figure 30: LRET measurements with labeled peptide substrate.
Left graph shows the curves obtained with increasing concentrations of SP (substrate peptide,
labeled). The right graph shows only the curves obtained for LBT-PglB with saturating Tb3+
(monoexponential) and with the addition of 2.2 pM labeled acceptor peptide (biexponential).
Curve fits were made using Sigmaplot.
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Conclusion
In order to investigate aspects of the OTase mechanism outlined above, dynamic
distances of pure, active PgIB in its apo state and upon substrate binding will be measured using
intramolecular and intermolecular LRET. This approach utilizes the pure, stable form of PglB,
optimized by protocols described in previous progress reports. In contrast to structural data, this
strategy is uniquely valuable because it ensures the data derived from the studies is
representative of the active states of enzyme. Specifically, a lanthanide-binding tag (LBT) was
genetically fused to create the construct LBT-PgB-His1o. The terbium ion (Tb 3 )-bound LBT
will function as a donor chromophore. Cysteines have been introduced into specific locations of
PglB as well as substrate peptide, allowing specific labeling using a thiol-reactive acceptor dye.
Several fundamental tasks have been completed toward development of an LRET system
for measurement of dynamic properties of the OTase reaction. These tasks include synthesis,
labeling and purification of the substrate and negative-control peptides, the double-cysteine
mutant of PglB was constructed, expressed, and measured for activity; the double-cysteine
mutant was used as a template for site-directed mutagenesis reactions yielding constructs with
cysteines in desirable locations for labeling, the LBT-PglB construct was made in the pET24a(+)
vector and the cysteine mutants placed in this construct, and the LBT-Ubiquitin construct was
obtained and expressed and purified, and aliquotted for future use. The sequence of the codon
sequence of the LBT has been optimized, yielding much-improved expression of LBT-PglB. The
important discovery has been made that LBT luminescence intensity is dependent upon the
fusion protein and buffer conditions. Finally, LRET was observed between the labeled substrate
peptide and LBT-PglB with Tb 3 , and the measurement agrees with expectations based on the
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available structural data. This observation provides strong evidence that the system described is
capable of successfully measuring distances between substrate and OTase and potentially
between labeled cysteines within the enzyme and the N-terminal LBT. Remaining tasks in the
measurement of intermolecular LRET distances include the synthesis of an additional negative-
control peptide which is less similar in sequence to the substrate. Unfortunately, the negative-
control peptide that was synthesized and labeled (described above) shows LRET in addition to
the substrate peptide, indicating some non-specific binding is occurring.
For intramolecular LRET measurements, the cysteine mutants in the LBT-PglB construct
must be expressed and measured for activity to determine which are suitable to carry forward
into testing, the labeling of the cysteine constructs of LBT-PglB with Bodipy-TMR must be
optimized and each active mutant will need to be labeled. These experiments are currently being
applied to an archaeal OTase AglB in addition to PglB.
In addition to the goals set forth above and the progress made toward achieving them,
there exist additional possibilities for using the LBT-PgIB system to investigate further aspects
of the reaction. A growing possibility is the attainment of a non-disruptive label that can be
specifically conjugated to the Und-PP-glycan substrate. Probe design alone could be highly
informative as to which characteristics of the polyprenyl moiety accounts for key interactions
and binding specificity. Determining the location of the binding pocket for this substrate and the
role the first linked sugar plays in determining specificity would introduce opportunities for
glycoengineering to advance. Along these lines, understanding these mechanistic components
will have implications for strategies such as directed evolution and rational design of the active
site for a desired cause; for example, altering specificity may allow incorporation of new probes
in vivo that would enable valuable exploration into the role of specific glycans in bacterial
211
pathogenesis. Therefore, establishing in a stepwise manner the principles by which the OTase
accomplishes its unique chemical transformation is of vital importance for opening up various
avenues for studying N-linked glycosylation in a realm of contexts.
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Materials and Methods
Synthesis of substrate and negative-control peptides
Standard Fmoc SPPS was used in production of the cysteine-containing peptides. 200 mg of
Novapeg Pink Resin was agitated (with N2 (g)) in dichloromethane (CH 2CI 2) for ten minutes. The
Fmoc protecting group was removed from the resin and subsequent amino acids by agitating in
20% piperidine in dimethylformamide (DMF) for five minutes (3X). Washes were done in DMF
for 1 minute (5X) and CH 2C 2 for 1 minute (3X). The success of each coupling was tested using
the TNBS test. Initially, coupling conditions were 4 (resin) equivalents of PyBOP, 4 equivalents
of amino acid and 8 equivalents of diisopropyl ethyl amine (DIPEA) were agitated in DMF with
the resin for 1 hour. After difficulty coupling 5Y, all subsequent couplings were done with 6
equivalents of PyBOP, 6 equivalents of amino acid and 8 equivalents of diisopropyl ethyl amine
(DIPEA), agitated in DMP with the resin for 2 hours. When leaving the incomplete peptide
overnight, the reaction was washed, dried in N2 (g) and stored at 44C.
Purification and labeling of substrate-peptide and negative-control peptide
Peptides were purified by reverse phase HPLC with a Waters 600 automated control module on a
YMC C18 preparative column eluting with acetonitrile/water containing 0.1% TFA. For
detection, a Waters 2487 dual wavelength absorbance detector was used to record at 228 nm and
280 nm. Standard HPLC conditions were 5% acetonitrile for 5 minutes followed by a linear
gradient from 5% to 95% acetonitrile for 30 minutes. Purity was confirmed by analytical HPLC
and correct mass validated by ESI-MS on a Mariner electrospray mass spectrometer. Bodipy
labeling was performed on HPLC purified peptides with N-terminal amines. The lyophilized,
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pure peptide was dissolved in 0.1 M NaHC03 and the concentration was determined on a
Shimazu Spectrophotometer by recording the absorbance at 280 nm in 6 M Guanidine, using the
Extinction Coefficient of tyrosine (PC = 1280 M-l cm-1). 0.52 pmoles of peptide was added to
1.3 pmoles of BODIPY@ TMR (Invitrogen), dissolved in 50 pL of DMSO. The reactions were
shaken for 4 hours and then purified by preparative HPLC as described above except with
monitoring wavelengths at 280 nm and 544 nm (excitation max for BODIPY-TMR). Standard
HPLC conditions were a linear gradient from 7% to 100% acetonitrile for 30 minutes. Purity
wasconfirmed by analytical HPLC and correct mass validated by ES-MS on a Mariner
electrospray mass spectrometer.
Emission spectra
Luminescence titrations were conducted on a Horiba Jobin Yvon Fluoromax-3 equipped with a
Spex 1934D3 phosphorimeter in 1 cm path length quartz cells. Sensitization of Tb(III)
luminescence was carried out by exciting tryptophan at 280 nm and recording the luminescence
at 544 nm. A 315 nm long-pass filter was used to eliminate interference from harmonic doubling.
In addition to components explicitly mentioned, all solutions contained 10 mM HEPES, pH 7.4,
and 100 mM NaCl. Instrument settings were made using the experiment type "Phosphorimeter
Emission Acquisition" with the following settings: Increments = 3 nm, integration time of Is,
scan start of 450 or 500 nm, scan end of 600 nm, excitation wavelength = 280 nm, number of
scans = 1, sample window = 10 ms, delay after flash of 0.05 ins, time per flash = 40 ms, number
of flashes = 300, signal collected = S, slit widths of 5 nm (excitation) and 5 nm (emission).
Aliquots of Tb(III) ions were added, and the luminescence was recorded to obtain a titration
curve. These data were fit using the EXCEL or SIGMAPLOT as appropriate.
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Lifetime measurements
Lifetime measurements were recorded on a Horiba Jobin Yvon Fluoromax-3 equipped with a
Spex 1934D3 phosphorimeter. The intensity at 541 nm was monitored following a lamp pulse at
280 nm from a xenon flash lamp. Lifetime measurements were made using the experiment type
"Phosphorimeter Decay Acquisition by Delay" on the Fluoromax-P with the following settings:
Initial delay and delay Increments 0.05 ms, max delay of 10 ms, number of scans = 2 (averaged),
sample window = 20 ms, time per flash = 70 ms, number of flashes = 20, signal collected = S,
slit widths of 5 nm (excitation) and 10 nm (emission).
Calculation of distances using lifetimes
The lifetime decay data was fit to a monoexponential or biexponential curve:
monoexponential: I(t) = I(0)exp(-t/T)
biexponential: I(t) = I(0) 1exp(-t/ti) + I(0)2exp(-t/t 2)
where 1(t) luminescence intensity, t = time, 1(0) = luminescence at t = 0, t = lifetime.
SIGMAPLOT was used to determine the best curve fit.The LBT construct without acceptor
present is fit to a monoexponential curve (i.e. one lifetime) and the LBT in the presence of an
acceptor is fit to a biexpontential (i.e. two lifetimes: LBT influenced and not influenced by the
acceptor). These lifetime values can then be used to calculate the distance between the donor and
acceptor using the Frster equation:
r = Ro[(I/E)-1]1/6
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where r = distance, Ro = Frster radius (50.9 A for LBT-Tb+ and Bodipy TMR), E = energy
transfer. Energy transfer (E) is calculated directly from the lifetimes derived from the curve fits:
E = (- TDA) TD
where TDA = lifetime of the donor in the presence of the acceptor, TD = lifetime of the donor
alone.
216
References
1. Jaffee MB, Imperiali B (2011) Exploiting topological constraints to reveal buried sequence
motifs in the membrane-bound N-linked oligosaccharyl transferases. Biochemistry 50:
7557-7567.
2. Jaffee MB, Imperiali B (2013) Optimized protocol for expression and purification of
membrane-bound PgIB, a bacterial oligosaccharyl transferase. Protein Expr Purif.
3. Lizak C, Gerber S, Numao S, Aebi M, Locher KP (2011) X-ray structure of a bacterial
oligosaccharyltransferase. Nature 474: 350-355.
4. Xiao M, Selvin PR (2001) Quantum yields of luminescent lanthanide chelates and far-red dyes
measured by resonance energy transfer. J Am Chem Soc 123: 7067-7073.
5. Hemmila I, Laitala V (2005) Progress in lanthanides as luminescent probes. J Fluoresc 15:
529-542.
6. Heyduk T (2002) Measuring protein conformational changes by FRET/LRET. Curr Opin
Biotechnol 13: 292-296.
7. Lohse MJ, Bunemann M, Hoffmann C, Vilardaga JP, Nikolaev VO (2007) Monitoring
receptor signaling by intramolecular FRET. Curr Opin Pharmacol 7: 547-553.
8. Nitz M, Sherawat M, Franz KJ, Peisach E, Allen KN, et al. (2004) Structural origin of the high
affinity of a chemically evolved lanthanide-binding peptide. Angew Chem Int Ed Engl
43: 3682-3685.
9. Jee J, Ishima R, Gronenborn AM (2008) Characterization of specific protein association by
15N CPMG relaxation dispersion NMR: the GB I (A34F) monomer-dimer equilibrium. J
Phys Chem B 112: 6008-6012.
10. Sculimbrene BR, Imperiali B (2006) Lanthanide-binding tags as luminescent probes for
studying protein interactions. J Am Chem Soc 128: 7346-7352.
11. Martin LJ, Hahnke MJ, Nitz M, Wohnert J, Silvaggi NR, et al. (2007) Double-lanthanide-
binding tags: design, photophysical properties, and NMR applications. J Am Chem Soc
129: 7106-7113.
12. Schmidt HL, Sperling LJ, Gao YG, Wylie BJ, Boettcher JM, et al. (2007) Crystal
polymorphism of protein GB 1 examined by solid-state NMR spectroscopy and X-ray
diffraction. J Phys Chem B 111: 14362-14369.
13. Weinstock DS, Narayanan C, Felts AK, Andrec M, Levy RM, et al. (2007) Distinguishing
among structural ensembles of the GB 1 peptide: REMD simulations and NMR
experiments. J Am Chem Soc 129: 4858-4859.
14. Ding K, Louis JM, Gronenborn AM (2004) Insights into conformation and dynamics of
protein GBI during folding and unfolding by NMR. J Mol Biol 335: 1299-1307.
15. Bouvignies G, Meier S, Grzesiek S, Blackledge M (2006) Ultrahigh-resolution backbone
structure of perdeuterated protein GB I using residual dipolar couplings from two
alignment media. Angew Chem Int Ed Engl 45: 8166-8169.
16. Louis JM, Byeon IJ, Baxa U, Gronenborn AM (2005) The GB 1 amyloid fibril: recruitment of
the peripheral beta-strands of the domain swapped dimer into the polymeric interface. J
Mol Biol 348: 687-698.
17. Evans DA, Wales DJ (2004) Folding of the GBI hairpin peptide from discrete path sampling.
J Chem Phys 121: 1080-1090.
217
18. Byeon IJ, Louis JM, Gronenbom AM (2004) A captured folding intermediate involved in
dimerization and domain-swapping of GBl. J Mol Biol 340: 615-625.
19. Jana S, Deb JK (2005) Strategies for efficient production of heterologous proteins in
Escherichia coli. Appl Microbiol Biotechnol 67: 289-298.
20. Cornvik T, Dahlroth SL, Magnusdottir A, Flodin S, Engvall B, et al. (2006) An efficient and
generic strategy for producing soluble human proteins and domains in E. coli by
screening construct libraries. Proteins 65: 266-273.
21. Hartley JL (2006) Cloning technologies for protein expression and purification. Curr Opin
Biotechnol 17: 359-366.
22. Esposito D, Chatterjee DK (2006) Enhancement of soluble protein expression through the
use of fusion tags. Curr Opin Biotechnol 17: 353-358.
23. Byeon IJ, Louis JM, Gronenborn AM (2003) A protein contortionist: core mutations of GBl
that induce dimerization and domain swapping. J Mol Biol 333: 141-152.
24. Jee J, Byeon IJ, Louis JM, Gronenborn AM (2008) The point mutation A34F causes
dimerization of GB 1. Proteins 71: 1420-1431.
25. Reynolds AM, Sculimbrene BR, Imperiali B (2008) Lanthanide-binding tags with unnatural
amino acids: sensitizing Tb3+ and Eu3+ luminescence at longer wavelengths. Bioconjug
Chem 19: 588-591.
218
Marcie B. Jaffee
Doctor of Biology
Massachusetts Institute of Technology
103 Inman St., Apt 1, Cambridge, MA 02139
mbjaffee@gmail.com 802.752.0189
Skills and expertise:
Molecular Biology
Protein expression and purification
Membrane proteins
Glycobiology
Peptide synthesis
Enzyme kinetics, spectroscopy, radioactivity
Tissue culture, D. melanogaster, E. coli
- Coding in Python, Perl
" Bioinformatics: sequence and phylogeny analysis
. Excel, Photoshop, Illustrator, Endnote
- Works well independently and as a team
- Excellent writer
- Experimental design and troubleshooting
- Learns and completes tasks quickly
Massachusetts Institute of Technology, Cambridge, MA
Ph.D. Biology
Columbia University, New York, NY
B.A. Biochemistry with Honors
Cum laude
RESEARCH EXPERIENCE
Graduate Research- Dr. Barbara Imperiali
S
0
0
S
S
0
S
2007 - 2013
2003 - 2007
2008 - 2013
Massachusetts Institute of Technology
Departments of Biology and Chemistry
Biochemical investigation of oligosaccharyl transferase from enteropathogen C. jejuni
Membrane-protein expression, purification, and stability optimization in E. coli.
Improved purified recombinant protein yield from .05 to 5 mg protein per liter of culture.
Bioinformatic sequence analysis and computer-program development; successfully uncovered
conserved motifs within divergent membrane-protein sequences.
Construction and expression of mutant enzymes to investigate bioinformatic predictions.
Kinetic characterization of wild-type and mutant enzymes; pH profiles and substrate-specificity
Design and development of LRET system to study conformational changes and substrate binding
in enzymatic mechanism of PglB.
219
EDUCATION
Research Intern- Dr. L. Aravind Summer 2007
National Institute of Health
National Center for Biotechnology Information
* Bioinformatic analysis of E2-ligase folds using phylogenetic, structure and sequence data.
* Created and manipulated sequence alignments using Blast and various text editors.
e Analyzed structural data and constructed figures for the resulting manuscript using Pymol.
Undergraduate Research- Dr. Daniel Kalderon 2006 - 2007
Columbia University
Department of Biological Sciences
* Genetic analysis of Hedgehog signal transduction in Drosophila somatic stem-cells
* Worked collaboratively to maintain a screen to identify genes involved in ovarian somatic stem-
cell development and regulation: included passing large collections of fly cultures and separatingflies based on phenotypic features.
* Observed and recorded phenotypic changes in mutants isolated in screen.
Research Intern- Dr. Daniel Reich Summer 2005
Johns Hopkins University
Department of Physics and Astronomy
* Research into biophysical applications of magnetic nanoparticles in human cells.
* Fusion of ferromagnetic nanowires into human cell lines to direct localization and culture.
e Designed and initiated assembly of a 3-dimensional cell-culture matrix for use as an improved
model of cell growth in vivo.
TEACHING EXPERIENCE
Teaching Assistant
e Introduction to Experimental Biology, LAB 7.02, MIT (2011)
* Physical Chemistry of Biomolecular System, LECTURE 7.10, MIT (2009)
e General Chemistry, LAB, Columbia University (2006)
* Volunteer ESL teacher, Community Impact Center, Columbia University (2004)
Mentorship and Tutoring
* MIT: Undergraduate Women's Mentoring Program (2012)
e Private tutor for local high-school student in Chemistry I, Boston, MA (2010)
* Volunteer tutor in Molecular and Cell Biology, Columbia University (2006-2007)
RELATED WORK EXPERIENCE
220
Part-time research assistant- Dr. Rachael Neve 2009- 2013
MIT Viral Gene Transfer Facility
Interpreted molecular biology vector manipulation and constructed visually informative vector
maps using DNA and graphic software programs.
Environmental Health and Safety (EHS) Committee Member 2009 - 2011
MIT Department of Chemistry
* Participated in EHS committee meetings and lab safety inspections.
Contract technical writer 2004 - 2007
New World Encyclopedia Project
* Performed research on varied topics and wrote articles for online encyclopedia entries.
PUBLICATIONS
Jaffee, MB. & Imperiali, B. Optimized protocol for expression and purification of membrane-bound
PglB, a bacterial oligosaccharyl transferase Prot. Exp. Purif 2013, 89(2):241-50
Jaffee, MB.& Imperiali, B. Exploiting topological constraints to reveal buried sequence motifs in the
membrane-bound N-linked oligosacchal transferases Biochemistry 2011 50(35):7557-67
Burroughs AM, Jaffee M, Iyer LM, Aravind L. Anatomy of the E2 ligase fold: implications for
enzymology and evolution of ubiquitin/Ub-like protein conjugationJ. Struc. Biol. 2008 162(2):205-18
PRESENTATIONS AND POSTERS
Jaffee, M.B. Ethical dilemmas in biomedical sciences Northeastern University, Invited lecture in
Course ESC 153: Science, Technology, & Society. Boston, MA, February 14 h 2013. (Oral)
Jaffee, M.B. and Imperiali, B. N-linked glycosylation in bacteria: Tractable systems for biochemical
& biophysical analysis. MIT Annual Retreat for Building 68, Cape Cod, MA. June 11-12, 2012.
(Poster); and MIT Protein Structure & Function Supergroup, Cambridge, MA, May 1 0 th 2012. (Oral)
Jaffee, M.B. and Imperiali, B. Investigating the mechanism of the oligosaccharyl transferase. MIT
Graduate Biology Journal Club, Cambridge, MA, August 2 4 a 2009. (Oral)
Jaffee, M.B. Biochemical techniques to investigate the mechanism of an enzyme. Undergraduate
Biological Chemistry Club of Wellesley College, Wellesley, MA, May 5th 2009. (Oral)
Felton, J., Jaffee, M., Reich, D. Directed Cell Assembly with Magnetic Nanowires American Physical
Society March Meeting, Baltimore, MD, December 5 h 2005. (Poster)
221
